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1. Abstract 
English version: 
It has been well known for centuries that injuries to the spinal cord usually result in dramatic 
consequences for the individual concerned, without the prospect for healing or cure. The ancient 
Egyptians declared that spinal cord injury (SCI) was “a condition not to be treated”. In the late 
1800’s to early 1900’s, the Spanish neuroscientist Santiago Ramon y Cajal demonstrated that the 
consequences of SCI were due to the failure of the central nervous system (CNS) to regenerate. 
Until the late 1940’s, the outcome of any individual suffering from SCI, and in particular those 
victims of both world wars, led to the judgement, that “injuries to the spinal cord are essentially a 
death sentence. If the injury itself didn’t prove fatal, then the complications … became fatal” (C.T. 
Liverman et. al., 2005). 
Over the last 30 years, numerous research groups have focused on numerous aspects of acute or 
chronic spinal cord injury, and a wide variety of intervention strategies have been developed, some 
of which are currently subject to clinical trials. 
 Within the last years, more and more has been gained showing the potential for axonal regeneration 
within the nervous system of both experimental animals and humans. While most of the 
regenerative capacity has been identified in the peripheral nervous system (PNS), it could also be 
demonstrated that axonal regeneration and compensatory sprouting takes place in the injured CNS. 
Such findings have led to the development of a number of approaches to support or enhance the 
regenerative capacity of the PNS and CNS. Within the CNS, the main thrust of these approaches 
focused either on new surgical methods, novel medications, cell based intervention strategies or, 
most recently, the application of tissue engineering strategies using artificial matrices.  
The aim of the present study was based on the two latter approaches, combining growth promoting 
glial cells and a newly developed, highly orientated growth promoting three dimensional matrix in a 
tissue engineering strategy to bridge acute spinal cord lesions in adult rats. The matrix used in this 
study was a prototype in the early stage of development. The investigation therefore focussed on 
three main aspects:  
The first part of the thesis addresses the issue of cytocompatibility. Multiple qualities of porcine 
collagen matrices were tested with a range of neural cell types in order to choose the best quality 
matrix for subsequent experiments. Inferior quality matrices could be identified and removed from 
further investigation by the instability of the substrate or by the poor growth of cells. The best 
matrix supported orientated growth, migration and proliferation of PNS and CNS glia. Furthermore, 
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highly orientated axonal growth will be shown in an in vitro assay using adult rat dorsal root 
ganglion explants. 
The second part of the thesis addresses issue of the biocompatibility with adult rat CNS tissues. The 
matrix was found to be biocompatible for up to 6 months following implantation into the acutely 
lesioned adult rat spinal cord. The matrix was not rejected in any way. On the contrary, there was a 
moderate cell infiltration into the matrix, with early and steady vascularization as well as long term 
axonal regeneration. Differences in the extent of graft-host integration, depending on prior glial 
seeding of the matrix, were also investigated.  
The third and final part of the thesis addresses the functional consequences of implanting the matrix 
into acutely spinal cord injured rats. A clear and statistically significant improvement of food pellet 
retrieval was demonstrated by the objective “staircase test”.  
The data are discussed in the context of the latest developments in experimental SCI intervention 
strategies, in particular, those which employ tissue engineering approaches to attempt to bridge the 
lesion site.  
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German version: 
Verletzungen des Rückenmarks bedeuten seit Jahrhunderten dramatische Konsequenzen für die 
betroffenen Menschen, ohne Aussicht auf Heilung. Schon die alten Ägypter bezeichneten die 
Rückenmarksverletzung als „nicht heilbare Erkrankung“. In den frühen Jahren des 20.Jhr. zeigte der 
spanische Neurologe Santiago Ramon y Cajal, dass dies durch fehlende Regenerationsfähig des 
ZNS hervorgerufen wird. Bis in den späten vierziger Jahren wurden Verletzungen des Rückenmarks 
prinzipiell einem Todesurteil gleichgestellt. Wenn die Verletzung selber nicht tödlich war, so waren 
die späteren Komplikationen als tödlich angesehen. 
Während der letzten 30 Jahre wurden akute und chronische Rückenmarksverletzungen von einer 
Reihe von Forschungsgruppen untersucht, und eine Anzahl verschiedener Therapieansätze wurden 
entwickelt welche zum Teil schon in klinischen Untersuchungen evaluiert werden.  
So konnte mehrfach das Regenerationspotential von Axonen des Nervensystems sowohl im 
Tiermodell wie auch beim Menschen gezeigt werden. Obwohl vielfach das Regenerationspotential 
im PNS gezeigt werden konnte, so wurde auch deutlich, dass axonale Regeneration und 
Aussprossung auch im ZNS stattfindet. Hier fokussierten die Vielzahl der Forschungsansätze auf 
Operationsmethodik, Entwicklung neuer Medikamente, zellbasierten Interventionsstrategien oder 
erst kürzlich der Einsatz des Tissue Engineering. 
Der Ansatz dieser Promotionsarbeit war der kombinierte Einsatz der zellbasierten Intervention mit 
der Applikation eines neu entwickelten, hochorientierten Kollagenträgers als Überbrückungs-
strategie im akut verletzten Rückenmark. Die hier verwendeten Matrizes waren Prototypen im 
frühen Entwicklungsstadium, so dass drei Hauptschwerpunkte untersucht wurden: 
Als Erstes wurde die Zytokompatibilität durch die Applikation einer Reihe verschiedener 
neuronaler Zellen untersucht. Dabei konnten verschiedene Prototypen aussortiert werden und 
orientiertes Wachstum der Zellen auf den Kollagenträgern nachgewiesen werden, unter anderem 
das orientierte Wachstum von Axonen in vitro. Als zweiter Aspekt wurde die biokompatible 
Verträglichkeit der Kollagenträger für bis zu 6 Monate im akut verletzten Rückenmark von Ratten 
untersucht. Hierbei konnte eine moderate Zellinfiltration und Vaskualisierung der Matrix 
nachgewiesen werden und keine Anzeichen für eine Abstoßung erkannt werden. Als dritter 
Schwerpunkt wurde die funktionale Regeneration untersucht, bei der eine signifikante 
Verbesserung des Verhaltens nach Verletzung durch den „Staircase-test“ nachgewiesen werden 
konnte.  
Abschließend wurden die Ergebnisse im Kontext der letzten experimentellen 
Interventionsstrategien zu Rückenmarksverletzungen diskutiert. 
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2. Introduction 
2.1. The spinal cord and its injuries 
Traumatic spinal cord injury is a serious condition that was described and documented well before 
the birth of Christ. Ancient papyrus documents, recorded in hieroglyphs, described the now classic 
clinical symptoms of a patient who suffered paralysis following spinal cord injury (SCI, see Hughes 
HT, 1988). For millennia, the identification and “surgical” management of SCI remained 
unchanged, from that of ancient Imhotep, to Hippocrates, Benjamin Bell and others.  
At present, of all catastrophic injuries, spinal cord injury (SCI) is considered to be one of the most 
complex. It has tremendous impact on the person concerned, afflicting the functional, medical, 
psychological and economic well being of the patient and the patient’s relatives. SCI occurs most 
frequently in young males (2:1) of 20-35 years of age, with the injuries most often taking place 
during summer time weekends (http://www.howardnations.com/spinalcord/spinal_cord_intro.html). 
It is often sport or work related, but other causes include traffic accidents and, particularly within 
the U.S., weapon related injuries. 
Due to the complex nature of the spinal cord, the injury itself and the medical outcome is extremely 
variable. Being embedded in the vertebral canal and surrounded by a fluid-filled thick and durable 
ligament (dura mater), the spinal cord is exceptionally well protected from the environment. 
Nevertheless, variable traumatic or endogenous injuries can occur, e.g. by rupture of the dura mater 
or intervertebral disks, contusion or compression, fractured vertebra, ruptured internal or external 
blood vessels, cancer, penetrating injuries, resulting in a wide range of histopathological outcomes. 
The classification of each individual SCI also usually depends on two factors: the intensity of the 
injury and the segmental level at which it took place. The heterogeneity of the clinical outcome of 
SCI dictates that each case is to be treated on its own merits.  
Since the pioneering work of Santiago Ramon y Cajal, the scientist responsible for the first 
indications as to why lesioned CNS axons fail to regenerate (Ramon y Cajal, 1928), enormous 
effort has been expended in an attempt to understand the cellular and molecular mechanisms 
involved in SCI. During the first minutes and hours after the initial insult, a secondary degenerative 
process is initiated that is proportional to the magnitude of the initial insult (Profyris et al., 2004). 
Today, however, it is known that in some SCI early axonal regeneration can occur, but does not last 
for more than a few weeks due to the development of a growth inhibiting environment after injury. 
It is now widely accepted that this inability to undergo functionally relevant axonal regeneration is 
based on numerous factors, the most prominent of which include the lack of axon growth promoting 
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factors and the presence of a growth inhibiting glial environment at the site of injury. A reduced 
regenerative capacity of certain populations of CNS neurons has also been suggested but then 
relative importance of this has been steadily declining over recent years. 
The last two decades have witnessed major advances in the understanding of the cellular and 
molecular mechanisms responsible for preventing axonal regeneration, many of which have been 
the subject of extensive reviews (i.e. Schwab and Bartholdi 1996; Kakulas 1999; Dumont, 
Okonkwo et al. 2001; Dumont, Verma et al. 2001; Dumont, Dumont et al. 2002; Bareyre and 
Schwab 2003). On this basis, many different and highly innovative intervention strategies have 
been developed, some of which are currently undergoing clinical trials or even accepted for use in 
acute spinal cord injury. For example, methylprednisolone is administered acutely after SCI 
(Bracken et al., 1997), oscillating fields are applied chronically (Shapiro et al., 2005; Tator 2005) 
and most recently, autologous olfactory ensheathing cells have been implanted (Feron et al., 2005). 
However, despite these promising results, no clinical treatment to cure SCI is yet available, and 
more data has to be obtained to reach that goal. 
2.2. Endogenous nervous tissue repair 
After injury, successful axonal regeneration has been studied in the peripheral nervous system, 
where intense axonal sprouting can lead to the re-innervation of the target tissue (Ramon y Cajal, 
1928; Hall, 1989, Pollock, 1995). The efficiency with which severed axons reach their former target 
area greatly depends on the type, size and location of a lesion. When a transected nerve (i.e. knife 
cut) of the finger undergoes end-to-end tension-less suturing shortly after an insult, there is often an 
almost complete return of motor and sensory function, while an injury to the major nerves in the 
upper limb area may result in consistent functional deficits due to incomplete or complete failure of 
regeneration (Meek et al., 2002). 
Over recent years, it has become clear that the capacity of the peripheral nervous system to 
regenerate is mainly based on the growth supporting properties of the peripheral glia: the Schwann 
cells. In combination with infiltrating macrophages and fibroblast (Thomas and Jones, 1967; Bunge, 
1993), a fairly stereotypic series of events is activated after injury of a peripheral nerve (for review, 
see Zorochne, 2000). Briefly, the degradation of axons and myelin and the phagocytosis of their 
debris by macrophages after axotomy triggers de-differentiation of Schwann cells and secretion of 
an array of growth factors. The cytokine IL-1 triggers Schwann cell proliferation and release of 
growth factors, predominantly NGF, BDNF and NT 3/4 (Doubleday & Robinson, 1995; Spector et 
al., 1995). These Schwann cell-secreted growth factors support both axon regeneration and neuron 
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survival. The simultaneous, enhanced expression of the low affinity NGF-receptor and its 
presentation on the Schwann cell plasma membrane is thought to enhance axonal guidance by 
concentrating and presenting bound growth factors to re-growing axons (Taniuchi et al., 1998). This 
concept is further supported by the formation of bands of Büngner; linearly aligned bundles of 
Schwann cells within basal lamina tubes in the distal nerve stump, through which regenerating 
axons are guided to their former target area (Roytta & Salonen, 1988). Furthermore, the expression 
of the growth promoting extracellular matrix molecules, laminin and fibronectin, as well as the cell 
adhesion molecules NCAM and L-1 provide additional support and guidance for axon extension 
(Bunge, 1993; Martini, 1994). 
Once the sprouting axons re-innervate the target area and start to increase in diameter, Schwann 
cells start to re-form myelin. Numerous small calibre axons become ensheathed as bundles, while 
individual, larger calibre axons become myelinated (Bunge, 1990).  
While axonal sprouting and functional repair generally takes place in the PNS, no such mechanism 
takes place in the central nervous system. In spinal cord injury, few examples of endogenous axonal 
regrowth have been demonstrated (Curtis et al., 1993; Wang et al., 1996, Breshnahan et al., 1997; 
Brook et al., 1998). Longitudinally orientated regenerating axons and accompanying Schwann cells 
have been observed at the lesion site in post mortem human samples and experimental animals 
following SCI (Wang et al 1996; Brook et al. 1998). The invasion of the peripherally derived 
Schwann cells into the lesion site is thought to compensate, to some extent, for the lesion induced 
loss of the highly orientated cyto-architecture in normal CNS white matter (Suzuki & Raisman, 
1992). However, the spontaneous endogenous axon regeneration is variable in extent and appears 
not to originate from long distance projection neurons. Nevertheless, the secondary degenerative 
events after acute SCI exaggerate the pathology at the lesion site and contribute to the eventual 
extent of functional damage. 
2.3. Cellular and molecular mechanism involved in preventing 
CNS regeneration 
Following the reports about successful, graft-induced axonal regeneration in the adult mammalian 
CNS in the early 1980s, many groups focused on the problem why such regeneration was not long-
lasting. Researchers could show that astrocytes form a glial scar, effectively blocking axons from 
entering and crossing the lesion site. Oligodendrocytes were found to express myelin associated 
axon growth inhibitory molecules. Furthermore, axotomised CNS neurons demonstrated only 
transient up-regulation of regeneration associated genes (Tezlaff et al, 1991).  
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After injury, there is rapid proliferation of astrocytes close to the lesion, which adopt a reactive 
phenotype. Hypertrophic processes extend at the edge of the injury site; eventually forming a tight 
mesh supported by tight and gap junctions. Furthermore, extracellular molecules (i.e. collagen type 
IV) are up-regulated and have been reported to contribute in sealing the lesioned tissue from 
surrounding healthy tissues and assisting in the inhibition of axon regeneration (Reiser et al., 1983; 
Hatten et al., 1991; Davies et al., 1997). This mechanical barrier has the capacity to prevent axonal 
sprouting physically, but also secondary processes are taking place. Reactive astrocytes were found 
to also express growth inhibitory ECM molecules, especially tenascin-C and certain chondroitin 
sulphate proteoglycans (CSPG). These molecules are known to be axon repulsive in the developing 
CNS, and their reappearance in injured adult CNS might be a factor in the repulsive status of the 
glial scar (Fawcett & Asher, 1999). 
Myelin and myelin associated proteins may play a role in preventing axonal regeneration and 
reduced CNS plasticity as first reported by Caroni & Schwab (1988). It was shown that the newly 
discovered protein, originally termed IN-1, is present in the lesioned CNS and is repulsive to axonal 
regeneration. Blocking this molecule by antibody application resulted in improved regeneration and 
plasticity. The IN-1 molecule was recently cloned, sequenced and renamed NOGO-A (Chen et al., 
2000; Prinha et al, 2000). Other molecules, for example, myelin associated glycoprotein (MAG) 
(Mukhepadyay, 1994) and oligodendrocyte-myelin glycoproteins (oMgp) have also been found to 
Figure 1: Schematic diagram of consequences of secondary tissue injury to the adult mammalian spinal 
cord. 
After the (small) initial insult, damaged axons die or retract. Myelin and its breakdown products are released in the 
region of the lesion. Macrophages infiltrate the injury site to clean up dead or dying cells and reactive astrocytes 
form a glial scar, larger as the primary insult (secondary injury).  
Modified from: http://www.wingsforlife.com/?LNG=en&id=163&zid=78&m= 
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have potent axon inhibitory properties (Wange et al., 2002). All myelin associated proteins were 
found to be ligands for a non-specific receptor (termed NgR) (Fournier et al., 2001; Wang et al, 
2002), which is located on neurite growth cones. NgR probably modulates the initial signalling that 
promotes cytoskeletal alteration and the subsequent growth cone collapse observed after neurite 
contact with myelin. 
Oligodendrocyte precursors and macrophages also were found to be repulsive for axon 
regeneration. They express the glycoproteins NG2 and neurocan, both possessing axon repulsive 
properties in cell culture and in vivo (Dou & Lewin, 1994, Fawcett & Asher, 1999; Jones et al., 
2002). Recently, raised NG2 expression was found in the crushed peripheral nerve, but was not 
associated with Schwann cells. It was reported that cells from the perineurium or epineurium highly 
express NG2 within the lesion site and even cap damaged axons. In contrast to the CNS 
environment, axonal regeneration took place in the peripheral nervous system while NG2 
expression is high (Rezajooi et al., 2004). 
Macrophage infiltration in SCI has been reported to be less dominant compared to lesioned 
peripheral nerves, resulting in slower and less efficient clearance of myelin debris, effectively 
prolonging the exposure of regenerating axons to the axon growth inhibitory molecules (Schnell 
and Schwab, 1990). The role of macrophages in the lesioned CNS therefore appears to be 
dichotomous, having potential beneficial effects for tissue repair but also detrimental effects 
inducing secondary damage during the first week after SCI takes place (review, Blight 1992).  
2.4. Grafting strategies to enhance CNS tissue repair and 
behavioural recovery 
“Making the paralyzed walk and the blind see have been standards of medical miracle and magic 
for much of recorded history, and it is not surprising that they remain with us as potent cultural 
images” (Blight, 2002). The impact of CNS repair strategies is such that, even today, any successful 
approach draws much attention in the media, either with or without prior publication in peer 
reviewed scientific journals. Based on the high public attention of SCI worldwide and the severity 
of the injury on each victim’s personal life, the many research groups which focus on SCI have 
developed a variety of novel and ingenious intervention strategies to promote tissue repair. Due to 
the high variability of SCI, such strategies focus on either acute or chronic SCI-related problems. 
Therefore, some groups concentrate on neuroprotective measures in acute trauma, while other 
groups take much effort in developing regenerative and transplantation strategies in acute or chronic 
SCI. Last but not least, very promising functional improvements have also been demonstrated 
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following physical therapy approaches (for reviews see Blight, 2002; Houle & Tessler, 2002; 
Becker et al., 2003). 
2.4.1. Orientated biomaterials as bridging scaffolds 
One of the above mentioned strategies consists of removal of the damaged spinal cord tissue and 
replacement with a growth promoting substrate in order to introduce a bridge for regenerating 
axons, facilitating reinnervation of distal spinal cord areas. Such a strategy is intended to replace 
lost tissue with an axon growth promoting substrate.  
In the early 1980s, pioneering research demonstrated that adult CNS neurons could regenerate 
axons into implanted PNS or fetal CNS tissues (David & Aguayo, 1985; Nornes et al., 1983). In 
later developments, successful axonal regeneration could also be supported in experimental SCI 
following the implantation of fetal spinal cord, growth factor expressing cells and even artificial 
nerve grafts into the lesion site (Bunge, 1994; Anderson et al., 1995; Cheng et al., 1996; Liu et al, 
1999; Woerly et al., 1999). 
In some of these studies, axonal regeneration was improved within the implant, but the orientation 
of this growth within the graft was poorly controlled (e.g. Liu et al., 1999). In order to support 
orientated regeneration, a number of highly orientated axon growth promoting scaffolds have been 
developed. The first of such guidance channels to be developed were simple tubes wrapped around 
the proximal and distal stumps of transected spinal cord and filled with a gel-like matrix or glial 
cells (Xu et al., 1995; Montgomery et al., 1996; Xu et al., 1997). These guidance channels 
supported significant axonal in-growth, which mainly occurred on the inner surface on the tubes. 
Recently advances have resulted in the development of artificial 3D, highly orientated, 
biodegradable matrices (Teng et al., 2002; Patist et al., 2004; Huang et al, 2005) which have been 
transplanted into transected spinal cord of experimentally injured animals. The biodegradability of 
these scaffolds plays an important role in promoting tissue repair, since non-degradable matrices 
could induce a harmful foreign body response which may lead to the constriction of the scaffold 
(for review see Ziats et al., 1988). A foreign body response is characterized by the formation of 
foreign body giant cells, encapsulation of the foreign object, and chronic inflammation. One 
scenario could be the fusion of macrophages to foreign body giant cells, which in response to a 
foreign body secrete degradative agents such as super oxides and free radicals, causing localized 
damage to implants and host tissue. 
Many of these matrices have been constructed using natural or synthetic polymers such as alginate, 
collagen or α–hydroxy acids (for review see Novikova et al., 2003). Through polymerization 
processes or specific freezing techniques, 3D matrices were developed which contained a highly 
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orientated and porous inner structure, allowing orientated axonal regeneration within. Today, 
synthetic polymers made of poly (L-lactic acid) (PLA) or poly (lactic-co-glycolic acids) (PLGA) 
are widely used in combination with biological gels or glial cells in order to bridge experimental 
SCI. Such scaffolds have been shown to be biocompatible, completely resorbable and provoking an 
immune response that was similar to that seen following “simple” spinal cord injuries (Gautier et al, 
1998). Significantly, it has been recognized that such bioengineering approaches can also be used to 
import functional molecules and drugs into areas of pathology (Friedman et al, 2002). It is likely 
that soft and elastic biodegradable scaffolds, being either acellular or carrying selected cell lines, are 
likely to represent the first generation of biosynthetic implants to be used for spinal cord repair in 
humans. 
2.4.2. Olfactory ensheathing cells 
Some of the earliest intervention strategies involved the implantation of tissues or cell suspensions 
(obtained from many sources, including fetal spinal cord tissue, autologous Schwann cells, 
olfactory ensheathing cells and genetically engineered fibroblast) into the lesioned spinal cord (for 
review, see Reier, 2004). 
A promising population of donor glial cells is derived from the mammal olfactory system: the 
olfactory ensheathing cell (OEC). The olfactory system is a part of the mammalian nervous system 
where on-going neurogenesis takes place throughout adult life. After fulfilling their usefulness over 
a period of a few weeks in the nasal epithelium, the sensory neurons are replaced. The axons of the 
newly formed neurons must find their way to the olfactory bulb in order to establish functional 
connections, a process which only takes place during development in most other regions of the 
nervous system (Farbman, 1990). It was found that a specific glial cell type, possessing both 
Schwann cell and astrocytic characteristics, was able to support this on-going regeneration 
(Doucette, 1984; Ramon-Cueto & Nieto-Sampedro, 1992). In numerous studies, the axon growth 
promoting potential of this cell type was recognized in different in vitro as well as in vivo 
paradigms. The OEC were initially believed to be specialized Schwann cells, since they expressed 
similar antigenic characteristics (Table 1).  
The expression of NGFr (also known as p75) has been particularly useful in the identification of 
OEC in primary cultures of the olfactory bulb and olfactory nerve. Such primary cultures could be 
distinguished as containing p75-positive Schwann-like cells (S-cells) and p75-negative, astrocytes-
like cells (A-cells). It has been shown that p75-purified OEC were able to promote axon growth in 
vitro and form a myelin sheath (Devon & Doucette 1992; Santos-Silva & Cavalcante 2001). Under 
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these conditions, they were also able to intermingle with cortical astrocytes while peripherally 
derived Schwann cells could not (Lakatos et al., 2000).  
 
Molecular marker Schwann cell OEC Astrocyte 
NGF-r (p75) + + - 
PSA-NCAM + + - 
GFAP weak weak + 
O4 + + - 
GalC + - - 
3-PGDH nd + + 
Neuroligin-3 + + + 
P0 + + - 
 
Table 1: Glial cell markers.  
   Note that Schwann cells and OEC do share a very similar molecular profile. 
   nd: not detectable   Modified from Wewetzer et al. (2002) 
 
OEC have been implanted into a number of animal models of spinal cord injury, where their 
capacity to myelinate axons was supported, but also their ability to promote axonal regeneration 
was observed (Franklin et al, 2000; Imaizumi et al, 2000; Raisman, 2001). It was found that OEC 
are able to migrate in the CNS parenchyma, while Schwann cells show signs of hypertrophy when 
implanted into lesions close to host astrocytes (Ramon-Cueto et al., 1998). Such data have led to the 
development of the wide-spread notion that highly (p75) purified OEC might be the donor cell 
population of choice to promote tissue regeneration. However, it is now clear that other groups also 
favour a mixture of OEC with their accessory cells, i.e. the “A cells” (Raisman, 2001; Santos-
Benito & Ramon-Cueto, 2003). Most recently, autologous OEC were subjected to a first clinical 
trial, showing the safety of the use of these cells in SCI in humans (Feron et al., 2005). 
2.5. Hypotheses tested in this thesis 
The main hypothesis of this thesis is that implanting a newly developed, highly orientated 
biomaterial into lesions of the acutely injured rat spinal cord would support orientated axonal 
regeneration compared to lesioned only animals (Figure 2) which did not receive a graft.  
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Furthermore, it was hypothesized that the combination of the biomaterial with purified OEC would 
greatly enhance axon regeneration and induce functional repair in the lesioned animals.  
 
To investigate the validity of these hypotheses; this project is intended to clarify the following 
points:  
• The establishment of standardized procedures allow the generation of NGFr purified 
cultures from adult rat olfactory bulbs in high numbers and of reproducible quality 
• Purified OEC combine with the orientated collagen type I material 
• The matrix can promote orientated growth by a range of neuronal and non-neuronal cells in 
vitro 
•  Cell-free and OEC-containing matrices are biocompatible in vivo 
• Axonal regeneration in acutely lesioned rat spinal cord is orientated within the matrices, and 
OEC combined matrices further support enhanced axonal regeneration 
• Functional recovery of the acutely lesioned adult rats takes place and the intensity of the 
recovery is sorted as OEC-matrices > non-seeded matrices > lesion only 
Figure 2: Matricel matrix implantation strategy in this thesis. 
Tissue is dissected out of the spinal cord in a partial transection. An 
appropriate sized collagen scaffold is implanted into the tissue gap, bridging 
the cut and lesioned nerve fibre tracts. 
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3. Materials and Methods 
3.1. Cell culture constituents 
This chapter describes the materials used for the cell culture experiments. It includes culture media 
ingredients and tissue culture plastics. 
3.1.1. Tissue culture media and buffers 
All solutions were diluted in distilled water (Milli-Q UF Plus, Millipore, Billerica, USA) unless 
stated otherwise. Solutions used for tissue culture were either autoclaved (30min, 121°C, 2 bar) or 
sterile filtered (0.22µm). The preparation of non-commercial media, solutions and buffers is 
described below. 
3.1.2. Commercial media 
All commercially available cell culture media were from obtained from GIBCO throughout the full 
length of the thesis. This was to ensure a maximum degree of reproducibility of the results 
according to the cell culture protocols presented in a later chapter. 
 
MEDIA      SOURCE 
DMEM / F12 nutrition mix GIBCO 
Neurobasal-A medium GIBCO 
Dulbecco’s modified eagles Medium, high 
glucose (4.5g/l) 
GIBCO 
Hanks’s balanced salt solution, without 
magnesium and calcium, HBSS 
GIBCO 
Neurobasal-A Medium GIBCO 
Trypsin/EDTA, 0.05% in HBSS GIBCO 
 
3.1.3. Chemicals and reagents 
Biotinylated dextran amine (12kDa, BDA) Molecular Probes 
Bovine serum albumin (BSA), Fraction V Serva Electrophoresis, Heidelberg 
Diamidinophenylindole (DAPI) Roche Diagnostics, Mannheim 
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Diaminobenzidine (DAB) SIGMA Aldrich, Taufkirchen 
Dimethylsulfoxide (DMSO) SIGMA Aldrich, Taufkirchen 
Forskolin ICN 
Gentamicin SIGMA Aldrich, Taufkirchen 
Gluthaldehyde MERCK 
Gluthamax-I, 200mM (100x) GIBCO 
Goat serum SIGMA 
Injectable water Delta Pharma, Pufflingen 
L-Glutamine (100x) GIBCO 
Paraformaldehyde MERCK 
Penicillin / Streptomycin (100U) PAA 
Percoll GE Healthcare 
Phosphate buffers MERCK 
Poly-L-Lysine SIGMA Aldrich 
Sucrose MERCK 
Triton-X-100 MERCK 
 
3.1.4. Supplements and growth factors 
B27 GIBCO 
Basic fibroblast growth factor (b-FGF) Peprotech 
BSA Path-o-cyte Pentex, Gibco 
Fetal calf serum, GOLD PAA Diagnostics 
Heregulin (HRG ß1) R&D Diagnostics 
Insulin SIGMA 
Progesterone SIGMA 
Putrescine SIGMA  
Selenium SIGMA 
Thyroxine SIGMA 
Transferrin, apo GIBCO 
Tri-Iodo-Thryronine, T3  SIGMA 
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3.1.5. Kits 
The following kits were for tissue culture and immunhistochemistry: 
CyQUANT cell proliferation assay Molecular Probes 
Vector ABC Kit (elite and standard) CAMON LABOR 
MiniMACS Starter Kit Miltenyi Biotech 
MiniMACS MS-Columns Miltenyi Biotech 
 
3.1.6. Tissue culture plastics  
4, 6, 24, 96-wells  Nunc 
25cm², 75cm² tissue culture flasks  Greiner 
3.5cm, 8cm, 12cm petri-dishes  Nunc 
Serological pipettes  Greiner 
Sterile filter pipette tips  VWR 
Sterile syringe filters (0.22µm)  PAA 
8-Well chamber slides  Nunc 
Superfrost-plus objective slides  Menzer 
Superfrost-plus GOLD objective slides  Menzer 
Syringes  ROTH 
Cellware, precoated   BD Biosciences 
 
3.1.7. Animals  
Animals used for cell harvesting or surgical procedures were young (3 month old) adult female SD 
or LEWIS rats. All animals were handled according to the federal law and rights regulations (Code: 
50.203.2-AC 23, 21/00) and the ethic committee of the university hospital RWTH Aachen. The 
following list summarizes the numbers and use of the animals: 
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Rat strain use number 
Lewis Cell harvesting 11 
Lewis Implantation study 80 
Sprague Dawleys (SD) Cell harvesting 7 
SD Implantation study 28 
 Table 2: Animals used 
3.1.8. Source of cell gifts 
Ready prepared cell types used besides adult rat olfactory ensheathing cells, dorsal root ganglia and 
Schwann cells were mainly gifts and listed as following: 
 
Cell type Source Tissue specification 
Early post-natal olfactory 
ensheathing cells 
Dr. Sue Barnett, Glasgow 
(UK) 
25cm² cell culture flasks 
Human post mortem 
olfactory ensheathing cells 
Prof. Dr. Didier Martin, 
Liége (B) 
Olfactory bulb tissue of three 
donors (78 and 82 years old 
female, 86 years old male) 
Post-natal rat cortical 
astrocytes 
M. Sc. Ronald Deumens, 
Maastricht (NL) 
25cm² cell culture flasks 
Human astrocyte cell line, 
U373 
Dept. of Pathology, UK-
Aachen 
2.5ml liquid nitrogen tubes 
Table 3: Animal cell sources from other institutes 
3.2. Collagen-based materials 
A number of type-1 collagen-based biomaterials were used in this study, most of which were 
provided by Matricel GmbH, Herzogenrath. “1.5%” and “3.8%” collagen type-1 matrices for 
preliminary investigations were also produced at the Helmholtz Institute of Technology, Aachen. 
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3.2.1. Non-orientated type-I collagen matrices 
3.2.1.1. Matricel “ACI-Maix” membranes 
ACI-Maix collagen type-I membranes are cell carriers used for autologous chondrocyte 
implantation (ACI®).  
Briefly, porcine type-1 collagen is harvested from interstitial membranes harvested in EC approved 
slaughter-houses (in compliance with directive EN 12442-2). Membranes are manufactured under 
strict quality control conditions (ISO 9001 and ISO 13485) using a series of chemical and 
mechanical treatments. Remnants of the chemical purification process (acids, organic solvents) are 
removed to prevent any toxic effect after exposure of cells to the ACI-Maix collagen membrane. 
ACI-Maix is a highly purified collagen preparation as indicated by the very low levels of non-
collagenous protein marker molecules such as cysteine (< 0.5%), tryptophan (< 0.1%) and 
hexosamines (< 0.5%). ACI-Maix is provided sterile (gamma irradiation) and endotoxin free.  
 
 
           Figure 3: ACI-Maix label (from Matricel GmbH) 
 
The safety of ACI-Maix, with respect to the transmission of infectious agents, has been established. 
ACI-Maix has a CE-mark for use as a covering membrane in autologous chondrocyte implantation 
techniques (Figure 3). The cytocompatibility and biocompatibility of 3 slightly different membranes 
(charges) have been tested in the present investigation to assess the best biochemical product 
properties for the production of three dimensional matrices. All matrices were of 5x4cm, with a 
smooth and a fibrous side and were delivered in gamma sterilized paper bags. The following 
charges were used: 
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Charge  Denaturation 
temperature before 
sterilization 
Denaturation temperature after 
sterilization 
03102ppt-1 60.1°C 44.7°C 
04002ppt-1 59.9°C 46.8°C 
04102ppt-1 60,0°C 48,0°C 
Table 4: Preparation and lot numbers of ACI-Maix membranes. 
The first three numbers of the lot numbers were used in this study to differentiate the  
membranes during experimental tests. 
 
3.2.2. Orientated three dimensional collagen matrices 
3.2.2.1. General 3D collagen matrix lyophilisation / fabrication 
Collagen matrices were prepared according to the patented uni-directional freezing process, as 
described previously (Schoof et al., 2001). Briefly, a suspension of 1.5 wt% porcine collagen was 
prepared. To control pore size, 1.5 wt% acetic acid and HCl was added, resulting in a pH of 3.2. 
The suspension was then solidified in a gradient freezing stage, the temperature of the upper and 
lower surfaces being controlled to maintain a fixed temperature differential and cooling rate. The 
resulting block of collagen matrix was freeze-dried, sterilized and was endowed with a highly 
uniform and porous microstructure with an average pore diameter of 50µm 
3.2.2.1.1. Helmholtz institute 3D matrices 
Helmholtz matrices were delivered in ParaFilm-sealed petri dishes. No information about quality 
details of the material could be gathered besides percentage of acidic acid used for pore formation 
during the fabrication process. Different sized matrices within the petri dishes were labelled with 
either 1.5% or 3.8% acidic acid use. All matrices used were considered to be sterile. No additional 
sterilization efforts were performed (e.g. UV-light, heat, ethanol), as recommended from the 
product quality team of the Matricel company. These matrices were solely used for preliminary 
experiments, obtaining qualitative results only. 
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3.2.2.1.2. Matricel 3D collagen matrices 
Matricel collagen matrices slightly differ from the previously described orientated matrices. The 
source of the collagen was the same as that used for ACI-Maix membranes being of porcine 
membrane collagen. 
Since the orientated Matricel collagen matrix was a prototype at the beginning of this study with 
relatively little preliminary in vitro data being available, it was important to test three different 
matrices which had significant differences in certain production stages (confidential data), resulting 
in different denaturation temperatures as listed below: 
Charge No. Crosslinking media Crosslinking 
reagents 
Denaturation 
Temperature before 
sterilisation 
Denaturation 
temperature after 
sterilisation 
SPGX 01 confidential confidential 99.1°C 89.0°C 
SPGX 02 confidential confidential 74,0°C 63.0°C 
SPGX 03 confidential confidential 70.0°C 61°C 
Table 5: Details of three Matricel collagen matrices.  
Altered crosslinking chemistry resulted different denaturation temperatures of each material tested. The chemicals 
used for crosslinking are known to the author, but must be kept confidential on request of Matricel GmbH. 
 
To assure blinded assessment of in vitro test conditions, these properties were only disclosed after 
the studies. Further, more limited in vitro studies were performed using a collection of different 3D 
matrices delivered in a 24-well tissue culture plate, as shown below (Fig. 4). All matrices within 
this collection had significant differences in production, including qualities of SPGX 01, 02 and 03. 
     
Figure 4: Matricel collagen sponges label. 
Matrices used in this study were obtained in these or similar containers.  
To assure “blinded” test result from the researcher, no further details  
about the matrix properties are supplied. 
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3.3. Cell culture protocols 
3.3.1. Tissue culture media 
Generally, all media used for cell culture were based on specific basal media supplemented with 
different ingredients. The combination of all ingredients of each media used was performed under 
sterile conditions. The recipe for each media is listed below. 
3.3.1.1. ONEC medium 
ONEC-medium is composed of DMEM/F12 medium, supplemented with 10% FCS, glutamine 
(1mM), penicillin/streptomycin (1:1000) and gentamicin (1:1000) (e.g. Ramon Cueto, 1992; 
others). 
3.3.1.2. SCOTTS medium 
SCOTTS medium is a growth enhancing, reduced serum containing medium prepared according to 
the original protocol from Dr. Sue Barnett, Glasgow (Barnett et al. 1993; Alexander et al. 2002; 
Barnett and Roskams 2002), supplemented with Sato-Mix (Bottenstein et al. 1979; Bottenstein and 
Sato 1979) with minor modifications.  
Two media (recipe listed in table 6) have been prepared in parallel, SCOTTS-GF (containing 
growth factors heregulin, bFGF and forskolin) and SCOTTS-No GF (without heregulin, bFGF and 
forskolin). Both media were mixed to adjust the final concentration of growth factors. 
 
Supplement Amount 
DMEM, high glucose 190ml 
ACM (astrocyte conditioned medium), sterile filtered 
(see 2.3.5.) 
50ml 
glutamine, (200mM) 2.5ml 
insulin (10ml/mg) 200µl 
gentamicin (10mg/ml) 200µl 
transferrine, apo 20mg/ml in HBSS 1ml 
bFGF 50µg/ml in HBSS 160µl 
heregulin ß1 (50µg/ml) in HBSS 160µl 
Forskolin ( 8mM in DMSO) 1µM 
SATO-mix, sterile filtered (see below) 4.4ml 
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SATO Mix 
BSA Path-o-cyte 5.72ml in 200ml HBSS 
Putrescine 322mg in 200ml distilled water 
Thyroxine 8.0mg in 20ml ethanol 100% 
Tri-iodo-thryronine, T3  6.74mg in 20ml ethanol 100% 
all combined, and 2ml of the following added: 
Progesterone 12.46mg in 20ml ethanol 100% 
Selenium 7.74mg in 20ml distilled water 
Table 6: SCOTT GF Medium recipe. 
3.3.2. Adult rat olfactory ensheathing cell culture 
Primary ensheathing cell cultures from adult female Sprague Dawley and Lewis rats (body weight 
200-300g) were prepared as described by others (Alexander et al., 2002; Ramon-Cueto & Nieto-
Sampedro, 1992). Under terminal halothane anaesthesia, the animals were rapidly decapitated. The 
head was sterilised by immersion in 70% ethanol. Bone rongeurs were used to open the skull and 
expose the olfactory bulbs. The pia was opened and olfactory bulbs were then carefully removed, 
immersed into a Hanks balanced salt solution (HBSS) filled petri-dish and placed over crushed ice. 
Under a dissecting binocular microscope, blood vessels and smaller pia were delicately picked away 
from the tissue. The brown superficial olfactory nerve layer and glomerular layer were separated 
from the deeper lying white matter regions by blunt dissection using No. 5 and No. 7 forceps. The 
olfactory nerve layer was transferred to fresh HBSS and chopped into small pieces. After further 
washing steps in HBSS, the pieces of olfactory nerve were digested by 15 minute incubation in 
0.05% trypsin/EDTA (Gibco, 37oC). After stopping the enzymatic reaction with DMEM/F12-
medium containing 10% FCS, the tissue pieces were spun at 1200 RPM (G = 1024) for 3 minutes. 
The supernatant was replaced with 1ml of ONEC-medium (see 3.3.1.1.) and the tissue pieces were 
gently dissociated. A volume of 4ml fresh ONEC-medium was added and the cell suspension was 
plated onto 25cm² culture flasks, pre-coated with poly-L-lysine (PLL, Sigma, 0.01%) and 
maintained for 4 days in the incubator (5%CO2, 37oC). Medium was than changed to a 50/50 
composition of ONEC medium and SCOTTS GF medium (3.3.1.2.), removing nerve debris, non-
adherent and dead cells. Cells were kept in culture by changing the 50/50 composition of culture 
medium every 2-3 days. By 10 days, primary cultures had usually reached confluency. 
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3.3.2.1. MiniMACS cell purification 
Confluent primary cultures of rat adult OEC were purified for p75 (NGF-receptor)-positivity using 
a polyclonal p75 antibody and the magnetic cell purification kit (MiniMACS) from Miltenyi. The 
purification method was carried out by following the manufactures protocol for goat-anti-rabbit 
micro-beads (http://www.miltenyibiotec.com/datasheets/files2/DS130-048-602-03.pdf). Primary 
polyclonal rabbit anti-p75 antibody (CHEMICON) was diluted to 1:1000 and the OEC were 
incubated in the primary antibody for 10 minutes at 4°C. 
After purification, positive cells were incubated in SCOTT-GF medium while negative cells were 
incubated in ONEC medium. Samples of cells before and after purification were taken to assess 
purity using immuncytochemical methods as described below. 
3.3.3. Post-natal rat olfactory ensheathing cell culture 
Post-natal rat olfactory ensheathing cells (pnOEC) were transported in ambient temperature culture 
flasks by overnight courier service from Dr. Sue Barnett’s laboratory in Glasgow, Scotland. These 
cells were kept in SCOTT-GF medium in the incubator and passaged regularly. To slow down cell 
division rate, medium was changed to mixtures of 1:1, 1:2 or 1:4 SCOTT GF: SCOTT No GF 
media as required.  
3.3.4. Post-mortem human olfactory ensheathing cell culture 
Post-mortem human olfactory ensheathing cells (hOEC) were prepared similarly to adult rat 
olfactory ensheathing cells. Olfactory bulbs from two cadavers were separated into grey and white 
matter. Grey matter was chopped into smaller pieces and treated enzymatically to attain a cell 
suspension. The suspension of cells was distributed equally into three 25cm² poly-L-lysine coated 
culture flasks and incubated (1:1 ONEC / SCOTTS GF medium) until confluency was reached. The 
cells were then subjected to the MiniMACS purification step as described above. The use of this 
tissue was approved by the ethic committee from the RWTH Aachen as well as the University 
hospital of Liège. 
3.3.5. Post-natal rat cerebral astrocyte cultures 
Early post-natal rat cerebral cortex astrocyte cultures were transported in 25cm² ambient 
temperature flasks from Ronald Deumens, MSc, Maastricht (NL). The cells were kept in ONEC 
medium until confluency and passaged regularly for higher cell numbers. When changing the 
medium after 2-3 days, old medium was aspirated and stored at -20°C (astrocyte conditioned 
medium, ACM) and new ONEC medium was added to the cultures. 
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3.3.6. Human astrocyte cell line cultures 
Human astrocytes (cell line U373, http://www.biotech.ist.unige.it/cldb/cl4964.html) were derived 
from two frozen aliquots and cultured similar to rat astrocytes. Old medium was aspirated and 
stored at –20°C. 
3.3.7. Adult rat Schwann cell cultures 
Adult rat Schwann cells (SC) were derived from six sciatic nerves of freshly killed adult Lewis and 
Sprague Dawley rats following the protocol of Weidner and colleagues (1999). Briefly, nerves were 
cut into small pieces and placed in culture dishes in DMEM/F12 plus 10% FCS without mitogens. 
After 2 weeks, the pieces were transferred to new dishes where they were enzymatically dissociated 
and then re-plated in DMEM/F12 plus 10% FCS supplemented bovine pituitary extract (2 mg/ml) 
and 20nM forskolin. The purity of the SC cultures, as assessed immunocytochemically using anti-
S100 and the Hoechst nuclear stain, was below 95%. Therefore, secondary Schwann cell cultures 
were usually subjected to MiniMACS purification using the same protocol and primary antibodies 
as described above. Positive cells were kept in SCOTTS-GF medium for expansion and subsequent 
use. 
3.3.8. Adult rat dorsal root ganglion cultures 
Adult rat dorsal root ganglion (DRG) explants were obtained from freshly killed adult Lewis and 
Sprague Dawley rats. In brief, the spinal columns of the rats were removed, split medially into 2 
roughly equal parts and the spinal cord removed. The DRG, which remained embedded in the spinal 
columns, were then removed from the cervical, thoracic and lumbar regions (approximately 20 per 
animal) and placed into Petri-dishes containing sterile, ice cold HBSS. Using a dissecting 
microscope, the nerve roots were cut away. The ganglia were bisected to open the capsule and were 
cultured in either ONEC-Medium or Neurobasal A medium supplemented with B27 supplement, 
glutamine and Pen/Strep antibiotics. 
3.3.9. Cryo-storage 
At different time points, successive cells were frozen in liquid nitrogen using specific cell freezing 
medium. For all cell types, the specific growth medium was supplemented with 10% DMSO, 10% 
FCS and 2% BSA. 1-3 million cells were diluted in 1ml freezing medium, pre frozen in a standard 
freezing container allowing static decrease of temperature of 1°C and transferred to the liquid 
nitrogen storage container for later use. 
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3.4. In vitro collagen scaffold investigations 
Unless otherwise stated, all OEC-containing experiments were performed in a 1:1 mixture of 
SCOTTS-GF / SCOTTS-No GF medium.  
3.4.1. Unorientated ACI-Maix-membranes 
 
    Figure 5: ACI-Maix membrane. 
 
Unorientated collagen membranes were of the same type of collagen as being used in the later 
delivered three dimensional collagen matrices. These matrices were used to test OEC growth on this 
type of collagen. 
ACI membranes were seeded with adult rat OECs only. Small pieces of membrane (~5x5mm) were 
cut using sterile scalpels and placed into 4 chamber wells with either the fibrous or smooth surface 
uppermost. Purified OEC were detached from the culture flask using a 0.05% trypsin solution, 
counted, washed and centrifuged to form a pellet. In most experiments, a starting concentration of 
5000 cells/µl was prepared from the pellet with culture medium to seed the cut membranes. A 20µl 
drop of cell suspension was placed onto the middle of the cut membranes. The 4-well chamber was 
then placed into the incubator for 1h to assure cell attachment. After this period, the wells were 
carefully filled with 500µl culture medium. After 1 day and subsequent 2-3 day intervals, the 
culture medium was changed with 1ml fresh medium. After 1, 3, 7, 14 and 28 days incubation, all 
membranes were then fixed in 4% paraformaldehyde (0.1M PBS, 4°C, 30min), washed three times 
in HBSS and stored in the cold room prior to immuncytochemical investigations. In a few 
experiments, different starting concentrations of cells were used. All other experimental methods 
remained the same in these experiments. 
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3.4.2. Orientated collagen matrices 
Preliminary data and practical experience of handling and seeding of 3D collagen matrices were 
obtained using material generated at the Helmholtz Institute. Only adult OEC cultures or pre-natal 
astrocytes were used in these experiments. All other experiments using 3D collagen matrices were 
performed with Matricel matrices (ParaMaix) and different cell types. 
 
3.4.2.1. Helmholtz Institute matrices 
Blocks of Helmholtz Institute matrices were cut into smaller pieces (~5x5x5mm) under sterile 
conditions using straight scalpels. The blocks were dropped into cell suspensions of different cell 
concentrations, using either purified or non-purified adult OECs or neonatal astrocytes. In some 
comparative cell seeding studies, 10µl drops of cell suspension were placed on top of dry or 
previously wetted collagen blocks. After seeding the materials, using either method, the cut 
collagen blocks were placed into the incubator for 1h. After incubation, excess fluid was removed 
and the blocks were placed into 6-well chambers containing medium. After 1, 3, 7, 14 and 28 days 
incubation, all matrices were fixed using 4% paraformaldehyde (as described above), washed three 
times in HBSS and stored in the cold room prior to immunocytochemical investigations.  
3.4.2.2. Matricel matrices 
Matricel three dimensional collagen matrices (ParaMaix) of 4x4x1cm (length, width, height) size 
were delivered in sterile containers. For tissue culture experiments, matrices were removed from the 
bags and kept in sterile petri dishes for further use. For most experiments, sterile soft tissue 
punchers (2mm diameter) were used to prepare cylinders of reproducible dimensions. In all 
experiments, the orientation of the pores within the matrix could be identified by eye.  
For cell seeding experiments, all previously prepared pieces of matrix were used originally dry. 
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To measure the volume of the prepared cylinders in advance, some cylinders were placed into petri 
dishes and 5µl of HBSS was applied sequentially to one side of the cylinder (Figure 6), using 
Gilson pipettes and micro-pipette tips, until no additional HBSS was taken up by the capillary 
forces of the collagen cylinder. A number of different cell types were seeded onto such cylindrical 
collagen matrices at a variety of cell concentrations, ranging from 100 cells/µl to 40,000 cells/µl. 
After measuring the total volume of cylinders, as described above, appropriate volumes of cells 
were either applied to either one side, to both sides or cylinders were rapidly placed into drops of 
cell suspension (at least twice the volume of a single cylinder) to assure complete rehydration of the 
cylinders. 
After such cell seeding procedures, the matrices were placed in an incubator for one hour to assure 
cell attachment. They were then carefully placed into 4-well or 6-well chambers and supplied with 
culture medium. 
All matrices were fixed at the chosen time points using 4 % paraformaldehyde, processed and 
stored as described above.  
3.4.2.2.1. Rheometry 
Measurements were made using a Rheometrics Scientific controlled stress rheometer. Fully 
hydrated samples of approximately 3mm thickness are placed between 25-mm diameter lower and 
upper parallel plates. The oscillation frequency was varied from 0.01 to 20 Hz and the strain was 
kept within the linear viscoelastic region for the measurements. The measurements were performed 
at 37 degrees Celsius. 
Figure 6: Rehydration of collagen cylinders.  
Cylinders were rehydrated with 5µl drops of HBSS buffer applied from the side until no more fluid uptake could 
be detected (right image). 
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3.5. Cytocompatibility tests of Matricel matrices 
Matricel three dimensional matrices (Para-MAIX) and membranes (ACI-Maix) were subject of 
intensive cytocompatibility studies, using a variety of methods and cell types. In all of these 
experiments, Matricel collagen matrix cylinders were always dropped into the appropriate cell 
suspension for seeding cells prior to the cytocompatibility test.  
3.5.1. Cell migration 
Cell migration on the matrix was assessed using matrices that had been fixed by 
immersion in 4% PFA at different time points after cell-seeding. The main 
infiltration density of cells within the matrix was measured using centrally 
located longitudinal slices (50µm) from at least 5 cylinders for each time point 
(see left image). For this, four equally distributed vertical lines were drawn 
centrally from the surfaces of the cylinders to the last cell which was contacted by 
each line. The distance of the cells from the cylinders surface was measured using 
“Image tool 3.0” software. The mean value for the line lengths for each series of 
experiments was then calculated.  
 
 
 
3.5.2. Cell proliferation (CyQUANT assay) 
To measure the cell proliferation rate during culturing of a defined number of cells at the beginning 
of the tests, a well established, commercially available cell proliferation kit (CyQUANT, Molecular 
Probes) was used. Although it does not directly measure DNA synthesis, the assay does measure the 
results of DNA synthesis — the intensity of fluorescence signal from the CyQUANT GR nucleic 
acid stain increases in proportion to the quantity of nucleic acid (i.e., the number of cells present) 
(Khanna, Chang et al., 1999; Jones et al., 2001). In a fluorescence microplate reader, the 
CyQUANT assay has a linear range from 50 to 50,000 cells at the concentration of the staining 
solution used. 
After lysis of cells by freezing to –80°C in lysis buffer containing 200µl of the CyQUANT GR 
staining solution, free DNA can be sampled in a fluorescence micro plate reader. The amount of 
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free DNA bound to the CyQUANT GR stain can be measured as absorbance from 485nm excitation 
and 530nm absorbance. 
For calibration of the system, OEC ranging from 100 cells up to 80,000 cells were placed into a 96-
well micro plate, centrifuged to collect the cells at the bottom of each well and immediately deep 
frozen to –80°C for lysis and later measurement. To measure cell proliferation, 100, 1000 or 5000 
cells were plated onto PLL coated 96-well micro plates or seeded onto ~10µl size Matricel collagen 
matrices. OEC were allowed to grow for 1-5 days. For each concentration and each time point at 
least 4 samples were used to achieve mean values after DNA measurement. At the chosen survival 
time, growth media was aspirated and all samples were immediately deep frozen to –80°C. For 
measurement of DNA content within the SPGX samples, the matrices were repeatedly crushed for 
one minute in 200µl of the buffer to extract the DNA. Shortly after application of the buffer, all 
micro-plates were positioned into the micro-plate reader and the absorbance was measured and 
automatically saved into an MS Excel format file.  
3.5.3. Matrix - dorsal root ganglion preparation 
To assess axonal regeneration within collagen matrices in vitro, rat dorsal root ganglion explants 
were applied to the surface of non-seeded SPGX matrices. Adult SD rats were killed by halothane 
inhalation. The back of the animal was rinsed with 70% ethanol and the spinal column exposed and 
removed. The column was cut medially into 2, roughly equal, halves. The spinal cord was removed, 
exposing residual dura mater, spinal nerve roots and the DRG. Using a dissecting microscope and 
fine forceps, the dura was cleared away and the individual ganglia removed and placed in sterile 
HBSS. The spinal nerve roots were cut away from the DRG which were then placed into fresh 
HBSS. The body of the ganglion was cut in halves to open the tough fibrous capsule that surrounds 
the DRG neuronal cell bodies. The bisected ganglion was then placed, cut surface-down, on top of 
the Matricel collagen matrices and incubated with either ONEC medium or Neurobasal A medium 
containing B27 supplement, glutamine and Pen/Strep antibiotics.  
3.6. Animal surgery 
3.6.1. Adult rat spinal cord laminectomy 
Adult female Lewis or Sprague Dawley rats (age > 3 month) were used for the in vivo studies (for 
detailed information see Table 7, page 77. The high cervical lateral funiculotomy was performed as 
described earlier (Liu et al., 1999). Surgical anaesthesia was achieved by intra-peritoneal injection 
of chloral hydrate (Sigma, 350mg/kg body weight) dissolved in injectable water. 
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The back of the head, neck and shoulders was shaved (Figure 7 A) and the skin sterilized with 70% 
alcohol prior to incision along the marked line, exposing the neck musculature (Figure 7 B).  
Using blunt dissection with scissors, the superficial muscle layers were cleared from the deeper 
layers (Figure 7 C), midline incision was made and the superficial layers retracted to expose the 
deeper layers overlying the cervical vertebrae between C3 – C5 (Figure 7 D). A further midline 
incision was made followed by blunt dissection to expose the dorsal surface of the C3-C5 vertebrae 
(Figure 7 E). Fine bone rongeurs were used to perform a laminectomy of the C4 vertebra, exposing 
the dorsal surface of the spinal cord (Figure 7 F). The dura was cut and reflected (Figure 7 G), after 
which a simple lateral funiculotomy or a 1-2mm lateral resection was performed (Figure 7 H), 
followed by haemostasis using Spongostan (commercially available gelatine matrix). If no further 
surgical procedure was required, the dura was then closed using 10/0 suture, and the muscle layers 
closed using resorbable 6/0 suture. The skin was closed using 4/0 or cat-gut sutures. After the 
operation, animals were placed under a warm infra-red light and allowed to recover. No routine 
pain or antibiotics relief were required and the following day, the vast majority of the animals 
moved freely about their cage, fed and drank without any indication of pain or discomfort.  
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3.6.1.1. Scaffold implantation 
Scaffolds were prepared in a manner similar to that for cell seeding. Briefly, cylinders of Matricel 
SPGX matrices were prepared and cut into approximately 1-2mm thick slices. These slices were 
then either incubated in HBSS at room temperature for immediate implantation or were seeded with 
a 40,000/µl OEC suspension. The seeded scaffolds were incubated in growth medium for 1-2 days 
to assure cell adhesion to the matrix. Before implantation, the scaffolds were washed in HBSS to 
remove any contaminating FCS. Scaffolds were then kept in cooled HBSS until implantation was 
performed. 
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Figure 8: Scaffold implantation. 
An appropriate sized implant was fitted into  
the acute lesion. Scale bar shows 1mm steps. 
 
The implanted matrix was inserted into the gap created by the resection such that the axis of the 
orientated micro-channels within matrix was parallel to the long axis of the spinal cord (Figure 8). 
Excellent contact was usually achieved between the matrix and the cut surfaces of the spinal cord. 
Following implantation, the dura, overlying muscles and skin were closed as described above.  
3.6.2. Anterograde labelling 
Anterograde labelling of the rubrospinal tract was performed using biotin dextran amine 
(MW=10kDa, BDA) as described earlier (Veenman, 1992; Kuchler 2002). Briefly, under deep 
chloral hydrate anaesthesia, the animal was placed into a stereotaxic apparatus. The skin over the 
skull was cut and reflected to expose the surface of the skull. A burr hole was drilled in the skull 
and a glass pipette was lowered into the brain following stereotaxic coordinates determined from 
the Paxinos Sterotaxic Atlas of the Rat Brain (posterior from bregma: 6.04, lateral to the midline 
suture = 0.75, depth form the brain surface = 7.0). A volume of 0.25µl of BDA was slowly injected 
into the red nucleus of the right hemisphere using finely controlled pulses of air. The glass pipette 
was kept in place for further 10 minutes to prevent reflux of the BDA on withdrawal of the pipette. 
The skin was sutured and the animal was allowed to recover and kept alive for further 14 days. 
Animals receiving such treatment showed no signs of pain, discomfort or altered behaviour during 
the subsequent 2 weeks. 
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3.6.3. Perfusion of animals 
Under terminal chloral hydrate anaesthesia, the thoracic cavity was opened, exposing the heart and 
lungs. The right ventricle was cut, and a blunt canula of a 50ml syringe was passed through the wall 
of the left ventricle and positioned into the aorta. A volume of at least 50ml of saline was then 
slowly passed through the animal’s vascular system. Thereafter, 250-300ml of 4% PFA in ice-cold 
0.1M PBS was used to perfuse the animals within 20-30 minutes, using a clinic perfusion kit. When 
the perfusion was completed, the spinal cord was exposed by the dissection of muscles and 
vertebras. The cord was carefully removed, being cut at the intersection of brain stem and C1. The 
brain of a few animals was also taken after opening the skull. All tissues removed from perfused 
animals were post-fixed for 4-24h in 4% PFA and stored in 20% sucrose in 0.1M PBS for at least 
three days in the cold room. They were then cut into tissue blocks and stored at –80°C for later 
processing. 
3.6.4. Slide preparation 
Fixed materials were placed into a cryostat at -22-24°C and cut longitudinally at either 50µm 
(matrix preparations) or 20µm (spinal cord preparations). They were then collected on to superfrost 
plus gold or superfrost plus objective slides. Preliminary studies had already revealed that the cut 
sections form the matrix did not reliably adhere to a range of routinely prepared slides including 
commercially available superfrost plus slides or slides coated with silane, poly-l-lysine or gelatine. 
After successful mounting, all slides were dried over night and immediately processed for 
immunocytochemical staining or frozen and stored at –80°C for later use.  
3.6.5. Immunocytochemical staining 
There was no major difference in the methods used regarding the staining of sections from either in 
vitro or in vivo experiments. 
3.6.5.1. Immunofluorescence  
Dried slides were washed three times in 0.1M PBS, then incubated in PBS containing 3% normal 
goat serum,1% BSA and 1% Triton X-100 (1 hour, room temperature). Sections were then 
incubated in primary antibodies (see 3.6.5.4) over night at room temperature. The slides were than 
washed three times in 0.1M PBS, and transferred to a dark chamber and incubated in one or a 
combination of the following fluorochrome–conjugated secondary antibodies: Alexa 584 
conjugated goat anti-mouse IgG, Alexa 488 conjugated goat anti-rabbit IgG, Alexa 584 goat anti-
mouse IgM (Molecular Probes, Eugena, OR, all diluted at 1:500) for 4h at room temperature. 
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Sections were then washed for three times in 0.1M PBS and counter-stained with the nuclear 
marker 4',6-diamidino-2-phenylindole (DAPI, 1µg/ml, 5 minutes) and cover-slipped using Fluoprep 
media (Bio Nervieux). Fluorescent sections were viewed and analysed using a Zeiss Axioplan epi-
fluorescence microscope connected to a Zeiss AxioVision CCD camera. Images were processed and 
stored using the Zeiss AxioVision 3.1. software. Contrast enhancement was performed using Adobe 
Photoshop 7 software.  
3.6.5.2. Immunoperoxidase staining  
Sections were washed, blocked and incubated in primary antibodies as described above. For 
peroxidase immunohistochemistry, the secondary antibodies used were: biotinylated goat anti-
mouse antiserum (Vector Laboratories, diluted to 1:300) or biotinylated goat anti-rabbit antiserum 
(Vector, diluted to 1:200) incubated for 30 minutes at room temperature, followed by the Vector 
ABC procedure for peroxidase staining and visualisation with 3,3'-diaminobenzidine (DAB, 
Sigma). Chosen sections were counterstained with thionin, dehydrated and cleared though 
ascending concentrations of alcohol and xylene and were then coverslipped using a 
dibutylphthalate/Histoclear mixture (National Diagnostics). 
3.6.5.3. BDA staining 
Sections of rat spinal cord containing the anterograde tracer BDA were permeabilised by extended 
washing in PBS containing 1% Triton X-100 and were then stained following the Vector ABC 
procedure for peroxidase staining and visualized with 3,3'-diaminobenzidine (DAB, Sigma). 
Sections were counterstained with thionin, dehydrated and coverslipped as described above. For 
some preparations, BDA was visualised using Alexa 488 or Alexa 594 streptavidin (Molecular 
Probes, diluted to 1:500). Sections were incubated in a dark chamber for 4 hours, washed three 
times in PBS and than cover slipped or processed for further immunocytochemical staining using 
complementary fluorescence markers (3.6.5.1). 
3.6.5.4. Antibodies 
Following primary antibodies were used in this study: 
Antibody Manufacturer Dilution
Monoclonal antibodies 
NGF-Receptor/p75 Chemicon 1: 5000
Neurofilament 200 Sigma 1: 2500
ß-III tubulin Sigma 1: 2000
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Vimentin (clone V9) Sigma 1: 20,000
P0 Gift (Dr. Archlos) 1: 5000
Nestin Chemicon 1:5000
RECA-I Serotec 1:10
Ox 42 Serotec 1:500
ED1 (CD 45) Chemicon 1:500
Collagen IV Gift (Dr. Buss) 1:200
CGRP Sigma 1:1000
BrdU Sigma 1 :5000
Thy 1.1 (CD90) Serotec 1:10,000
Polyclonal antibodies 
NGF-Receptor/p75 Chemicon 1:1000
Neurofilament 200 Sigma 1:5000
GFAP DAKO 1:5000
S100 DAKO 1:5000
Serotonin Sigma 1:1000
NG2 Sigma 1:500
Laminin Sigma 1:500
Fibronectin Gift (Prof. Morris) 1:10,000
   
Table 7: Antibodies sources and incubation concentration for overnight incubation. 
3.6.6. Immunohistochemistry: statistical data acquisition 
Immunohistochemical stainings of at least two - four sections of experimental rat spinal cord tissue 
were used for data acquisition in combination with a Zeiss Axioplan microscope and ImageTool 
software (UTHSCSA, freeware). Sections either stained for ED1, GFAP or neurofilament were 
used according to the following methods: 
3.6.6.1. ED1 (macrophage response) 
To assess the immune response to the matrices and host spinal cord, four images (using the 40x 
objective) from either matrix or host spinal cord (after lesion only) were taken following the scheme 
below. The images were either taken from the edges inside the implants or within the spinal cord 
where no cystic cavitations or other defects were visible (red boxes, shown below). In all cases, the 
images were acquired 100µm away from the implant-spinal cord interaction area. Such images 
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represent an area of 0.15mm² of the tissue. At least two sections from each experimental animal 
were studied. Cell profiles positively stained for ED1 were later counted from each image using 
ImageTool and collected for statistics using MS Excel and SPSS 11. 
 
 
 
3.6.6.2. GFAP (astrocytic process length and number) 
To assess the astrocytic response, at least two sections of each animal were studied. 100µm distant 
from the rostral and caudal edges of the implant (dotted line), the number of bundled processes 
entering the matrix was counted. The maximal penetration depth (e.g. red bar, shown below) of the 
processes was also measured using the Axioplan software.  
 
 
 
 
3.6.6.3. Nf200 (axonal response) 
To obtain quantitative data of axonal regeneration a 40x objective was used to count the number of 
axonal profiles crossing virtual lines in rostral, central and caudal areas of the implants as seen in 
the schematic drawing below. The rostral and caudal lines were ~100µm away from the implant-
host interface (dotted line). 
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3.6.7. Scanning electron microscopy 
Scanning electron microscopy (SEM) was performed in collaboration with Dipl. Ing. M. Bovi 
(Dept. of Pathology, UK Aachen) and was used to analyse the longitudinal morphology of the pores 
within SPGX collagen matrices, alone or following seeding with 20,000/µl OEC. For this purpose, 
PFA fixed matrices were post-fixed in 4% gluthaldehyde for one hour, washed several times in 
0.1M PBS and cut along their longitudinal axis with a razor blade. They were then dehydrated 
through a series of ascending alcohol concentrations and finally transferred into 100% acetone. 
Using a Polaron E3000 critical point drying apparatus, several matrices were dried, then mounted 
on to stubs and sputter coated with gold. Prepared specimens were then loaded into an ESEM XL30 
FEG scanning electron microscope (Philips EO, Eindhoven, NL) and examined with an accelerating 
voltage of 5kV.  
3.7. Behavioural analyses 
Behavioural analyses were performed to assess the extent of any functional recovery by operated 
animals after lesion only, implantation of non-seeded Matricel collagen matrices or OEC-seeded 
Matricel collagen matrices. A total of 39 adult female Lewis rats were used for such behavioural 
analyses. All animals were placed on a restricted diet of 12g per rat per day and went through a 
period of training (of at least 6 weeks) prior to any surgical manipulation. A minimum mean 
performance of 8 food pellet retrievals from the left side stairs was required during the training 
period before animals could progress to the surgical phase of the experiments. Following the 
laminectomy at C4 (see above), at least 10 animals per group received either a lateral funiculotomy 
(Group 1), lateral funiculotomy plus implantation of SPGX 02 matrix (Group 2) or lateral 
funiculotomy plus implantation of SPGX 02 matrix pre-seeded with 40,000/µl OEC (Group 3). A 
fourth group received Spongostan (Johnston&Johnston) implantation as a material control.  
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3.7.1. Staircase test 
The staircase apparatus provides a simple, efficient and easy to quantify test of skilled paw reaching 
in the rat (Montoya et al., 1991). Rats are placed into the Perspex box and can reach down either 
side of a ramp to grasp, lift and retrieve 4mg food pellets positioned either side of the ramp on the 
steps of the staircase. Rats must make a coordinated reach and grasp to retrieve a pellet. The test is 
highly suitable for unilaterally lesioned animals as used in this study, because the apparatus 
prevents the use of the unaffected limb for pellet retrieval from the affected side. The staircase test 
apparatus was purchased from Camden instruments, London, UK. Each stair within the test 
chamber was filled with 4 pellets of specific animal testing dustless precision pellets (Lohmann 
Research Equipment, Castrop-Rauxel, Germany). The animals were allowed to stay in the cases for 
15 minutes, one day per week. After each test the number of pellets taken from the stairs serves as 
the dependent variable for statistics and graphical representation. 
3.8. Statistical Analysis 
All animals used in the experiments were object for data acquisition. Nine animals fulfilling 
exclusion criteria of general ill health prior to perfusion, poorly located implants or even implants 
lost during immunohistochemical processing were removed from the data set in order to allow 
realistic statistical analysis. For behavioural analysis, training of all animals has been recorded 
weekly over the full survival time. Animals performing poorly during the training period were 
excluded from subsequent behavioural analyses. 
Linear correlation analysis was performed to examine the relationship between behavioural deficits 
and animal group used. Values were given as mean ± standard error of the mean (SEM). Statistical 
significance was set at P<0.05 (*) for all tests. 
For comparison of two data sets a 2-tailed Student t-test was performed. Where multiple data points 
or groups were compared, either one-way ANalysis Of VAriance (ANOVA) or general linear model 
analysis was performed, followed by Bonferroni post-hoc testing and repeated measures where 
applicable. For all types of analysis, MS Excel 2000 was used to collect and present data while 
SPSS v13 was used for statistical analysis of each data set. 
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4. Results 
4.1. Collagen materials 
General comment: 
In this tissue engineering approach for the treatment of acute spinal cord injury, the suitability of a 
range of possible type I collagen cell carriers was tested both in vitro and in vivo. The testing of a 
number of orientated and unorientated collagen matrices in vitro was deemed necessary to choose 
the most suitable collagen scaffold for subsequent in vivo tests. This ultimately reduced the number 
of animals required for the whole investigation. As part of these preliminary studies, collagenous 
membranes from Matricel, as well as sponge-like matrices from the Helmholtz institute were used. 
Before in vivo integration and behavioural investigations could begin, a total of 9 different SPGX 
prototypes were investigated. 
4.1.1.  Collagen membranes 
Three slightly different unorientated collagen membranes (ACI Maix) were used to assess glial cell 
binding and viability. This type of cell carrier has already been demonstrated to be biocompatible 
and is currently being used in the clinic as a medical product for autologous chondrocyte 
implantation (ACI, Cherubino et al., 2003). The membranes are composed of a fibrous side and a 
smooth side (Figure 9).  
 
 
Figure 9: SEM image of the fibrous side of ACI-Maix matrix.  
Note the different sized, unorientated collagen fibres.
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Both sides are theoretically equally functional for cell application. All matrices used in this study 
were cut into squares of approximately 5x5mm under sterile conditions. In most cases, both sides 
could easily be distinguished from each other allowing the consistent choice of the rough side to 
receive the cells. When placed into Hanks balanced salt solution (HBSS), all membranes became 
rapidly rehydrated. Small drops (~100µl) of HBSS placed on top of the cut membranes induced a 
slight colour change of the phenol red, from red to orange, suggesting the presence of residual acid 
within the dried membranes. All membranes used were stable for at least 4 weeks of cell culture, 
not showing any signs of degradation or instability, either while handling during media changes or 
in later immunohistochemical steps. 
4.1.2.  Collagen matrices 
Orientated sponge-like three dimensional matrices were obtained from two different facilities at the 
outset of the investigations: the Helmholtz Institute and Matricel GmbH.  
4.1.2.1. Helmholtz matrices 
Relatively little was known about the biochemistry of the Helmholtz Institute-derived material due 
to inadequate labelling. Generally, the production process of these matrices was similar to the 
process used to manufacture Matricel matrices at later time points. The designated materials were 
used for preliminary cell culture experiments only and named “1.5%” or “3.8%” respectively. 
According to the Matricel team, this was an indication of the amount of acetic acid used in the 
freezing process. For all experiments, at least n=4 small cubes of ~ 5x5x5mm were prepared under 
sterile conditions using straight scalpels. In preliminary investigations, drops of HBSS were placed 
onto the surface of cubes of the Helmholtz matrix. Interestingly, the HBSS remained on the surface 
of the Helmholtz matrix (Figure 10). 
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No change of colour of the HBSS could be seen. After 1-2 minutes, the drops were incorporated 
into the Helmholtz matrices, leading to a slight shrinkage of the collagen cubes. When rehydration 
was complete, a slight change in colour of the phenol red from red to orange could be seen, 
indicating the presence of acidic remnants within the matrix. A similar slow rate of rehydration was 
observed when the Helmholtz matrices were placed into a few ml of HBSS, with the matrices 
floating on the surface of the medium before eventually absorbing the fluid and sinking. All 
rehydrated cubes were easy to handle. They were highly flexible and regained their original shape 
within a few seconds of being squeezed. Further cutting of the material could be achieved using 
either sharp scissors or scalpels. 
4.1.2.2. Matricel matrices 
Three dimensional type I collagen matrices from Matricel (ParaMaix) were supplied 15 month after 
the start of the project. Three types of matrices (code named SPGX 01, 02 and 03) were initially 
delivered (review table 5).  
All three types of matrix had been prepared following slightly different protocols (see Table 
3.2.2.1.2). The general appearance of the three SPGX matrices was largely the same in terms of 
colour, shape and size. The matrices were white, of 4x4x1cm dimensions with highly orientated 
pores or channels orientation along the shortest axis. The blocks of collagen matrix were covered by 
a thin layer of unorientated collagen fibres, effectively sealing and protecting the pores within 
(Figure 11).  
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All matrices were easily cut into cubes and tested using the same technique as described for 
Helmholtz matrices. SPGX 01 behaved rather differently from SPGXs 02/03 when being cut with a 
scalpel. While SPGX 02/03 were easy to handle and revealed clean surfaces after cutting, SPGX 01 
demonstrated rough or slightly broken surfaces. Small drops of HBSS (100µl) applied to the cubes 
(n=4) of either type of matrix were rapidly absorbed (within less than one second) resulting in 
dramatic shrinking of the matrices. The drop of HBSS used in these experiments only produced a 
slight change of colour of the phenol red. Further hydration of the matrices resulted in them 
regaining their original shape. Cubes dropped into a few ml of HBSS sank to the bottom of the dish 
almost immediately. All Matricel matrix cubes rehydrated in excess amounts of medium (at least 2x 
the matrices volume) gained 25-30% of their original size and could easily be cut. For further 
investigations of the matrices, reproducibly sized cylinders were generated using a 2mm sterile 
tissue punch. Replacing the punch after the preparation of 5 cylinders permitted very clean cylinder 
surfaces. The cylinder was then carefully pushed out of the punch using sterile 1.5mm diameter 
bone fixation needles. The rounded end of each needle prevented damaging the collagen cylinder 
surface. All cylinders extracted by this method had highly uniform dimensions. Furthermore, dry 
cylinders that had been accidentally compressed were able to regain their shape following complete 
rehydration. Dark field microscopy of 20µm thick cryostat sections revealed many more highly 
orientated pores or channels within the Matricel matrices than in the Helmholtz matrices (Figure 
12). Sections of the Helmholtz matrix revealed areas of no pore formation while Matricel matrices 
were uniformly orientated. 
Figure 11: Matricel collagen matrix. 
Dehydrated Matricel collagen matrices generally were of Styrofoam like structure. A thin layer 
of unorientated collagen fibres seal the upper and lower sides of the matrices in some cases 
(black arrows) and were generally removed before an experimental setup. The uniform pore 
formations may be visible macroscopically (double arrow), and were easily identified at high 
magnification using SEM (right image, bar = 50µm). 
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In cooperation with Dr. Paul Dalton of the Deutsche Wollforschungsinstitut (DWI), the viscoelastic 
properties of SPGX 02 matrices were investigated. It was found that the rehydrated matrices are a 
viscoelastic material, predominantly elastic, with a shear modulus of 4,53 kPa plus/minus 1,81 kPa, 
independent of applied frequency between the range of 0,01 and 20 Hz. Compared to spinal cord 
material without dura (10-12 kPa, from dog), it is slightly softer (Tunturi 1978; Tunturi 1980). 
Spinal cord tissue with dura is much stronger in comparison (240kPa, cat spinal cord) (Chang, 
Hung et al. 1988). Five disk-like matrices (1.5cm diameter, 3mm thickness) were tested after 
hydration.  
 
4.2. In vitro cytocompatibility 
In vitro cytocompatibility is a major issue in cytotoxicity and biocompatibility investigations (for 
example Deutsche Industrienorm EN ISO 10993-5). Such investigations include cell cycle, cell 
migration, cell adherence and apoptosis upon contact between the cells and the biomaterial. All 
these factors describe and define the compatibility of a biomaterial for a specific cell type. Tests for 
cell morphology, cell cycle and cell migration were performed primarily with adult rat olfactory 
ensheathing cells, but a range of other cell types were also used (see below) for cell morphology 
tests.  
Figure 12: Inner orientation of Helmholtz and Matricel matrix. 
Note the inner structure within each matrix, shown by dark field microscopy. 
The Helmholtz “1,5%” matrix (A) shows areas of uneven orientation on the 
left side, while the right side shows normal orientation. Matricel collagen 
matrices (B) show high pore orientation at any area within the cryo-cut 
materials. 
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4.2.1. Cell culture 
4.2.1.1. Adult olfactory ensheathing cells 
Adult rat olfactory ensheathing cells (OEC) were always obtained shortly after killing the animal. In 
general, for each batch of OEC cultures, two animals were killed and processed in parallel to 
generate the primary cultures. Freshly dissociated cells did not allow an accurate standard cell count 
due to high amounts of cell debris. Therefore, in all primary cultures being established, each 
dissociated olfactory bulb was plated onto a PLL coated 25 cm² culture flask. In some cases, only 
one of the primary cultures generated good quality cells (in terms of cell cycle and cell shape), 
while the second culture either showed poor adherence of cells, slow cell growth or irregular shape 
of cells in comparison. A total of 18 primary cultures of adult OECs were generated, 13 of which 
were used for this investigation. The cultures contained approximately 200,000 cells after 4 days of 
incubation (at the time of the first medium change). Cultures not reaching confluency within 14 
days were discarded.  
Primary cultures contained a mixture of cells with different morphologies. In general, three main 
morphological types could be identified: 1) spindle-shaped cells, 2) small-flat, cubic endothelial-
like cells and 3) large flat polygonal, fibroblast-like cells. In most cases, all three morphologies 
were found in clusters, forming a single layer of cells when confluent (Figure 13 A, B). 
Immunofluorescence of samples of these cells revealed 10-30% p75-positive cells after 10 days of 
culture (Figure 13 C), which demonstrated small bi- or tri-polar cell bodies.  
Approximately 90% of the p75-positive cells were also positive for S100, GFAP and nestin (Figure 
13 D, E). All p75-negative cells were found to be vimentin-positive, while most (>80%) of these 
cells were also positive for fibronectin (Figure 13 F). Roughly 50% of the fibronectin-positive cells 
were also positive for Thy 1.1. Since almost all p75-positive OEC also showed positive staining for 
S100, the more intense S100 staining was chosen to identify these cells in many of the following 
experiments. For comparison of all antibodies used see chapter 3.6.5.4.  
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Since one of the goals of this study was the establishment of an enriched or purified population of 
p75-positive OEC, a number of enrichment/purification protocols were assessed, including the use 
of growth factors specific for OEC proliferation, “cold-flush” and immunopanning (Nash et al., 
2001; Plant et al., 2002). None of these approaches were found to be ideal for our purposes. 
However, the MiniMACS system was found to be an efficient and cost effective approach for the 
enrichment of p75-positive cells. Comparison of small cell samples (up to 50,000 cells) prior to and 
after purification showed high efficiency of the system when using polyclonal anti-p75 antibodies 
to enrich p75-positive OEC (positive fraction). A small percentage (~5%) of p75- or S100-negative 
cells could be identified within the positive fraction. These cells usually contained a larger nucleus 
than positive cells. Conversely, less than 0.01% p75-positive cells could be identified in the 
negative fraction (Figure 14 A). Approximately 25% (+/- 20%) of the starting cell population was 
lost during the cell enrichment protocol. In positive fractions, cultured in OEC medium, the 
percentage of p75-positive cells slowly reduced over time, with a concomitant increase in the 
number of fibroblast like cells. Therefore, a serum reduced, growth factor-containing medium 
(SCOTT GF) was used (Barnett et al, 2002, with minor modifications) for culturing p75 purified 
OEC.  
Figure 13: Adult OEC primary cultures.  
A range of cell morphologies could be found shortly after passaging the cells. Spindle- or triangular shaped (s), 
endothelial-like (e) or fibroblast-like (f) cells, sometimes grew in clusters (A+B). After 10 days of tissue culture, 
10-30% of the cells were p75-positive, while all cells were vimentin (Vim) positive (C). p75- positive cells were 
also weakly positive for GFAP (D) and nestin (E). Large, vimentin-positive cells were found to express fibronectin 
(FN) that was scattered throughout the cell body (F).  
A: 10X, B: 40X 
Immunhistochemistry: All monoclonal antibodies were revealed using Alexa-598-conjugated secondary antibodies 
(red), and all polyclonal antibodies were revealed using Alexa-488-conjugated secondary antibodies (green). 
Nuclei were identified by DAPI-staining (blue). This system is used on all following figures. 
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Using this medium, positive fractions attained cell division rates (doubling time, dt) of 1 cell cycle / 
1.5-3 days. This finding was calculated after each culture flask was passaged, comparing the 
number of cells directly after plating a culture flask [X1] with the number of cells counted before 
passaging [X2], taking in account the time of culture [d].  
The following equation was used: [dt=1/(log(X2/X1)/log(2))*d].  
The cells retained their spindle or triangular morphology in this medium for at least 6 passages 
(Figure 14 B). At this point, all cells were positive for S100, p75 and nestin. Therefore, positive 
fractions were considered to be purified OEC, while negative fractions were considered to be 
enriched olfactory nerve fibroblasts (ONF). 
 
 
Once both culture media were established, the optimal time points of application of the two media 
were investigated. Initial use of SCOTT-GF medium directly after olfactory bulb dissociation 
resulted in rapid cell proliferation of spindle shaped cells for up to 7 days. These non-purified OECs 
then rounded, detached from the flask surface and eventually died. It was therefore decided to 
change the initial ONEC medium gradually (by 20% steps towards SCOTT-GF medium over the 
course of 10 days) until high confluency was reached and OEC were subject to enrichment. Positive 
OEC were then kept in SCOTT-GF medium only, while ONF were eventually transferred back to 
ONEC medium in a gradient change of medium. ONF kept in SCOTT GF medium did not undergo 
cell proliferation and died after two weeks of culture (not shown). Due to these findings, all further 
primary olfactory bulb dissociations were cultured using the protocol listed in materials and 
methods.  
OEC could be rapidly expanded using SCOTT-GF medium after purification. Since ONF did not 
survive in this medium, small contaminating populations of fibroblasts became negligible. To 
reduce media costs, 2nd passages after MiniMACS treatment were further cultured in SCOTT-½ GF 
medium, resulting in only a slight reduction of cell proliferation rate (not shown). OEC in SCOTT-
Figure 14: Adult OEC primary cultures after p75-MiniMACS purification.  
Within the negative fraction (A), S100 positive cells were only found on rare occasions. The positive fractions (B) 
were considered highly enriched or pure for p75-positive cells. These cells showed spindle-shaped, triangular or 
flattened cell morphology and a variable intensity of nestin expression. "Old" p75-positive cell cultures (C) 
demonstrated multiple-processes after 10-15 passages, but all OEC still expressed NGFr and GFAP. 
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No GF became mitotically quiescent within 2-3 days (not shown). The subsequent return of these 
cells to SCOTT-GF medium prompted a rapid return to the proliferative state (not shown). 
A similar growth pattern could be seen when purified OEC were directly cultured in Neurobasal-A 
medium plus B27 supplement. Within one day, all cells became mitotically quiescent. Cells could 
be maintained in a viable state for more than 4 weeks in the absence of a change of medium 
(experiment performed twice). When placed into fresh Scott-GF medium, cell proliferation could 
once again be identified by 2 days.  
Long term cultures of OEC revealed a morphological shift to a multi-process bearing, star-like 
appearance. Double staining for p75 and GFAP revealed no major change in immunoreactivity in 
these cells (Figure 14 C). Due to the slight change of cell morphology it was decided to expand 
cultures from one animal only up to ~20Mio cells (approximately 6-8 passages) for later 
experimental use.  
4.2.1.2. Post mortem human olfactory ensheathing cells 
Post mortem human olfactory ensheathing cells (hOEC) cultures were established using the exact 
dissociation, purification and culture protocol as used for adult rat OEC. Olfactory bulbs from only 
3 cadavers could be obtained for use during this study. One of these bulbs became infected by 
bacteria after 10 days; another bulb did not produce enough living cells after dissociation and had to 
be discarded. Therefore, all data shown is from the remaining human bulb. 
There was no great difference between the rat OEC purification protocol and that adopted for the 
human bulbs. Although the human bulb was more than three times larger and presumably contained 
at least three times more cells than a rat olfactory bulb (simply estimated by the difference in size) 
only 200,000 living human cells could be identified after 4 days of culture. Cell populations were 
enriched for p75-postivity (MiniMACS) after 10 days and maintained in culture using Scott ½ GF 
medium. All purified cells showed strong S100 and p75 immunoreactivity, however only 90% of 
these cells were positive for nestin. All nestin positive cells were also positive for fibronectin 
(Figure 15 A-C). Most cells adapted a more flattened morphology than the spindle shape 
morphology seen with rat cells. Furthermore, a few cells demonstrated atypical, large multi-nuclear 
cell bodies (Figure 15 B, C).  
4.2.1.3. Early post natal olfactory ensheathing cells 
Two cultures of early post natal rat olfactory ensheathing cells (pnOEC) were obtained from Dr. 
Sue Barnett. They had been purified using a FACS-system, sorting for O4-positive cells prior to 
being sent to Aachen (Barnett & Hutchins, 1993). Both cultures could be readily expanded using 
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Scott ½ GF medium, with doubling times of approximately ~36h (+/-7 h). It was possible to expand 
these OEC up to 200,000 cells/cm² without cell death or reduction of cell proliferation rate. After 
seeding these cells onto tissue culture plastic at densities of 10,000/cm², subsequent passages of 
cells showed normal spindle-shaped morphology and cell growth (Figure 15 D). All cells were 
positive for nestin, p75 and S100. Only occasional cells were found to be positive for fibronectin. 
This antigenic expression pattern was stable for at least 12 passages. 
Such populations of expanded pnOEC were used for a variety of experiments involving collagen 
matrices. For most experiments, aliquots of passage 4-5 frozen cells were used after thawing and 3-
5 days of culturing, when stable growth and normal morphology had returned. Long term cultures, 
frozen for up to three times only showed minor differences to “primary” cultures. The morphology 
of many cells changed from spindle shape to flattened shape morphology. 
4.2.1.4. Astrocytes 
The human astrocytoma cell line (U373) and rat post natal day four (P4) astrocytes (AC) were 
cultured identically, using ONEC-medium and PLL-coated flasks. Both cell types could be easily 
expanded to high concentration (up to 250,000 cells/cm²) and showed similar dividing times of up 
to 48 hours. Most AC and U373 cells were found to be positive for GFAP (up to 95%). Few cells 
were immunopositive for vimentin only. No cells were found to be positive for nestin (Figure 15, E, 
and F) or p75, while some cells did show fibronectin immunoreactivity. The morphology of these 
cells was typically flattened. Some isolated U373 cells were found to be ~2-5xs larger than the 
other cells in culture, showing a unique morphology with numerous vacuoles like structures within 
the cell soma. These cells were usually found to be weakly stained for GFAP (Figure 15 G, 
asterisk), but this phenomenon was not investigated further. 
The media from both cell types was stored for later use in the SCOTT-medium preparations. The 
growth of both cell types was stable for at least 15 passages, without morphological changes. 
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4.2.2. Cell – matrix interaction 
Overview 
Since this project involved the development of a prototype matrix to be used in spinal cord injury, 
numerous forms of collagen matrix were tested in a preliminary round of studies. The main reason 
for doing this was to better understand the properties of the new materials and to reduce the 
number of animals to be used in the investigation. Also, the main interest in this study was the 
fabrication of a specific glial cell – matrix scaffold. Therefore, OEC were used for all experiments, 
while other glial cell types were mainly used for morphological comparison only. To achieve this 
goal within the time allotted for the thesis, some of these preliminary experiments were not repeated 
Figure 15: Immunocytochemistry of the various glial cell types.   
Human OEC (A-C), 21d after p75-MiniMACS purification. The cells 
displayed a range of immunocytochemical stain intensities and cell sizes. 
All cells were positive for S100, while >90% of these cells also 
demonstrated nestin expression (A). Most cells that expressed nestin were 
also found to be immunoreactive for GFAP (B) and fibronectin (C). Some 
individual cells showed an unusually enlarged cell cytoplasm (B, asterisk) 
which may have represented fused cells with multi-nuclei formations (C, 
star). Post natal OEC (pnOEC) showed a spindle-shaped morphology only 
(D), expressing a similar antigenic phenotype to that of adult rat OEC (not 
shown). Rat astrocytes (AC) and human astrocytoma (cell line U373) 
showed similar immunocytochemical profiles, being strongly positive for 
GFAP (E-G). Only occasional cells were GFAP-negative (E), while no 
cells were found to be positive for nestin (F). At very rare occasions, U373 
astrocytoma cells showed much enlarged cell bodies containing large 
nuclei (G, asterisk). 
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more than once nor were they statistically analyzed. More complete analyses, including statistical 
analysis were performed on the SPGX 02 matrices.  
4.2.2.1. Preliminary investigations 
4.2.2.1.1. Helmholtz matrices 
At the start of this project, the Matricel facility was not fully established, nor was it ready to 
produce orientated matrices until 14 month later. Therefore, orientated 3D matrices from the 
Helmholtz institute and Matricel collagen membranes were used in order to gain tissue culture 
experience and develop protocols for handling the cells and materials. Due to the preliminary 
character of these investigations, only qualitative data were acquired.  
In all cases, immunohistochemical preparations were rather difficult, due to the high porosity of the 
matrix. This resulted in poor adhesion of matrix sections to the glass slides with many sections 
appearing deformed, broken or folded. Such sections had to be discarded. During the later stages of 
the project, Superfrost plus GOLD slides (MENZER) were used, improving section adhesion. 
OEC, AC and DRG explants were used on the 1.5% and 3.8% Helmholtz Institute matrices. In the 
first cell application experiments, using 20µl drops of cell suspension, non-purified cultures of OEC 
at 1000 cells/µl were applied onto 5x5x5mm collagen cubes (n=17), containing mainly ONF and 
app.10-20% OEC. Droplets applied onto dry collagen cubes initially remained on the surface, 
indicating a degree of hydrophobicity of the material (also see chapter 4.1.2.1.). However, cells 
were eventually incorporated into the sponge within one minute. Some non-purified OEC were also 
applied onto collagen cubes previously incubated with medium alone in order to rehydrate and wash 
the material before use.  
OEC survived for at least 3 weeks on the matrices. Most cells investigated attached to the matrix 
surfaces, extending thin processes (Figure 16 A). S100-negative cells were clearly larger than the 
S100-postive cells (see Figure 16 B), and extended more flattened processes. Only few S100-
positive OEC could be found on the sections. Since the pores within the collagen matrix were 
cylindrical (Kuberka et al., 2002), it was possible to take microscope images of the flattened 
collagen surface in a few sections. Here, p75-negative, Thy 1.1 (CD90)-positive cells clearly 
showed a flattened, fibroblast-like morphology while p75-positive OECs showed a spindle-shaped 
morphology (Figure 16 B, star).  
Pore orientation seemed to be more uniform in 1.5% collagen matrices, while 3.8% matrices 
displayed areas of the unorientated pore formation (see Figure 12). No specific 
immunohistochemical staining, using anti-collagen type I antibodies could be established, but all 
collagen materials were found to be non-specifically stained with a polyclonal anti-fibronectin 
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antibody. The quality of the Helmholtz matrices was somewhat variable, some of which started to 
disintegrate during co-incubation with non-purified OECs within 14 days. Cells still adherent to 
such matrices showed a rounded morphology (e.g. Figure 16 C). Other samples of Helmholtz 
matrices appeared to be more stable, remaining intact for up to 4 weeks (maximum investigation 
time, n=3). 
During these first investigations, protocols for enrichment and enhanced proliferation of OEC were 
not yet established and only relatively low cell numbers could be used. Therefore highly enriched 
astrocytes (AC) were used to study high cell densities in long term studies (4 weeks) on Helmholtz 
matrices since these cultures doubled within every 2-4 days. After placing cubes of matrix into cell 
suspensions (containing 20,000 AC/µl), specimens were studied at 1, 7, 14, 21 and 28 days (n=2-4 
each). The experiment was repeated 3 times, using two different AC starting populations. 
AC integrated into the collagen pores for up to 200µm and extended long orientated processes 
(Figure 16 D). Most cells were concentrated on the surface and up to 150µm deep within the 
matrices after 1 day. Only occasionally could cells be found deeper inside the matrix (Figure 16 D, 
arrow). Up to 28 days after seeding, the density of GFAP-positive cells strikingly decreased at the 
surface of the matrix, down to a depth of 50µm (Figure 16 E, F). Concomitantly, increasing 
numbers of GFAP-negative/ vimentin-positive cells migrated and extended orientated processes 
into the matrix, reaching distances of up to 600µm by 1 day after seeding and up to 2mm by 4 
weeks after seeding.  
To assess if the orientated matrices were capable of supporting axonal regeneration, DRG explants 
were placed onto cubes of Helmholtz matrices in 12 experiments and cultured for 14 days. DRG 
bound to the matrix over the first week. By 14 days, numerous cells migrated out of the DRG for 
distances of up to 1mm. Most of these cells were vimentin-positive. Relatively few of these cells 
were also positive for S100 (Figure 16 G). Occasional neurofilament-positive neurites extended, in 
a largely orientated manner for up to 500µm into the matrix, most being closely associated with the 
few p75-positive Schwann cells. In contrast, no neurites could be observed extending over the 
surface of the matrix itself. All DRG led to partial disintegration of the collagen material below the 
DRG surface, giving the impression of that the DRG had sunk slightly into the matrix.  
To summarise, the preliminary results using the Helmholtz institute orientated collagen matrices 
allowed the following points to be noted: (i) both types of collagen matrices supported cell 
migration and cell survival for up to 4 weeks, (ii) some of the matrices disintegrated as early as 10 
days when in contact with OEC, while others showed signs of disintegration or dissolution when in 
contact with DRG, (iii) some neurites extended into the collagen matrix in association with S100- 
and p75-positive cells (presumably Schwann cells), (iv) in most experiments, Thy 1.1 (CD90)-
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positive (or vimentin-positive/S100-negative) cells showed more complex process formation and 
better migration than either Schwann cells or astrocytes. 
 
 
4.2.2.1.2. ACI-Maix membranes 
ACI-Maix membranes (in 3 different forms, chapter 3.2.2.1.2) from Matricel were used to assay the 
collagen biomaterial that had been prepared to a certified quality. These membranes were of 
medical device quality and certified for sterility, and contained the form of collagen that was to be 
Figure 16: Cells seeded on Helmholtz matrices.  
A: Non-purified OEC seeded onto 3.8% matrix revealed orientated growth of OEC (green cells, S100) and ONF 
(red cells, vimentin) up to 1mm within the collagen matrices by 10 days after seeding. B: Thy 1.1 (CD90) positive 
ONF showed a large, flattened morphology on the matrices, while OEC (star) remained spindle-shaped. C: 21 
days after seeding, both cell types (OEC and ONF) adopted a rounded morphology when the 3.8% matrices 
disintegrated. Only a few cells with small processes could be found (arrow). Most cells expressed S100. D-F: 
GFAP-positive astrocytes seeded onto 3.8% matrices showed a strong surface binding, and failed to migrate into 
the matrices within 7 - 28 days. However, a population of GFAP-negative, vimentin-positive cells (F, arrow) 
extended into the collagen matrices for 1mm or more by 28 days. In parallel, the density of the GFAP-positive 
astrocytes at the surface of the matrices appeared to decrease over time. G-I: Dorsal root ganglia (DRG) applied to 
empty matrices, 14 days in culture. Numerous cells migrated out of the DRG (G, DAPI nuclei), some of which 
belonged to S100-positive Schwann cells.  High magnification images revealed NF200 positive axons regenerating 
into the matrix (H, arrow), which were accompanied by S100-positive Schwann cells (I, arrow). 
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used in the development of the Matricel matrices. For these investigations, only purified OEC were 
seeded on the membranes and all investigations were assessed in a qualitative manner since the aim 
of this study was to assess if OEC could survive and grow on this specific type of collagen.  
Both sides of the membranes readily absorbed the 20µl drops of cell suspension (containing 10,000 
cells/µl) that were applied to the middle of the 5x5mm samples. Additional medium was applied 
until the membranes were completely wetted to assure cell survival (see methods part). Eight 
squares of each type of membrane were seeded, mainly on the rough side to include slight three 
dimensional characteristics of this culture experiment.  
 
 
For immunohistochemistry, all membranes were cut transversally, through the middle of each 
sample in order to pass through the centre of the applied cell suspension. Therefore, most cells were 
concentrated at the middle of each prepared slice. Viable OEC were seen on each membrane at 1, 7, 
14, 21 and 28 days post seeding (Figure 17 A-F). One day after seeding, early process formation 
could be seen on all membranes (Figure 17 A). The cells showed thin process formation into the 
fibrous surface of the membrane. When cultured over 7 days, almost the complete surface and 
deeper layers of the membrane were covered with OEC, suggesting cell migration and proliferation 
(Figure 17 B-E). Matrices stained at 14 (Figure 17 F) and 21 days showed complete adherence and 
Figure 17: Purified OEC on ACI-Maix matrices.  
A, 1 day: Small process formation could be seen 1 day after seeding OEC onto ACI-Maix matrices. B-E, 7 days: All 
three ACI-membranes tested showed cell attachment and process formation in histological sections of the 
membranes. The complete rough sides of the matrices 031 (B) and 040 (C) were populated by OEC 7 days after 
seeding. High power microscopy revealed long process formation on ACImaix 040 (D, arrow) and Matrix 041 (E, 
arrow). These processes seemed to closely follow the collagenous fibres of the matrices. The collagen fibres on the 
rough side of the membrane were also heavily populated by OEC 14 days after seeding (F). Codes 031, 040 and 041 
represent different forms of the ACI-membranes. 
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covering of individual collagen fibres, clearly indicating that OEC were viable on this form of 
collagen. 
4.2.2.2. Matricel collagen matrices 
Matricel collagen matrices were considerably different to any of the biomaterial used earlier in the 
investigation. They were therefore tested in vitro using the same protocols as mentioned earlier but 
with a clear emphasis on obtaining quantifiable data on cell viability, cell growth and cell 
proliferation. 
4.2.2.2.1. Basic experiments 
Three slightly different Matricel collagen matrix prototypes were provided for the investigation (see 
materials and methods). In contrast to Helmholtz institute materials, Matricel collagen matrices 
showed rapid fluid absorption. This feature was used to first identify rehydration characteristics and 
then specify passive cell seeding capacities. A dramatic initial shrinkage of the standard 2 X 12mm 
matrix cylinders could be seen at the point of application, following the addition of consecutive 5µl 
drops of HBSS (Figure 18 A). Nine to ten 5µl drops (i.e. 45-50µl) of HBSS were needed to 
completely rehydrate such cylinders (this procedure was repeated on 6 individual samples). The 
completely rehydrated matrix cylinders appeared slightly larger than dried cylinders (Figure 18 B), 
which possessed a volume of approximately 37.7µl (according to the equation: hrV ××= 2π ). In 
all subsequent experiments, a maximum seeding volume of 45µl was therefore applied to the 
standard matrix cylinders. Matricel collagen cylinders which had been rehydrated with HBSS also 
showed a density gradient of the phenol red.  
The ability of the SPGX 02 cylinders to absorb cells was determined by applying 45µl of 20,000/µl 
OEC cell suspension using a variety of application methods. The relatively high concentration of 
20,000 cells/µl was chosen as a compromise between obtaining the highest possible cells seeding 
without the suspension becoming too viscous. Concentrations higher then 50,000 cells/µl resulted 
into a gel-like suspension that was difficult to handle and was, therefore, not used.  
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Figure 18: SPGX matrices, initial cell seeding experiments.  
A-B: Hydration of collagen cylinders. 2mm wide cylinders were hydrated step-wise using sequential 5µl HBSS droplets applied to 
one end of a cylinder. After two drops, the cylinder shrank (A). When 55 µl HBSS were applied, a small portion of fluid remained 
beneath the cylinder, indicating complete rehydration (B, arrow). The rehydrated cylinders seemed to be ~25% larger than the dry 
cylinders. On both preparations, a filter-like effect of the phenol red separation could be identified at the application side. C-E: Cell 
application, DAPI-staining. When 55µl of 20,000/µl OEC were applied to one end of the matrices, the cells entering the matrices 
showed a density gradient-like distribution (C). After application of 2x 22.5µl 20,000/µl OEC onto both ends of the cylinders, most 
cells were found at the application site (D) and also up to 1-2mm into the matrices. Only few cells were found at the centre of the 
cylinders. When the cylinders were immersed in at least 100µl of 20,000/µl OEC (E), they demonstrated a better penetration of the 
scaffolds (compared to C, D). F-I: Application of varying cell concentrations, 3 days in tissue culture. Small yellow arrows indicate 
the distribution of considerable cell numbers. A cylinder dropped into 5,000/µl OEC showed equally distributed cells on the cylinder 
surface (F). Cylinders dropped into 10,000/µl OEC (G) showed approximately 30% deeper cell penetration into the cylinder 
compared to (F). Cylinders dropped into 20,000/µl OEC (H) revealed an even better loading of cylinders. When cylinders were 
dropped into 40,000/µl OEC (I), most cells were found to be concentrated at the surface of the cylinder (large arrow), less deep 
penetrating compared to (H). K-L: OEC applied onto cylinders at 40,000/µl showed rounded cell morphology by 3 days of culture 
(arrows). This behaviour was not observed at OEC concentrations of 20,000/µl or less.
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When the OEC were applied to one end of the cylinders (n=8), they remained largely at the 
application site, distributed in a slight density gradient (Figure 18 C). A small amount of the cell 
suspension ran along the side of the cylinders, but no cells could be detected at the opposite end of 
the matrix cylinders as early as 1 hour after seeding. Considerable numbers of cells penetrated the 
cylinders for ~200µm from the sides and ~1000µm from the seeded end (i.e. along the axis of the 
pores/channels within the matrix), with individual cells distributed up to 2mm depth into the 
matrices. At this early time point, relatively few cells penetrated the centre of the cylinders. When a 
volume of 22.5µl of OEC suspension was applied to both ends of cylinders (n=10), the complete 
surfaces of the matrix cylinders became covered with cells (Figure 18 D). Most cells were 
concentrated at the ends of the cylinders, penetrating for distances approximately 400µm at 
considerable cell numbers (few cells penetrated much deeper). The OEC located at the sides of the 
cylinders penetrated for distances of approximately 200µm, but the centre parts of the cylinders 
remained relatively empty.  
As a final method of application, cylinders (n=8) were rapidly immersed into a 100µl drop of OEC 
suspension for 30 minutes, assuring complete rehydration of the cylinder. Using this method, a 
more uniform cell distribution across the full surface of the cylinders could be achieved (Figure 18 
E). Cells penetrated the sides of the cylinders up to 250µm (+/- 50µm), while cells at ends 
penetrated the matrix cylinders for up to 600 µm (+/- 150µm). There was a clear density gradient of 
cells within the matrices, the centre of each cylinder remaining almost empty. Nevertheless, this 
method of cell seeding produced the most even and reproducible loading of the matrices and was 
therefore chosen as the method of choice for the subsequent cell / matrix experiments.  
To assess the degree of penetration of the matrix cylinders by cells suspensions of varying density, 
cylinders were immersed in OEC suspensions at initial seeding densities ranging from 1000 to 
40,000 cells/µl and cultured for a short period of time (1 and 3 days, 3 cylinders / time point). 
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Graph 1:  Penetration depth of OEC into Matricel collagen cylinders at different cell concentrations. 
Collagen cylinders seeded with OEC at concentrations between 1,000 and 40,000 cells/µl showed an increase of 
penetration depth at increasing cell concentrations, from either the ends of the cylinders or from the sides of the 
cylinders. Cylinders cultured for 3 days after seeding (green bars) showed deeper penetration from the top side by 
cells at concentrations of 5,000-20,000.compared to cylinders cultured for 1 day only (grey bars), which was 
highly significant (p>0,01; ANOVA).  
Values are mean ± SEM, n=3 for every mean value. (Data for 1 day culture of matrices with 40,000 cells/µl are 
missing due to bacterial infection of the cylinders and was not repeated due to the high number of OEC needed for 
this study [app. 20 Mio cells]). 
 
Two striking characteristics could be identified: (i) low cell density of 1000 OEC/µl showed a 
maximum penetration into the matrix of 400µm ± 27µm compared to 850µm ± 26µm when 40,000 
OEC/µl were seeded onto the cylinders after three days (Graph 1, dark green bar; Figure 18, F-I). 
When the penetration depth of cylinders seeded with 20,000 OEC/µl was compared after 1 (grey 
bars) and 3 (green bars) days of culture, a difference in cell penetration depth of up to 350µm 
±45µm (20,000 OEC) could be identified (Graph 1), (ii) at concentrations of 10,000 cells/µl or 
higher, some OEC demonstrated a rounded morphology, rather than spindle shaped. The number of 
rounded cells at 40,000/µl was considered very high after 3 days of culture compared to lower cell 
densities (Figure 18 K-L).  
In the first series of cell culture experiments with three dimensional orientated collagen matrices, all 
three Matricel collagen matrices (SPGX 01, 02, 03) were cut into cylinders as described above and 
seeded with astrocytes, adult OEC or early post natal OEC using a cell concentration of 20,000 
cells/µl and the above mentioned dropping technique. Cylinders were then cultured for 1, 7, 14, 21 
and 28 days (n=3 for each incubation time) and prepared for immunhistochemistry.  
** ** **
    
 
 
66
In all cases, rounded cells attached to the matrices within one hour and occasionally started to 
extend small processes (Figure 19 A-C). The cell density and distribution was in accordance to the 
prior seeding experiments. By 3 days, the penetration of the cells into the matrix was up to 100µm 
deeper than compared to directly after seeding processed cylinders. At this time, all cell types 
Figure 19: Short term culture of glial cells on SPGX 02 and 03 matrices.  
A-C: OEC and AC adhered to both SPGX 02 and SPGX 03 matrices within 1hour after seeding. Only occasional 
cells were found to extend small processes, but all cells were found in close contact to the collagenous scaffold. D: 
Most postnatal OEC (pnOEC) extended bipolar processes along the collagen matrix 1 day after seeding, resembling 
the orientated tubes of the matrix. Cells were highly concentrated at the cylinders surfaces. E: AC extended bipolar 
or multipolar processes 1 day after seeding. Most cells were concentrated at the surfaces of the cylinders. F-G: Adult 
rat OEC formed processes similar to pnOEC on both SPGX 02 and SPGX 03 matrices 1 day after seeding. Most cells 
were found at the collagen wall (G). H-I: OEC (SEM images, green colouration) adhered to the collagen matrix 4 
days after seeding, extending either orientated bipolar (H) or unorientated flattened processes (I). Some parts of 
individual, bipolar-shaped cells were only partially attached to the scaffolds, leaving large areas of the cell surface 
apparently free in the extracellular space (arrows). 
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demonstrated longer processes than could be seen at 1 day post seeding. Most of these processes 
appeared to follow the orientation of the internal pores/channels of the collagen matrix (Figure 19 
D-G). 
After four days of culture, SEM revealed 2 striking morphological phenotypes of cells within the 
matrix: either longitudinally orientated processes of OEC (Figure 19 H), or cells with a more 
flattened appearance (Figure 19 I). Interestingly, not all cells appeared to display complete 
adherence to the matrix, many parts of the cells or processes appeared to be without direct contact 
to the collagen walls.  
After 7 days in culture, adult OEC, early pnOEC and AC had all extended long, orientated 
processes within the matrix (Figure 20 A-C). These processes extended along the collagen pores, 
either as bipolar, spindle-shaped (as in the case of the OEC, Figure 20 A-B) or as multi-polar cells 
(as in the case of astrocytes, Figure 20 C). Very few cells were found to be rounded, without any 
processes. This morphological appearance usually occurred at very high cell densities at the matrix 
surface. While individual cells within the matrix could not easily be distinguished, astrocytes still 
clearly formed longer processes (typically 50-100µm) when compared with either type of OEC 
(typically 20-50µm), which were practically indistinguishable. By 14 days in culture, all glial cell 
types had migrated deeper into the matrix, either from the sides or from the ends of the cylinders.  
The collagen cylinders coded SPGX 02 and SPGX 03 retained their structural integrity up to day 28 
in the tissue culture conditions. At this time point, all 3 glial cell types could be detected at any 
location within the cylinder (examples in Figure 20 D, G), extending long and orientated processes. 
At the centre of the cylinders, the OEC maintained their spindle-shaped, highly orientated 
morphology (Figure 20 E-F). Matrices coded SPGX 01, however, lost their structural integrity 
between 7-21 days in the presence of all three glial cell types. The former orientation of the pores 
disappeared as the matrices gained a more disorganised form (Figure 20 H-I). The surface of most 
cylinders developed holes, and the cells did not look as healthy as they did at earlier time points. 
For example, most cells had short, or no processes and some cells demonstrated fragmented nuclei, 
an indication of apoptosis (Chang et al. 1996; Richter-Landsberg and Vollgraf 1998; Li et al., 
2001). The friable nature of SPGX 01 cylinders resulted in approximately 50% of the material being 
lost during the immunohistochemical processing.  
Motivated by the slight increase of penetration depth over 3 days (shown in Graph 1) further 
experiments were performed to demonstrate OEC migration over increasing incubation times (1, 7, 
14 and 28 days, n = 4 per incubation time). For these experiments SPGX 02 cylinders were dropped 
into OEC cell suspensions (20,000 cells/µl from newly generated OEC populations) and the 
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migration of the cells into the centre of the cylinders showed an almost linear increase of over the 
time (Graph 2). 
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Since cell loaded matrices were intended to be implanted in in vivo models of SCI in the later stages 
of the project, three 7 day seeded SPGX 02 matrices were manipulated with forceps to assess the 
effect of excessive handling on the viability of cells within the scaffold. The matrices were 
compressed slightly and it was found that, 1 hour later, the superficially located cells had retracted 
their cell processes and demonstrated rounded morphologies (Figure 20 J) with fragmented nuclei 
(Figure 20, K). 
 
Graph 2: Migration of OEC within the matrix.  
OEC reveal an almost linear rate of migration on SPGX 02 matrices. The migration of OEC is greater when 
following the main orientation within the matrix (white bars) when compared to the migration of cells 
penetrating the cylinder from the side (dark bars, measured by slope difference).  
Values are mean ± SEM, n=4 cylinders per incubation time. 
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Figure 20: Glial cells on SPGX collagen matrices, 7-28 days culture.  
A-C: Post natal OEC (pnOEC, A), adult OEC (B) or AC (C) showed orientated growth on 
either SPGX 02 or SPGX 03 matrices after 7days of culture. D: pnOEC infiltrated the 
complete SPGX 02 cylinders by 28 days, demonstrating a density gradient from the highly 
populated cylinder surfaces to the centre of the scaffold. E: pnOEC at the centre of these 
cylinders showed highly orientated growth along the collagenous pores (arrows). F: OEC 
showed (similar to pnOEC) orientated cell growth within the centre of the scaffolds after 28 
days of culture. G: Astrocytes also infiltrated the complete scaffolds, showing a density 
gradient of growth similar to pnOEC after 28 days of culture. H: pnOEC on a disintegrating 
SPGX 01 matrix after 7 days of culture. Some cells demonstrated a rounded morphology 
while the matrix revealed signs of rupture. I: OEC on a SPGX 01 matrix also demonstrated a 
rounded morphology as the matrix disintegrated (arrow). J: Surface of an OEC seeded 
scaffold, 1h after mild compression with forceps. The matrix was clearly disrupted and most 
cells demonstrated a rounded morphology. K: High magnification of figure J, showing 
rounded cell morphology and signs of nuclear destruction (arrows) by some cells.  
All scaffolds were seeded with 20,000/µl cells. The schematic diagram represents the 
location of the cylinder from which the images were prepared. 
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Thus, on the basis of these tissue culture investigations, of the 3 coded Matricel collagen matrices, 
SPGX 01 could be ruled out as the scaffold for the in vivo bridging experiments due to its rapid loss 
of integrity. No substantial differences in cell growth or cell morphology on SPGX 02 and 03 
matrices could be observed in these investigations. Therefore, in anticipation of the later in vivo 
experiments, six samples of both 02 and 03 matrix were implanted into adult rat spinal cord. As 
described later, an excessive inflammatory response led to removal of SPGX 03 from further 
investigations (see section 4.3.4.1 for inflammatory response presented and discussed in later parts). 
 
4.2.2.2.2. Specific SPGX 02 Matricel collagen matrix experiments 
To understand the cell- SPGX 02 matrix interactions in more detail, additional in vitro tests were 
performed using mainly OEC. Other cell types were used to investigate cytocompatibility with a 
range of glial cells as well the ability to support neurite outgrowth. 
In order to identify cell proliferation, a kit was used which measures the entire amount of DNA 
(CyQUANT, Molecular Probes) within a test sample. Following the manufacturers protocol for 
DNA measurement, a relatively linear correlation of the calibrated absorbance ratio with increasing 
cell numbers could be demonstrated (Graph 3) and was used for determining the number of cells 
based on the absorbance measured on each sample of collagen matrix.  
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Graph 3: CyQUANT calibration.  
OEC seeded onto 02 matrices display an almost linear fluorescence relative to the number of cells applied. At 
low cell numbers, the autofluorescence signal of ~1232 of empty matrices greatly influences the graph.  
Values are mean ± SEM, n=4. 
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This method was used to estimate increasing cell numbers following the loading of 5,000 cells onto 
the 3D matrices. Four matrices / data point were used and the experiment was repeated 3 times. In 
each of the experiments, a relatively strong autofluorescence signal of non seeded matrices was 
detected (e.g. 1232 at 0 cells applied, Graph 3). It was therefore decided to use 5000 cells for the 
following seeding experiments. Data from one of the experiments is demonstrated below (Graph 4) 
since within each of the three experimental set-ups different OEC populations were used showing 
different cell proliferation rates. 
When 5,000 cells were applied to Matricel collagen matrices (i.e. 3D), an increase of fluorescence 
could be identified during the subsequent 5 days in tissue culture. A similar increase could be seen 
when the same experiment was performed on tissue culture wells (i.e. 2D, Graph 5).  
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Interestingly, when both experiments (2D and 3D) were compared, a lower starting fluorescence 
was detected in the 3D matrix experiment (discussed later). Also, a similar proliferation could be 
seen on the 3D matrix in comparison to the 2D growth of OEC. This data allowed the doubling time 
Graph 4: Growth of 5000 OEC. 
OEC were seeded either on PLL coated dishes (i.e. 2D) or SPGX 02 matrices 
(i.e. 3D). In both setups, a 6 fold (or greater) increase of fluorescence could be 
identified after 5 days of culture.  
Values are given as mean ± SEM for n=4. 
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(see equation in section 4.2.1.1) of each experimental setup to be calculated over the 5 day period. 
In both cases, the doubling time of the populations was in the range of normal cell culture using 
SCOTTS GF medium (see 4.2.1.1. “Adult olfactory ensheathing cells”), being 0.94 days for the 3D 
matrix experiment and 1.66 days for the 2D experiment on the PLL coated 96-well shown in this 
graph.  
 
In summary, these experiments showed that OEC applied to the SPGX 02 Matricel collagen 
matrices were viable and capable of both mitosis and migration. Application of cells onto the 
matrices seemed to be optimal in the range of 20,000-30,000 cells/µl regarding penetration depth. 
Four different additional cell types were seeded onto SPGX 02 matrices for further comparison: 
human OEC, human astrocytoma cells, rat Schwann cells and rat dorsal root ganglia. 
4.2.2.2.3. Other cell types used 
Human OEC and human astrocytoma cells (U373) were seeded onto matrix cylinders at 20,000 
cells/µl (n=3 cylinders for each time point and cell type) and cultured for up to 4 weeks similar to 
earlier experiments. Both human cell types readily attached to the matrix within 1 hour, extending 
long, orientated processes (Figure 21 A-F) between 1-28 days. After 4 weeks of culture, matrix 
cylinders were found to be almost completely infiltrated by both cell types. All specimens studied 
from either cell type showed mainly orientated cells within the centre of the matrices (Figure 21 D, 
E). Round cells were rarely found, even though the cells were highly concentrated at the matrix 
surface, similar to other glial cell types studied earlier. 
Schwann cells seeded onto the SPGX 02 cylinders (20,000 cells/µl, drop-seeding, n=33 total) 
attached within one day, extending small bipolar processes (Figure 21 G). From day 7 to 28, there 
was a considerable increase in the number of rounded cells, while the overall density of Schwann 
cells qualitatively decreased (Figure 21 H-J). At day 28, the general morphology of process bearing 
cells changed from a bipolar to a multi-polar form, with smaller processes or rounded cell bodies 
(Figure 21 I). This important difference in the interaction between the biomaterial and different 
populations of glia was reproducible, having been repeated 3 times. It may also have important 
consequences on the suitability of this form of Matricel matrix for alternative repair strategies, for 
example the repair of peripheral nerve defects. Dr. Bozkurt at the RWTH University Hospital is 
currently investigating the growth of Schwann cells on modified forms of SPGX 02 matrices in 
greater detail. 
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Adult rat dorsal root ganglia (DRG) explants were used to study axonal regeneration on the 
orientated matrices in vitro. DRG were disected, cut in half and placed onto rehydrated blocks 
(approximately 3x3x10mm) or cylinders of SPGX 02 (n=49, 4 separate experiments). The surfaces 
Figure 21: hOEC, U373 and SC matrix preparations.  
A-D: Human OEC (hOEC). One hour after seeding, hOEC bound to the 
collagenous walls (arrows) of the matrix (A). 14 days after seeding, hOEC 
populated large areas of the matrix, concentrating in a thin layer at the cylinder 
surface (B, arrow). The process formation of these cells was highly orientated (C). 
28 days after seeding, some hOEC were found at the centre of the matrix (D). E-F: 
Human astrocytes. Human astrocytoma (cell line U373) attached to the matrix and 
extended long processes into the collagen cylinder 14 days after seeding (E). U373 
cell processes were bundled and highly orientated along the longitudinal axis of the 
pores (F). 
G-J: Schwann cells (SC) attached to the collagen cylinder 1 day after seeding, 
extending highly orientated bipolar processes (arrow) along the collagenous walls 
(G). After 7 days, some Schwann cells throughout the matrix had adopted a 
rounded morphology (H). Many more rounded vimentin and S100-positive 
Schwann cells were detectable by 14 days after seeding (I, arrows). By 28 days 
after seeding, only very few SC were found to be process bearing. Most cells were 
rounded within the matrix or formed clusters close to the surface of the cylinders 
(J). 
Double head arrow shows pore orientation.
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of DRG were covered by a thick connective tissue capsule, preventing any penetration by 
regrowing axons. Therefore, care was taken to place the cut surface of the DRG into direct contact 
with the matrix in order to allow intimate contact between the ganglion and the biomaterial. DRG-
matrix combinations were cultured for 2-4 weeks, either using ONEC Medium or NBA medium. It 
was found that DRG did not bind strongly to the collagen matrices using either medium earlier than 
7 days after explantation. Matrices moved during media change often lost contact with the DRG and 
had to be discarded. Later than 7 days of culture, the contact area between DRG and matrix 
appeared much more stable and by 14, 21 or 28 days after culture, DRG remained firmly attached to 
the matrix. A total of 37 stable DRG – matrix preparations were investigated. 
Immunohistochemistry revealed that cells migrated out of the DRG, almost completely infiltrating 
the whole matrix within 14 days. More cells seemed to migrate out of the material when ONEC-
medium was used. These cells were found to be positive for vimentin (Figure 22 A). Roughly 50% 
of the preparations showed at least some individual axons extending into the matrix. Up to 25% of 
these DRG explants showed strong, multiple axonal regeneration into the collagen matrices, in 
several instances forming bundles (Figure 22 B, C). All such regenerating axonal bundles were 
highly orientated, following the direction imparted by the pores within the matrix. In contrast, no 
axons were found to grow over the outer surface of the matrices. All DRG placed onto the collagen 
blocks were found to be slightly sunken into the material (Figure 22 D). The collagen structure 
immediately below the explants appeared to have lost its highly linear orientation for up to 200µm 
(Figure 22 E, yellow line). 
The use of ONEC medium apparently induced the strongest axonal regeneration compared to NBA 
medium. In such cases, axons were in close contact to S100-positive Schwann cells (Figure 22 F, 
E). Schwann cells could be detected several hundreds of microns deeper into the matrix than the 
regenerating axons. Generally regenerating axons extended up to 3mm into the matrix within the 
collagen pores after 2 weeks. A few, individual axons were found to extend to the other side of the 
matrix (12mm) after 4 weeks of culture, but more detailed analyses were not performed because the 
investigation is now being conducted by Drs. Brook (Dept. Neurology) and Bozkurt (Dept. Plastic 
Surgery) at the University Hospital of Aachen. 
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In summary, the in vitro investigations using SPGX02 matrices demonstrated the following points: 
(i) this form of matrix supported cell growth along the longitudinally arranged inner pore structure 
Figure 22: DRG explants on 
SPGX 02 cylinders, 14 days in 
culture.  
Many vimentin-positive cells 
 migrated out of the DRG into the 
 collagen matrix cylinder within 
 14 days. Many cells 
 demonstrated bundle-like 
 formations following the 
 longitudinal axis of the collagen 
pores (A). In ~50% of the explantation 
experiments, axons extended into the 
cylinder, following the orientated 
channels (B). Some axons also adopted 
bundle-like formations (C, magnification 
of B), following the orientation of the 
collagen pores (double head arrow). In 
most cases, the DRG appeared to be 
partially "immersed" into the surface of 
the matrices (curved surface), and 
migrating cells formed a smooth contact 
at the lateral contact area of DRG and 
collagen cylinder (D, arrow). Most axons 
were accompanied by S100-positive 
Schwann cells (E, arrow). F: A cLSM 
overview revealed that some axons (red 
arrow) were not accompanied by 
Schwann cells, which extended processes 
into the matrix without axons also (green 
arrow). 
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of the matrices and cell migration of a variety of cell types, including human glia and neurites, but 
(ii) Schwann cells seemed unable to maintain such sustained interactions with the matrix, (iii) the 
integrity of orientated channels was maintained for up to 4 weeks in all experiments, supporting 
longitudinally cell processes, including neurites as presented.  
4.3.  Biocompatibility 
 The biocompatibility of either non-seeded or OEC seeded Matricel matrices was studied after 
implantation into acutely lesioned (i.e. lateral funiculotomy) adult rat spinal cord at level C4. At 
chosen survival times, animals were perfused and the degree of integration and the host tissue 
responses were studied using a variety of markers specific for ECM, neural, vascular and 
inflammatory cell types. The results were compared to a control group, in which no scaffold was 
implanted after funiculotomy and one in which an alternative material (i.e. Spongostan, see below) 
was implanted. All spinal cord images shown on the next pages are orientated with the rostral 
aspect of the cord being positioned to the left (or in some cases, towards the upper part of the 
images).  
4.3.1. Animal surgery 
A total of 126 animals were used to analyse biocompatibility, tissue repair and functional recovery 
induced by Matricel 3D collagen matrices. A total of 16 animals died either during or shortly after 
the surgery (Table 7). Only two animals died some weeks after surgery for unknown reasons, but 
most likely not as a direct result of the lesion (according to the veterinarian on duty). 
The spinal cord was exposed after intraperitioneal (i.p.) injection of the anaesthetic agent chloral 
hydrate (375mg/kg body weight). The spinal column was rapidly exposed using both sharp and 
blunt dissection techniques of the overlying neck muscles. Only minor bleeding occurred during 
this approach. Following laminectomy of the dorsal C2-C4 vertebrae and opening of the dura, the 
subsequent unilateral funiculotomy of the spinal cord occasionally resulted in heavy bleeding. 
Haemostasis was achieved using Spongostan, a 100% resorbable unorientated porcine gelatine 
matrix (Johnson & Johnson).  
After performing the chosen surgical procedure (i.e. scaffold implantation or lesion only), animals 
were sutured. In most cases, the dura was closed using 10-0 suture. Muscle layers were also closed 
and the skin sutured. Animals then received 2.5ml sterile saline i.p. and were allowed to recover 
under a warming infra red light. The next day, most animals were able to move freely about the 
cage, taking food and water and showing no signs of pain or discomfort.  
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Table 7: Details of animals used.  
This table summarises the total number of rats used in this investigation. It also includes animals used for data 
acquisition which is not presented in this thesis, e.g. 2 animals with 4 weeks survival time, were a mixture of OEC (p75-
negative and -positive OEC) were implanted. 
 
Experimental animals 
Project Animal use Material 
implanted 
Survival 
time 
Number 
used 
Cell culture OEC / DRG   19 
Preliminary  
biocompatibility 
Lesion only (control)  1-4 weeks 11 
   5-8 weeks 1 
   ≥9 weeks 6 
 Matrix SPGX 02 1-4 weeks 12 
   5-8 weeks 0 
   ≥9 weeks 1 
  SPGX 03 1-4 weeks 4 
   5-8 weeks 0 
   ≥9 weeks 0 
 Matrix plus cells SPGX 02 1-4 weeks 21 
   5-8 weeks 2 
   ≥9 weeks 5 
  SPGX 03 1-4 weeks 6 
   5-8 weeks 0 
   ≥9 weeks 0 
 Animals lost during 
or shortly after 
surgery 
  8 
Sum    77 
Behaviour study Lesion  ≥12 weeks 11 
 Matrix   ≥12 weeks 10 
 Spongostan  =12 weeks 5 
 Matrix plus cells  ≥12 weeks 15 
 Animals lost during 
or shortly after 
surgery 
  8 
Sum    49 
Total Sum    126 
    
 
 
78
4.3.2. Scaffold preparation and implantation 
For implantation, cylinders of SPGX 02/03 matrix were prepared and were cut transversally into 
approximately 1-2 mm thick disk-like slices. In most cases, the slices were slightly compressed due 
to the cutting process. They were then either placed into sterile HBSS or OEC suspensions (40,000 
cells/µl) for rehydration and cell seeding. As reported earlier, compressed matrices regained their 
shape once rehydration was completed. Cell containing scaffolds were cultured for 2 additional 
days to assure cell adhesion prior to implantation.  
Both types of scaffolds were then transferred to the operating room on ice and washed in HBSS to 
completely remove any contaminating substances (i.e. FCS). They could easily be further cut into 
desired sizes to fit snugly into the spinal cord funiculotomy. The longitudinal orientation of the 
scaffolds was easily assured. Both types of scaffolds were carefully placed into the lesion site 
caused by the funiculotomy (see Materials & Methods) and a good implant –host contact was 
usually observed.  
4.3.3. Macroscopic appearance of spinal cord and matrix stability 
Animals were perfused with 4% PFA before the spinal cords were removed. It was apparent that the 
scaffolds were only weakly bound to the spinal cord during the first week post implantation. 
However, as early as 2 weeks post implantation, all implanted scaffolds appeared to be thoroughly 
bound to the host tissue and could not easily be removed without damaging the cord itself. At later 
time points, scaffolds were well integrated, showing a smooth and dense surface macroscopically 
(Figure 23). 
The gross morphology of the scaffold implanted spinal cords showed only minimal differences to 
non lesioned cords. There was no obvious necrosis at or around the lesion implant, nor were there 
any signs of cystic cavitation. Furthermore, late post surgery time points (≥3 month survival time) 
showed no macroscopic signs of matrix instability. Longitudinal sections of the scaffold implanted 
cords revealed typical orientated matrix. No obvious signs of disintegration of the SPGX 02 matrix 
could be observed up to 6 month post surgery.  
2w empty 4w OEC seeded 
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4.3.4. Spinal cord lesion  
Three surgical paradigms were used (lesion only, lesion plus graft of non-seeded matrix, lesion plus 
graft of OEC seeded matrix) and were analysed using a panel of monoclonal and polyclonal 
antibodies (see table 7). In general, each experimental group showed some individual variations. 
This was particularly evident in individuals without properly closed dura of the preliminary study 
group, which showed massive cell infiltration from the lateral side, including invasion by skeletal 
muscle in a few animals. These animals also showed high variations according to the size of the 
host – matrix interface area and cavities. In the following figures, unless otherwise stated, 
antibodies used for immunofluorescence have been indicated in boxes, using coloured text to allow 
easy correlation.  
  
4.3.4.1. Astrocytic and immune responses 
Astrocytes are the main glial cells within the spinal cord. They usually react to injuries by sealing 
off the injury site, forming astroglial scar tissue. One characteristic of this is elevated and intense 
GFAP and nestin immunoreactivity compared to resting astrocytes (Hatten et al. 1991; Shearer et al. 
2003). Both cytoskeletal antigens were therefore used in order to demonstrate the astrocyte reaction 
and possible glial scar formation in each experimental group. Furthermore, macrophages are a 
population of inflammatory cells which also react strongly to injuries, increasing their expression of 
Figure 23: Integration of matrices after two / four weeks in the spinal cord. 
The integration of non-seeded matrices seems less well accomplished after two 
weeks (left) compared to 4 week survival time and OEC seeded matrices 
implanted. Representative cords were chosen for this comparison. 
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the integrin CD45 (leucocyte common antigen and ED1, Birkeland et al., 1988; Popovich et al., 
1997). The macrophages play an important role in clearing debris from injury sites and support 
rejection of foreign substances. Therefore, astrocytic and immune responses are sometimes shown 
in parallel to evaluate the integration of the matrices into the spinal cord combining possible 
astrocytic scaring response and macrophage rejection response. Also, the first part of this section 
will present qualitative data as immunohistochemical images, while the second part is focused on 
quantitative analysis of the data. 
In this section, the macrophage and astrocyte responses shown led to the removal of SPGX 03 
matrices from this investigation as mentioned on page70. Implantation of non-seeded SPGX 02 and 
03 matrices into the spinal cord provoked a massive accumulation of inflammatory cells at the host–
matrix interface by one week. The area of dense infiltration was approximately 200-300µm wide 
(Figure 24 A, arrow). GFAP-positive astrocytes also extended finger-like processes into the contact 
areas (Figure 24 A, asterisk). The polyclonal anti-GFAP antibody demonstrated a relatively strong 
unspecific staining in the scaffolds. Thionin and DAPI counterstains of implanted non-seeded 
matrices revealed the nuclei of cells that had migrated into the margins of the matrix (Figure 24 A, 
B, stars), but the centre of the matrices remained relatively empty. ED1- positive macrophage 
distribution and density was highest at the implant-host interface and also in cyst-like cavities in all 
animals. Only occasional ED1-positive cells were found in the centre of non-seeded matrices. All of 
the ED1 positive cells showed a rounded morphology. 
Two weeks after implantation of non-seeded matrices, a more uniform appearance of GFAP 
immunoreactivity could be observed. The medial host – matrix contact area showed a distinct 
borderline without extended astrocytic cell processes, while the caudal and rostral interfaces 
showed occasional processes extending into the matrix (Figure 24 C, arrow). The astrocytic GFAP 
immunoreactivity was slightly raised for up to 100µm around the implant. In some cases, small 
(200-500µm) cyst- like formations could be detected close to the implant, mainly caudal of the 
implantation sites. All the immunoreactive cells displayed a rounded morphology, with a range of 
cell diameters (between 10-20µm). Many immunoreactive cells could be found at the centre of non-
seeded scaffolds as well as few a millimetres rostral and caudal from the implantation site, but the 
density of these cells remained highest at the implant-host interface. The intensity of ED1 
immunoreactivity within the scaffolds seemed to be greater (up to 400µm into the implant) in the 
non-seeded SPGX 03 preparations compared to non-seeded SPGX 02 implants (compare Figures 24 
C and D), however, the number of ED1-positive macrophages invading the implant at this survival 
time was similar between 02 and 03 implantation groups (see Graph 5 below). The main differences 
between SPGX 02 and 03 matrices were clear by 4 weeks after implantation. SPGX 03 matrices 
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seeded with OEC were heavily infiltrated with cells, presumably macrophages (Figure 24 E) with 
no visible matrix remaining, while non-seeded or cell loaded SPGX 02 matrices were populated by 
visibly lower cell numbers (see Graph 5 below). Occasionally, in some of the SPGX 02 implanted 
animals, higher cell densities could be found, especially on more dorsally located sections where 
there was a gap between the host and matrices (Figure 24 F, H, star) or where connective tissue 
infiltrated the lesion areas (Figure 24 F, asterisk). Nevertheless, the density of cellular infiltration in 
the central area of the implants was much lower compared to SPGX 03 matrices (compare Figure 
24, E and F; Graph 5). In animals receiving SPGX 03 matrices, numerous small (or large, not 
shown) cavities could additionally be seen scattered within rostral or caudal areas of the lesioned 
cord (Figure 24 G, asterisk), but the incidence of these cavities had diminished by 4 weeks in most 
SPGX 02 implanted animals (Figure 24 H). The extent of reactive astrocytosis between SPGX 02 
and 03 matrices was similar, showing straight borderlines between host tissue and scaffold as 
already seen at 2 weeks with a few more processes extending into the matrices with some animals 
(Figure 24 H, arrow).  
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Graph 5: Macrophage infiltration into SPGX 02 and SPGX 03 matrices. 
At two weeks, no difference in numbers of macrophages could be seen in non-seeded 
SPGX 02 or SPGX 03 matrix implants (n=3 each). However, a significant difference 
between cell-seeded matrices could be seen after 4 weeks. The SPGX 03 matrices (n=3) 
evoked a significantly more intense inflammatory response compared to SPGX 02 
matrices (n=6). 
Significance measured by Student t-test, p< 0.05 (*), values are given as mean ± SEM. 
*
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The animals receiving SPGX 03 matrices always demonstrated the most intense ED1 positive 
macrophage response within the scaffolds four weeks after surgery (Figure 24 I; Graph 5), and also 
up to 1mm caudal and rostral of the lesion site. Additional rounded ED1-positive macrophages 
could also be identified further away from the lesions, mainly in white matter fibre tracts. 
Compared to SPGX 03 matrices, non-seeded or OEC seeded SPGX 02 matrices only induced a 
mild macrophage response (Figure 24 I, J; Graph 5). 
Most ED1-positive macrophages in SPGX 02 implanted animals were either located rostral or 
caudal from the lesion sites (star) or within areas, where no clear contact had been established 
between the matrices and the host tissues. These differences were highlighted by the quantifications 
performed on this material. While non-seeded SPGX 02 and SPGX 03 showed no difference in the 
number of macrophages 2 weeks after implantation, a significant difference was found after 4 
weeks. Here, OEC seeded SPGX 03 matrices provoked a significantly (p< 0.011) greater 
macrophage infiltration (2.4x) into the collagen matrix compared to OEC seeded SPGX 02 matrices 
(Graph 5). 
In addition to the macrophage responses detected within the two different types of biomatrices, the 
macrophage responses in the host tissues around the implants were also assessed. Therefore, the 
number of macrophages found within the matrices was directly compared to that of macrophages 
found in the close vicinity of the implants, and expressed as a ratio. Values < 1 indicated a more 
intense macrophage response within the spinal cord than in the matrix, while values > 1 indicate a 
higher macrophage response within the matrix. Following this paradigm, it was obvious that SPGX 
03 matrices (seeded with OEC) provoked a significantly different response compared to SPGX 02 
matrices (non-seeded or seeded with OEC respectively). 
 
 
Figure 24: Astrocytic and immune response.  
A,B: Few cells infiltrated non-seeded SPGX 02 matrices by 1 week (A). GFAP-positive astrocytes were distinct from the matrix 
(arrow). A strong response by ED1-positive macrophages cells was detected around the lesion site and within cysts (B, cy) of 
SPGX 03 implanted animals, while no cells were found within the matrices (stars). C: A distinct borderline of intensely GFAP-
positive astrocytes could be observed by 2 weeks (arrow). D: Two weeks after implanting SPGX 03 matrices, the intensely 
GFAP-positive border contained cysts (cy) which were heavily loaded with ED1-positive macrophages (asterisk). E: High 
densities of thionin stained cells invaded SPGX 03 implants after four weeks.  F:  Non-seeded SPGX 02 matrices, 4weeks. High 
densities of infiltrating cells were observed at the host - matrix interface in this dorsal section only. G: The ED1 immunoreactivity 
of infiltrating macrophages demonstrated an intense cellular response to OEC seeded SPGX 03 implants. The GFAP 
immunohistochemistry demonstrated a densely packed, almost fusiform pattern of reactive astrocytes around the implants. H: 
OEC seeded SPGX 02, 4 weeks. Relatively low ED1-positive cellular response was observed. Only areas without intimate host-
matrix contact demonstrated regions of high macrophage density (star). The astrocytes forming the reactive GFAP-positive 
borders to the implant presented few processes that entered the matrix (arrow). I,J:  The ED1-positive macrophage response was 
intense to the OEC seeded SPGX 03 matrices, while comparable SPGX 02 matrices were only mildly infiltrated by such cells at 4 
weeks. Most ED-1 positive macrophages were distributed around the host - matrix interface and along Wallerian degenerating 
white matter (J, star). K: Non-seeded SPGX 02 implant, 8 weeks. Some GFAP-positive processes extended into the matrix 
(arrows). Few macrophages were visible within the scaffolds, while high densities of these cells were found within small cysts 
(cy). L,M: OEC seeded SPGX 02 matrices, 3 months. Many GFAP-positive processes extended into the rostral (L) and caudal 
(M) parts of the collagen matrices (arrow). Only occasional macrophages were found within the implants or at high density in 
small cystic cavitations (cy).  
Yellow lines indicate matrices dimensions and borders. 
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It was clear that SPGX 03 matrices provoked a massive inflammatory response (ratio 1,7 ± 0,31, 
n=3), while animals implanted with SPGX 02 matrices showed a much milder inflammatory 
response (OEC seeded, ratio 0,71±0,09, n=6; non-seeded, ratio 0,53±0,13, n=3; Graph 6).  
 
On the basis of these observations, it was decided to proceed with the in vivo investigations using 
only SPGX 02 matrices. It was important to only use one type of matrix for the following 
experiments. An additional implantation group with non-seeded SPGX 03 matrices was not 
performed due to the clearness of the presented results and to spare animal life. 
 
At long survival times (i.e. up to 6 months), SPGX 02 matrices remained relatively stable, showing 
some signs of disintegration of the orientated collagen pores only at the implant-host interfaces. The 
distribution of GFAP immunoreactivity was similar for both seeded and non-OEC seeded matrices, 
but relatively heterogeneous within these groups, as indicated by the relatively large standard 
deviations in the quantitative data.  
Graph 6: Macrophage response ratio matrix / spinal cord. 
SPGX 03 matrices seeded with OEC (n=3) provoked significantly greater  
inflammation inside the matrices compared to either naïve (n=3) or OEC seeded 
SPGX 02 (n=6) implants. In the latter implants, a relatively more intense 
inflammatory response is found within the spinal cord than within the implants 
(values < 1).  Significance measured by Student t- test, p< 0.05 (*), values are given 
as mean ± SEM. 
*  
*  
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Graph 8: Number of astrocytic process infiltrating SPGX 02 matrices. 
The number of astrocytic processes seen within each matrix correlated well with the data for length of 
ingrowth, as demonstrated in Graph 7. While there was no statistical significance, there was a clear 
trend for more processes to penetrate the OEC seeded implants (n=8) after more than 12 weeks 
compared to non-seeded matrices (n=5).   
Significance measured by one-way ANOVA, p< 0.05 (*), values are given as mean ± SEM. 
Graph 7: Length of astrocytic processes within SPGX 02 matrices. 
Astrocytic process penetration into the matrix could be seen in either non-seeded (n=3) or OEC seeded 
02 implants (n=6) after 4 weeks and later survival times (n=5, n=8 respectively). Although no 
significant difference could be detected at 4 weeks, there was a clear but non-statistically significant 
trend of longer process ingrowth in longer survival time preparations. Here, the highest difference at 12 
weeks was found between caudal processes within non-seeded implants compared to OEC seeded 
implant processes at rostral (p > 0.128) and caudal (p > 0,078) sites.  
Significance measured by one-way ANOVA, p< 0.05 (*), values are given as mean ± SEM. 
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At survival times of 8 weeks - 6 month, there was a clear but statistically non-significant trend for 
more processes to enter the matrix for greater distances in animals implanted with OEC seeded 
matrices (Graph 7 and 8, also compare Figure 24 K-M). Interestingly, poorly positioned implants 
demonstrated a greater reactive astrocytosis in the host spinal cord. In these animals, only bridge-
like strands of tissue connections were found to span the gap between the implant and the host. 
Most of these bridges were composed of GFAP-positive host astrocytes.  
Within all long-term scaffold implanted animals, ED1-positive staining was only intense at the 
rostral or caudal interfaces between matrices and host spinal cord. The long term implanted animals 
showed almost no macrophage response inside either implants (8-10 cells / 0.15mm²), the slightly 
higher response of macrophages within OEC seeded matrices compared to non-seeded matrices was 
not significant (Graph 9, green bars).  
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In contrast, the inflammatory response within the adjacent host spinal cord was significantly greater 
than that seen in the implants (25-30 cells / 0.15mm², p< 0.00001). Interestingly, when the ED1 
reactivity was compared between all other groups of non-seeded and seeded matrices, there was a 
consistent trend for a slightly more intense inflammatory response in OEC seeded implants; 
however these values were not statistically significant (Graph 10). 
Graph 9: Macrophage infiltration in SPGX 02 matrices compared to that in host spinal cord at 12+ 
weeks. 
Within non-seeded scaffold implanted animals (n=5) and OEC-seeded scaffold implanted animals (n=8) the 
macrophage inflammation response was significantly much stronger in the host spinal cord compared to 
either matrix implantation model. The slight difference of macrophages found in the spinal cord of either 
OEC seeded or non-seeded matrices was not significant (p< 0.74).  
Significance measured by one-way ANOVA, p< 0.01 (**), values are given as mean ± SEM. 
****
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4.3.4.2. Vascularisation 
Vascularisation of the lesion site and implants was confirmed using RECA-1, collagen IV and 
laminin immunohistochemistry. RECA-I identifies a specific rat endothelial cell antigen and 
collagen IV and laminin are two extracellular matrix molecules present in the basal lamina of 
blood- and lymphatic vessels (Barsky et al., 1983; Kramer et al., 1984; Duijvestijn et al., 1992).  
As early as 1 week after implantation, newly formed blood vessels penetrated both non-seeded and 
seeded forms of SPGX 02 matrices. The diameter of the vessels was between 5-30µm, similar to 
small to medium sized vessels scattered in non-lesioned spinal cord tissue. At this time point, only 
particular areas of the scaffold seemed to be infiltrated by endothelial cells (Figure 25 A, box). 
Some vessels surrounded the lesion areas (small arrows), while the vessels inside the scaffolds 
seemed to follow the matrix pore orientation (Figure 25 B, C).  
 
 
Graph 10: Macrophage infiltration into non-seeded and OEC seeded SPGX 02 matrices. 
Generally, more macrophages tended to be found in OEC seeded implants compared to non-seeded matrix 
implanted animals. Also, the inflammatory response seemed to peak at two week survival times, while only 
very low numbers of macrophages were found in late survival times compared to all other survival times.  
Significance measured by one-way ANOVA, p< 0.05 (*), values are given as mean ± SEM. 
n=2      n=2 
n=3      n=3 
n=3      n=6 
n=5      n=8 
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From two weeks post surgery to the latest survival times, all implanted matrices remained 
vascularised, the vessels generally demonstrating a range of diameters between 5-30µm, which was 
similar to contralateral blood vessels found within the white matter (Figure 25 G-J). 
Although most vessels were orientated in parallel with the pores or channels within the scaffolds, a 
small proportion (app. 10-20%) appeared to be tangentially orientated. In most cases, blood vessel 
formation was dominant within the host tissue close to the implantation sites (0-300µm, Figure 25 
C, G). Interestingly, many of these vessels seemed to be orientated towards the lesion/implantation 
sites (Figure 25 G). The vascularisation of the implants was also clearly demonstrated by collagen 
type IV and laminin immunohistochemistry. However, there were obvious differences between the 
intensity of immunoreactivity at the lesion/implant sites and the rest of the surrounding tissues – 
particularly for collagen type IV staining. In these cases, the blood vessels near the implant-host 
interfaces were easily identified, while almost no staining could be observed on vessel walls a few 
millimetres away from the lesion. 
 Lesion only animals showed different blood vessel morphology. Two weeks after funiculotomy, 
the connective tissue-filled lesion sites were vascularised by relatively few collagen type IV 
immunoreactive blood vessels, with no main orientation visible (Figure 25 K). By eight weeks, 
many vessels in the surrounding parenchyma appeared to be orientated towards the lesion sites; 
however, few could still be detected deep within the lesion itself (Figure 25 L).  
 
In summary, from as early as one week after implantation, all SPGX 02 scaffolds were found to be 
vascularised, while the degree of the vascularisation was more variable in some animals within the 
test groups. 
 
 
 
Figure 25: Matricel matrix vascularization.  
A, B: Non-seeded matrices, 1 week. Blood vessels mainly surrounded the matrices (A, arrows), but a few vessels 
penetrated the centre of the matrices (B, magnification of A). C: OEC seeded matrices, 1 week. Numerous vessels 
(arrows) were found at the host - matrix interfaces (red arrows). Only few vessels seem to follow the pore orientation 
(double arrow). D, E: OEC seeded matrix, 2 weeks. The well integrated graft (D, overview) demonstrated blood 
vessels within the orientated collagen pores (E, arrows).  F: OEC seeded matrix, SPGX 03, 2 weeks. Blood vessels 
entered the matrix, similar to SPGX 02 preparations (D, E), following the pore orientation. G-J: Vascularisation 
(arrows) was stable from 4 weeks to 4 month survival time on OEC seeded SPGX 02 matrices. K: Lesion only, 2 
weeks. Few vessels were stained within the loose fibrous ECM (yellow arrows), while many vessels surrounded the 
lesion borders (black arrows). L: Lesion only, 6 weeks: Blood vessels were only found adjacent to the lesion borders, 
while the connective tissue seemed to be poorly vascularised. M: Lesion only, 6 months. Extensive vascularisation 
was only dominant adjacent to the lesion borders (arrows), while the connective tissue within the lesion site itself 
was intensely stained for laminin without presenting a blood vessel-like morphology. 
Double-headed arrows indicate matrix pore orientation, yellow line indicates host- matrix interface, red line 
indicates lesion area. 
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4.3.4.3. NGFr positive cells 
NGFr (p75)-positive staining was always dominant in spinal nerve roots of operated or non- 
lesioned animals. Within the spinal cord itself, p75-positive staining revealed the fine axons in the 
superficial layers of the dorsal horn as well in the meninges. 
One to four weeks after surgery, p75-positive cells could be found in the lesion site of lesion only 
animals as well as in the implanted non-seeded SPGX 02 matrices (Figure 26 A, B). Even though 
background staining was generally found to be intense in these animals after DAB-
immunhistochemistry, p75-positive cells could clearly be distinguished from this unspecific 
background staining (Figure 26 B), showing longitudinally extended processes in some cases. The 
migration of p75-positive cells into non-seeded 02 matrices appeared to be more closely confined to 
the area of the implant-host interface (Figure 26 C, D). The migrating cells in lesion only animals 
appeared to be unorientated in many areas of the lesion site (Figure 26 B). However, those cells 
penetrating the non-seeded matrices adopted the longitudinal orientation of pores/channels (Figure 
26 D, arrow). Many p75-positive cells could be found in close proximity to damaged spinal nerve 
roots (dr) (Figure 26 D, asterisk).  
Animals implanted with OEC-seeded SPGX 02 matrices demonstrated NGFr-positive staining 
throughout the whole scaffold as well as close to the implant-host interface. In the absence of any 
pre-labelling, it was not possible to differentiate between donor p75-positive cells (OEC) and those 
derived from the host. The implant-host interfaces were positive for NGFr-immunoreactivity in a 
band of approximately up to 200µm width; however, almost no specific cell morphology could be 
clearly identified in this area.  
Interestingly, one animal studied three hours after implantation revealed a relatively strong GFAP 
staining of the p75-positive OEC (Figure 26 E,F) compared to later time points (from one week up 
to six month, only very weak GFAP immunoreactivity was correlated with p75-positive OEC). 
For example, four weeks after implantation, OEC seeded matrices showed relatively uniform 
distribution of p75 positive cells within the matrices (Figure 26 G), while a staining for GFAP from 
the same animal showed no comparative staining of cells within the matrix (Figure 26 H). 
Between 4 weeks and the longer survival times of 3-4 months, the relative distribution of p75-
positive cells within the scaffolds remained stable. Relatively few positively stained cells extended 
into non-seeded matrices (Figure 26 I, J); while the OEC seeded scaffolds remained populated with 
NGFr-positive cells (Figure 26 K, L) in all cases, following the orientation of the collagen pores 
within the matrices. These results indicated that OEC seeded implants retain some of the seeded 
cells due to the differences of p75 stainings comparing non-seeded matrices with seeded matrices at 
late survival times (> 3 month).  
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Figure 26: NGF-receptor (p75) immunohistochemistry.  
A,B: Lesion only animals, 2 weeks. P75-positive cells infiltrated the connective 
tissue within the lesion sites. Many of the cells were orientated in parallel with 
each other, migrating towards the lesion epi-centre.  C, D: Non-seeded matrices, 1-
2 weeks. P75-positive cells were mainly found at the host - matrix interface, 
forming a layer of immunoreactive cells and processes that was approximately 
200µm in width. Only few cells extended into the matrices (arrows). Some cells 
seemed to migrate out of damaged dorsal roots (dr) (D, asterisk). E, F: OEC 
seeded matrix, 3 hours after implantation. Near adjacent sections revealed both 
p75-positive and GFAP-positive cells within the matrix.  G, H: OEC seeded 
matrices, 4 weeks. While p75-positive staining was dominant within the matrices 
and at the host-matrix interfaces, hardly any GFAP staining could be detected 
within the matrices on near adjacent sections. Here, only occasional cells were 
stained positive for GFAP. I, J: Non-seeded matrices, 3 month survival time. P75-
positive staining was intense around the implants, as seen in transverse sections (I). 
Dorsal roots (dr) and degenerating spinal cord tissue (asterisk) were most strongly 
stained. Few p75-positive cells were also detected within the longitudinal sections 
of the matrices (J). K, L: OEC seeded matrices, 3 month survival time. The entire 
scaffolds as well as dorsal roots and meninges demonstrated intense p75-
immunoreactiviy. Bundles of p75-positive cells were orientated within the pores of 
the scaffolds, while other p75-positive cells were also found within the host spinal 
cord (white arrow). Double-headed arrows indicate matrix pore orientation, 
yellow line indicates host- matrix interface. 
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4.3.4.4. ECM deposition 
Extracellular proteins are secreted by many cell types during migration, growth and differentiation. 
Therefore, the extracellular matrices can be deposited in the intercellular interstitium or be linked to 
the cell membranes. In this study, the distributions of chondroitin sulphate proteoglycan (NG2), as 
well as laminin and collagen type IV were investigated.  
As shown in section 4.2.4.2, laminin immunoreactivity could be used to identify the ECM 
surrounding the vascular bed. It was also found at the implant-host interfaces and within the 
meninges at all time points. Laminin immunoreactivity could be found in both OEC-seeded and 
non-seeded scaffolds as early as one week after implantation (Figure 27 A, B). The protein was 
diffusely distributed within the scaffolds but concentrated at the scaffold surface. The distribution 
pattern of laminin within the scaffolds was more clearly cellular at later time points, being 
expressed on orientated cells within the scaffolds (Figure 27 C-D), while at the interfaces laminin 
appeared to be in the extracellular space surrounding rounded, negatively-stained cells (probably 
macrophages, Figure 27 D).  
A distinct laminin border was seen in animals 1 week to 3 months post implantation (Figure 27 A-
D) as well as associated with the dura and spinal nerve roots (Figure 27 E-F). Cross sections of one 
late stage animal showed laminin expression within the implant loosely correlated to the former 
grey matter of the spinal cord (Figure 27 F, yellow line). Vimentin immunohistochemistry of near 
adjacent sections confirmed substantial cellular infiltration into the scaffold in these areas, possibly 
indicating regional differences in tissue responses to the scaffolds (i.e. grey matter versus white 
matter). Double immunohistochemistry with anti-nestin and anti-laminin antibodies revealed that 
within the host tissue, the laminin distribution was closely associated to nestin expressing cells 
(Figure 27 I), while within the scaffolds, a distinct separation of both proteins was visible (Figure 
27 J). Within the scaffolds, laminin expression was also associated with structures resembling blood 
vessels while nestin immunoreactivity was associated with the cells and processes of donor OEC 
and host Schwann cells. In the surrounding host tissues, nestin was most likely associated with 
reactive astrocytes.  
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Figure 27: Laminin expression on SPGX 02 implanted animals.  
A: 1 week. A non-seeded collagen matrix implanted animal showed intense laminin expression within the matrix as 
well as within the fibrous connective tissue (arrow). B, C: 2 weeks, OEC seeded matrices. Variable laminin staining 
was detectable within the matrices, revealing both cellular and extracellular distributions (B, C, arrows). The 
meninges (mg) were intensely laminin immunoreactive (B). A distinct laminin borderline was detected between 
matrices and host tissue. D: 4 weeks, OEC seeded matrices. Laminin expression was found to be associated with 
blood vessels (arrows), fibrous cells within the matrices and rounded cells within the host tissue. E: 3 months, OEC 
seeded matrices. Laminin expression associated with the meninges (mg), dorsal roots (dr) and connective tissue 
(arrow) remained strong. Within the matrices, laminin expression was most intense close to the grey matter (below 
yellow line). F-H: 3 months, non-seeded matrices. Laminin expression appeared to be most intense in areas close to 
spinal cord grey matter (F, yellow line), while the whole matrices were infiltrated with vimentin-positive cells in 
adjacent sections (G). A distinct deposition of laminin was visible at the host - matrix interface (H, arrow). I: 3 
months, non-seeded matrices. Laminin expression colocalized with the area of nestin reactivity at the host - matrix 
interface. J: 3 months, OEC seeded matrices. Nestin-positive cells were not closely correlated with laminin-positive 
blood vessels (bv), while weakly stained laminin deposits were found on some nestin-positive cells (arrows, yellow 
correlation). 
Yellow line indicates host- matrix interface. 
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NG2 immunoreactivity was associated with the meninges of all animals. OEC seeded and non-
seeded Matricel scaffolds were both infiltrated by NG2-positive cells and ECM at all time points, 
with no clear difference in the pattern between both implantation groups at all survival times. 
Raised NG2 expression appeared to be qualitatively greatest in animals in which the transplantation 
was less successful and degeneration of the host spinal cord was more dominant.  
An elevated NG2 expression was detected within the lesion area of all animals studied (Figure 28 
D). Two weeks after implantation of non-seeded matrices, the intensity of NG2 immunoreactivity 
was higher at the rostral interfaces (illustrated in Figure 28 E) than at the medial or caudal interfaces 
(Figure 28 A, D, E). Lesioned only animals demonstrated NG2 staining mainly in the connective 
tissue within the lesions (Figure 28 B). Furthermore, connective tissue around major cystic cavities 
showed the highest NG2 immunoreactivity (arrow, Figure 28B). In some animals, the expression of 
NG2 within the OEC seeded scaffolds decreased from 4 weeks (Figure 28 D) to 3 month post 
implantation (Figure 28 E), especially at the central parts of the implants (arrows). The expression 
pattern of NG2 within the scaffolds (Figure 28 F-G) was mostly flattened cell morphology-like, 
with some blood vessels (bv) being stained. Caudal to the implanted scaffolds (+1mm, Figure 28 
H), NG2 expression was reduced to small vascular deposits that were 3-4 times smaller to ED1 
immunoreactive macrophages.  
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Collagen type IV immunoreactivity was associated with blood vessels (as described earlier in 
section 4.3.4.2.) as well as with the implanted scaffolds or within the connective tissue filling the 
gaps of lesioned only animals. In all groups, the deposition of collagen type IV was also highest in 
the meninges and spinal roots, similar to laminin and NG2. Other positive structures demonstrated 
thin, multi-process formations on matrix implants one week after surgery (Figure 29 A). At the 
implant-host interfaces, collagen type IV deposits were also found in a relatively dense, 50µm thick, 
formation between host tissue and matrices, whether seeded or not (Figure 29 B, arrow).  
Figure 28: NG2 expression in experimental animals.  
A: The expression of NG2 in non-seeded SPGX 02 implants was high two weeks after surgery. This expression was 
highest around the implantation site, being more extensive at the rostral area (asterisk). B: 2 weeks, lesion only. A 
NG2-rich connective tissue filled out the lesion site. Tissue surrounding cystic cavities also showed high expression 
of NG2 (arrow). C: 4 weeks. NG2 expression within the matrices showed orientated formation within the matrix 
pores (arrow). The rostro-lateral area of the host tissue (asterisk) was more strongly stained for NG2 compared to the 
caudal host tissue. D: In a poorly orientated implant intense expression of NG2 could be identified within the graft, 
while the rostral-lateral host tissue (asterisk) also showed greater expression of NG2 compared to the caudal host 
tissue. E: Three months after implantation of OEC seeded matrices, a slight difference in the expression density was 
visible in all animals, showing high expression of NG2 at the lateral parts of the matrices, while the more centrally 
located parts of the matrix were less intensely stained (compare arrows, D, E). F, G: NG2 expression in long term 
OEC seeded matrix implants was cellular within the matrices (arrows). H: 1mm caudal of the implants, the intense 
expression of NG2 revieled a very small vesicle-like morphology, clearly different from the morphology found 
within the matrices. 
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Figure 29: Collagen type IV immunohistochemistry.  
A: OEC seeded matrices, 1 week. Strong staining was detectable in the dorsal roots (dr), 
meninges (red arrow) and also at the host - matrix interface (asterisk). Strong staining was 
also observed within the matrices themselves. B: Higher magnification of A: The 
collagenous ECM deposits at the matrix - host interface was ~50µm thick (arrow). Some 
cellular collagen IV-positive structures were located within the matrices. C: OEC seeded 
matrices, 2 weeks. Most staining was associated with blood vessels (bv). The ECM at the 
matrix-host interface appeared thinner than that observed at 1 week survival time. D: OEC 
seeded matrices, 4 weeks. There was relatively little collagen immunoreactivity within the 
matrices, whilst substantial staining could be observed in degenerating areas of host tissue 
(arrow) as well as on blood vessels (bv).  E, F: OEC seeded matrices, 3 month survival time. 
Numerous p75-positive cells were also immunoreactive for collagen type IV (asterisks), 
while blood vessels (bv) and the deposits at the host - matrix interface were p75-negative. G: 
OEC seeded matrices, 3 months. Collagen IV immunoreactivity within the matrices was 
more significant in the outer-most areas, close to the meninges, than in the inner areas. Blood 
vessels were intensely stained. H: Lesion only, 2 weeks. A loose, fibrous connective tissue 
filled the gap caused by the lesion. However, a denser, fibrous collagen IV-positive tissue 
(arrow) could be observed between spinal nerve roots and the ECM of the lesion site. Intense 
staining could also be identified in dorsal roots (dr), the meninges (mg) and within the host 
tissue surrounding the lesion site. I: Lesion only, 4 weeks. Intense collagen type IV 
immunoreactivity was deposited within a "plug" of connective tissue (arrow). J: Lesion 
only, 3 months. Collagen type IV expression was only detectable at the border of major 
cystic cavitation at the lesion site (arrow). Many small calibre blood vessels were also 
observed in the vicinity of the cysts. Laterally located, thin tissue bridges (asterisk) which 
demonstrated collagen IV immunoreactivity could also be observed in lesioned only animals. 
Yellow line indicates host matrix interaction site (A-D) or lesion dimensions (H, I). 
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Between 2-4 weeks, the thickness of this collagen type IV band usually reduced by 50% (20-30µm) 
and was crossed by or composed of multiple blood vessels (Figure 29 C, D). OEC seeded matrices 
revealed collagen type IV associated with p75-positive cells three month after implantation (Figure 
29 E, F), a distribution that was also present in dorsal roots (not shown). While blood vessels (bv) 
were stained for collagen type IV only, many process bearing cells simultaneously expressed 
collagen type IV and p75 (Figure 29 F, asterisk). 
Those lateral areas where the scaffold, dura and host spinal cord interacted revealed loose 
connective tissue that was particularly strongly stained for collagen type IV (Figure 29 G). 
Generally, collagen deposits within lateral parts of all lesion sites seemed highest in close proximity 
to the dura. In lesion only animals, the deposition of collagen IV was most prominent within the 
loose connective tissue filling the gaps of short term survival times (Figure 29 H, I). In long term 
animals within this group, intensely stained collagen type IV deposits were usually located around 
the fluid filled cavities (Figure 29 J) and lateral tissue bridges close to the dura (asterisk). 
4.3.4.5. Axonal response 
The axonal response was studied using antibodies to neurofilament 200 (NF200), often in 
combination with either GFAP or NGFr (p75) double immunofluorescence. Some animals where 
also investigated for the distribution of serotonin and CGRP-positive axons in the lesion sites. As 
early as one week after implantation of non-seeded matrices, single regenerating NF-positive axons 
were found in the scaffolds (Figure 30 A, C). Many but not all of these axons were accompanied by 
p75-positive cells for up to 200µm only within the matrices (arrow, Figures 30 B, C, star, Figure 30 
F). By 2 weeks, numerous, more bundled regenerating axons were found in OEC seeded implants 
(Figure 30 D, E) that in the non-seeded matrices (Figure 30 F). The regenerating axons within the 
OEC seeded matrices were clearly associated with p75-positive cells (Figure 30 D, E) and followed 
the orientation of the scaffolds (Figure 30 E arrow). In contrast, the regenerating axons in non-
seeded matrices were never found to be bundled. Nevertheless, these axons seemed to follow the 
pore orientation of the matrices, alone or in combination with migrating p75-positive host cells. 
At two weeks post operation, lesioned only animals showed qualitatively more regenerating axons 
compared to non-seeded scaffold implanted animals (Figure 30 G, compare with F). Numerous 
fibres could be identified in the connective tissue filled gaps, some of which were associated with 
p75-positive cells (not shown).  
    
 
 
98
 
 
 
 
 
Figure 30: Axonal regeneration, 1-2 weeks.  
A-C: Non-seeded matrices, 1 week. Only a few individual axons (A, asterisk) regenerated into the matrices, mainly following the 
orientation of the pores. Some of these axons were associated with p75-positive cells (B, C arrows). D,E: OEC seeded matrices, 2 
weeks. Numerous axons migrated out of the host tissue into the matrices (D), being accompanied by p75-positive cells in most 
cases (E, asterisk). Most cell aggregates followed the orientation of the pores (double arrow). F: Non-seeded matrices, 2 weeks. 
Fewer axons migrated into the matrices (e.g. compared with seeded matrices in D), not all being accompanied by p75- positive 
cells (asterisk). G, H: Lesion only, 2 weeks. Numerous axons entered the loose ECM from rostral and caudal. Most fibres showed 
a random growth direction (G, centre). H: Axons were able to leave the strongly GFAP positive lesion border. Some fibres 
seemed to follow GFAP positive processes (asterisk). 
Double-headed arrows indicate matrix pore orientation, yellow line indicates host- matrix interface (A-F) or lesion dimension 
(G). 
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The growth of the regenerating axons within the ECM filled lesion site of lesion-only animals was 
random, showing no particular orientation (Figure 30 G), contrary to the marked orientation of 
Figure 31: Axonal regeneration in matrix implantations, 4 weeks.  
A-E: OEC seeded matrices. Extensive axon in-growth into the matrices could be observed. All axons were 
accompanied by p75-positive cells, appearing as bundles (A). Axons were unorientated at the host - matrix interface 
(asterisk), but grew in a highly orientated manner when entering the matrices (B). Most axons were grouped together 
as small bundles or fascicles, some of which were large in diameter and probably ensheathed by the p75-positive 
cells (C). D: Some of the axonal fibres were positive for serotonin (asterisks), reaching the caudal matrix-host 
interfaces. E: Only occasional fibres were positive for CGRP (asterisks). F-H: Non-seeded matrices. Fewer axons, 
which appeared as individual axons rather than bundles, were detected within the non-seeded matrices (F, G). Very 
few of these fibres were positive for serotonin (H, asterisks). A few of these fibres seemed to leave the matrices in an 
unorientated manner caudally (arrow). 
Yellow line indicates host- matrix interfaces. 
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regenerating axons within the matrix implanted animals (seeded or non-seeded). Some of these 
regenerating axons clearly used GFAP-positive astrocytic cell bodies and processes to traverse the 
lesion-host interface (Figures 30 H, asterisk; 32A).  
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The random orientation adopted by many of the axons regenerating into lesion-only areas made 
them inappropriate for the quantitative analysis adopted for this investigation. Single axons could 
cross the references lines multiple times, leading to an over-estimation of the true axonal content. 
These data were regarded as being unreliable, and had to be discarded.  
By 4 weeks post surgery, intense axonal regeneration could be identified in OEC seeded matrices 
(Figure 31 A). Regeneration took place from both rostral and caudal interfaces, but no distinction 
could be made if axons entered the scaffolds from rostral and caudal sides simultaneously or if 
some of these axons truly crossed the implant from one side to the other. In some cases, 
unorientated regenerating axons were found within loose connective tissue close to the implant-host 
interface area. Upon entering the scaffolds, such axons became highly orientated, following the 
longitudinal direction of the pores within the matrix (Figure 31 B, C). Serotonin (5HT)-positive 
axons were found at both rostral and caudal interfaces (Figure 31 D), but relatively few axons were 
positive for CGRP (Figure 31 E). As with NF-immunoreactivity, the non-seeded scaffolds at 4 
weeks demonstrated considerably fewer 5HT- or CGRP-positive axons (Figure 31 F, G, H). The co-
localisation of NF with GFAP-positive astrocytic profiles was more prominent at the lesion-host 
interface, 4 weeks after lesion-only surgery (Figure 32 A, arrows). The tortuous path of many of the 
regenerating axons around the rounded macrophages was also striking at this survival time (Figure 
32 B, stars).  
At long survival times (>3 month), the appearance of the axonal regeneration in all groups seemed 
to be similar to that found at 4 weeks. Many regenerated NF200 positive-fibre bundles could still be 
detected within the OEC seeded collagen matrices (Figure 32 C), while occasional nerve fibres 
grew in an orientation that was tangential to the main longitudinal axis of the collagen pores (arrow, 
Figure 32 C).  
 
 
Figure 32: Axonal regeneration, long-term.  
A, B: Lesion only, 4 weeks. A few axons crossed the intense GFAP-positive astrocytic scar at the lesion edge, following the 
GFAP-positive processes into the lesion site (A, arrows). The growth of the axons within the connective tissue of the lesion sites 
was largely unorientated at this survival time (B, asterisks). C: OEC seeded matrices, 3 months, phase contrast image. Bundles of 
orientated axons extended into the matrices (mx). Unorientated axonal growth could be observed at the caudal host - matrix 
interfaces, where some axons appeared to follow the surface of the matrix (double arrow). D, E: OEC seeded matrices, 3 months. 
Axons from host spinal cord (asterisk) crossed the intensely GFAP-positive implant-host interface (star), using astrocytic 
processes as the bridging substrate to cross the interface (arrows). A neuronal cell body is nicely stained on this section (D, 
asterisk), located in close approximation to the host-matrix interface. F: OEC seeded matrices, 3 months. Some of the regenerating 
axons were likely to have been derived from local, damaged dorsal roots (dr, arrow indicating growth direction). G, H: OEC 
seeded matrices, 3 months, rostral of the lesion. Anterograde BDA labelling of the rubrospinal tract (G, arrow) revealed the 
normal trajectory of axons within the host tissue (ht), rostral to the implanted matrix (mx). Only few axons could be identified in 
close proximity to the implant-host interface (star). I-L: Non-seeded matrices, 3 months. A few axons could be found within the 
centre of the matrices, in most cases being accompanied by p75-positive cells (I). Some matrices were infiltrated by regenerating 
axons which appeared to be derived from spinal tissue adjacent to the medial aspect of the implant (J, cross section), possibly 
from the spinal grey matter (J, gm; K higher magnification) or dorsal roots (J, L, dr). Many fibres appeared to follow the surface 
of the implanted matrices (L, arrow). 
Yellow line indicates host- matrix interfaces. 
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The regenerated axons crossed the intense GFAP- positive implant-host interfaces, occasionally 
using astrocytic processes to bridge the interfaces before entering the matrices (Figure 32 D, E).  
It also became clear that intact and healthy neuronal cell bodies were localized close (< 100µm) to 
the implanted matrices (Figure 32 D, asterisk), an important finding regarding neuronal sparing 
(which will be discussed later).  
Most large calibre axons formed bundles when extending into the scaffolds, while some fine axons 
were found crossing from one bundle to the next one. In some cases, multiple fibres were observed 
to originate from damaged dorsal roots, entering the scaffolds as bundles (Figure 32 F). 
Anterograde tracing of rubrospinal axons using biotinylated dextran amine (BDA) injected into the 
red nucleus (Figure 32 G) indicated no sign of regeneration by the injured rubrospinal tract into 
either non-seeded or seeded matrices (6 animals studied, Figure 32 H). In all cases, BDA positive 
nerve fibre branches could be seen extending medially 1-3mm rostral of the implantation sites. Of 
the few labelled fibres that reached the implant-host interfaces, none were found to enter the 
matrices.  
Of the NF-positive axons detected in the non-seeded collagen matrices, some individual axons were 
found in close correlation with p75-positive cells (Figure 32 I). Transverse sections revealed that 
axonal regeneration generally took place close to the implant-host interfaces (Figure 32 J, K) and 
few of these regenerating fibres could be seen to have originated from damaged dorsal roots (Figure 
32 L). 
Quantification of the axonal response in both non-seeded and seeded matrices demonstrated that 
most axons were found at 4 weeks as compared to the later survival times (Graph 11).  
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Generally, the OEC-seeded matrices provoked up to 100-200% more nerve fibre ingrowth 
compared to non-seeded matrices at early time points. Furthermore, there was a tendency for fewer 
axons to be found in the middle of all the implants (seeded or non-seeded), but this was not 
statistically significant (P< 0,28 rostral; P< 0,46 caudal (one way ANOVA), average mean of all 
survival times and groups). Nevertheless, the number of axons found in adjacent white matter is 
much higher. Here, a minimum number of 180 axons (+/- 10, n=5 sections) within 500µm were 
counted within a single focal plane of the sections, not taking in account fibres seen above or below 
the focal plane. This finding will be discussed later.  
By performing a one way ANOVA analysis on the combined axonal penetration into the rostral and 
caudal areas of the implants (by number of axons / 500µm host-matrix interface), it was possible to 
confirm the main hypothesis that OEC seeded implants induce greater axonal regeneration than 
non- seeded implants (Graph 12). 
 
Graph 11: Axonal regeneration in SPGX 02 implanted animals. 
Detailed overview of the axonal regeneration data at different implant areas. OEC seeded 
matrices tended to support greater axonal regeneration. Both seeded and non-seeded 
matrices revealed greatest axonal penetration at 4 weeks. More sophisticated statistics of 
these data are performed on later graphs.  Values are given as mean ± SEM. 
n=3 
n=7      n=9 
n=2 
n=3 
n=6 
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The number of axons regenerating rostrally and caudally into OEC seeded implants (158 ± 27) at 4 
weeks was significantly greater than in non-seeded implants (58 ± 14; p>0.011) at the same survival 
time, as well as in both OEC seeded (73 ± 9; p>0.009) and non-seeded implants (39 ± 14; p>0.001) 
at later survival times. Additionally, there was a tendency for more axons to regenerate into the 
OEC seeded implants than into non-seeded implants (p> 0,059) of later survival times. 
 
In summary, it can be stated that axonal regeneration within the matrices did take place and that 
OEC seeded matrices supported greater regeneration than the non-seeded matrices. 
Graph 12: Axonal regeneration in SPGX 02 implanted animals. 
Combined axonal regeneration into rostral and caudal areas of the matrices was analysed to give 
an overall indication of ability of the matrices to support regeneration.  Significantly more axons 
grew into OEC implanted animals at the shorter survival times (i.e. 2-4 weeks) than the longer 
survival times (12 weeks or more). OEC-seeded matrices induced more axonal growth than non-
seededmatrices. At longer term survival times, the number of axons found in OEC seeded 
matrices was reduced by ~50% compared to shorter survival times. Significance measured by 
One-way ANOVA, p<0.05 (*), p< 0.01 (**), values are given as mean ± SEM, number of axons / 
500µm host-matrix interface. 
*
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4.4. Functional studies 
As described in the methodology section, 4 groups of animals were used to investigate the 
functional recovery of animals. The behavioural effects of implantation of non-seeded or seeded 
collagen matrices were compared with two control groups: lesion only animals and a group where 
an unorientated gelatine matrix (Spongostan, Johnson & Johnson) was implanted. The staircase test 
was used to quantitatively assess the functional recovery of the operated animals. 
4.4.1. Staircase tests 
The staircase test provided a relatively fast and easy assay to test forelimb recovery. For testing 
animals, thorough training was required before surgery could be performed. Firstly, animals had to 
be motivated to eat the food pellets by maintaining them on a restricted diet, reducing their food 
intake to 12g per day. These animals presented stable or a very slow gain of body weight during the 
full investigation period. Only a minor difference (5-10%) in body weight could be detected 
between lesion only animals and those receiving collagen matrix implants (Graph 13). Significance 
was only found when comparing lesion only animals with those that received non-seeded matrices 
(p=0.011). 
 
 
Graph 13: Animal body weight after end of the study.  
At 3-6 month after surgery, the body weight of lesion only animals (L, n=6), non-seeded matrix implanted 
animals (S, n=6) and OEC-seeded matrix implanted animals (SC, n=7) showed a moderate increase in 
comparison to their weight at delivery (190g, red dotted line).  One-way ANOVA revealed a significant 
difference between lesion only compared to non-seeded matrix implanted animals (p<0.011).  Significance, 
p<0.05 (*), values are given as mean ± SEM.
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Once the animals had identified the food pellets as being edible (usually within one week of daily 
training), they showed no problems in accepting it for the stair-case analysis. Animals were then 
habituated to the testing device by placing them into the staircase chamber, where the stairs had 
already been loaded with pellets. Most animals initially showed signs of fear, remaining in the 
corner of the cages. Only when the food pellets were presented to the animals using long forceps, 
could they be tempted to approach the staircase. The animals then quickly learned to retrieve the 
food pellets. After 4-6 weeks of staircase training, most animals reached a maximum performance 
of 18 pellets retrieved using the left forelimb. Comparison of the food retrieval capacity of both 
forelimbs revealed that animals displayed a slight but non-significant preference for the use of the 
left forelimb (Graph 14).  
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A total of 15% (n=6) of the trained animals showed poor motivation to retrieve pellets and were not 
used for surgery or behavioural analysis. 
The earliest animals to be assessed this way demonstrated a tendency to avoid use of the left 
forelimb, concentrating instead on pellet retrieval using the right forelimb. It was therefore decided 
to further motivate animals by decreasing number of food pellets on the right stairs by 50%. Many 
animals then started food pellet retrieval using the lesioned forelimb.  
Graph 14: Staircase training. 
Animals (numbers are given on the right side) were placed into the staircase weekly for 5 minutes and the number of 
retrieved pellets was counted. A slight but non-significant preference of the left forelimb (+/- 10%) could be seen.  
 Significance measured by one-way ANOVA, p<0.05 (*), values are given as mean ± SEM. 
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Graph 15: Staircase test after surgery, all data.  
Animals receiving any implant showed 5-8 times higher food 
pellet retrieval compared to lesion only animals. Food pellet 
retrieval was higher but not statistically significant on non-
seeded SPGX 02 implanted animals compared to scaffold plus 
OEC or Spongostan implanted animals. The recovery of 
function seemed to stabilise 10-12 weeks after surgery. 
Animals from the Spongostan implanted control group were 
allowed to survive for 12 weeks only, while animals from the 
three remaining groups were allowed to survive for up to 20 
weeks. Significance measured by general linear model, 
multplei-comparison, p< 0.05 (*), values are given as mean ± 
SEM. 
Food pellet retrieval was up to 5-8 times greater in scaffold implanted animals (with or without 
cells) compared to control (lesion only) operated animals (Graph 15, raw data). Animals receiving 
non-seeded SPGX 02 implants showed a surprisingly better trend for pellet retrieval compared to 
OEC-scaffold implanted animals (mean maximal retrieval of 15,5 plus-minus 1,2 compared to 8,5 
plus-minus 1,9). Also, a similar functional recovery to OEC seeded Matricel collagen matrices was 
observed within the Spongostan implanted group. While all three scaffold implantation groups 
reach stable pellet retrieval within 3 months, lesion only animals maintained a poor performance of 
3 pellets retrievals that was achieved within a few weeks. 
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These findings were assessed using general linear model with multicomparisons. Statistical analyses 
could be performed between all groups for up to 11 weeks (odd weeks only) post operation and 
indicated that non-seeded matrices induced a statistically significant improvement in pellet retrieval 
in comparison to lesion-only animals (p< 0.01), whereas the OEC seeded matrix or Spongostan 
demonstrated improvements which were surprisingly not statistically significant (p<0.11 and 
p<0.54 respectively). 
 * 
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Since the main emphasis of this thesis was the use of Matricel collagen matrices, another statistical 
analysis was performed to compare both seeded and non-seeded SPGX 02 (ParaMaix) implantation 
groups with lesion only animals; this also allowed for expansion of the test to survival times of up 
to 15 weeks (minimum N=5 per group, odd weeks only, see graph 16). 
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Here, significant differences were identified for either implantation group compared to the control, 
lesion only group. Non-seeded matrices showed a highly significant improvement in pellet retrieval 
(p< 0.002) whereas OEC seeded matrices showed a moderate, but still statistically significant 
improvement (p< 0.021) in comparison to lesion only animals. Additionally, there was no 
significant difference comparing both implantation groups with each other (p> 0.289).  
Since the food retrieval performance achieved by all trained animals showed some degree of 
variability, it was finally decided to express the results in terms of post-lesional performance of all 
animals expressed as a percentage of the maximal pre-lesion training score. To this end the 5 best 
scores obtained by each animal during the final stages of the training period were compared with 
their 5 best scores following surgery and treatment generating an average impression of the final 
Graph 16: Staircase test after surgery, comparison of SPGX 02 matrices with lesioned only animals.  
SPGX 02 implants, either non-seeded (n=7) or pre-seeded with OEC (n=8) demonstrated a significant 
improvement in pellet retrieval compared to lesioned only (n=5) animals (p<0.002 vs. p<0.021). 
Nevertheless, there was no significant difference between both matrix implant groups (p<0.289). The mean 
pellet retrival of the three groups before surgery was plotted at 0 weeks survival time.  Significance 
measured by general linear model, multi-comparison, p< 0.05 (*), p< 0.001 (**) values are given as mean 
± SEM. 
 * 
** 
 n.s. 
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status of the animals at the end of the investigation. The values for the left (operated) forelimb are 
shown in graph 17. Lesion only animals were capable of a 20% (+/-16%) return of function 
following lateral funiculotomy. Most remarkably, the non-seeded matrix promoted the greatest 
degree of functional improvement (90% +/- 4%) whereas the OEC seeded matrix and Spongostan 
matrices induced more moderate levels of improvement (58% +/- 8% and 60% +/- 16% 
respectively). Statistically significant differences were only identified for non-seeded matrices 
compared to lesion only animals (p<0.0002), while there was a strong tendency for better 
performance of OEC seeded matrices compared to lesion only animals (p< 0.072), but also for non-
seeded matrix implanted animals compared to OEC seeded animals (p< 0.057). Spongostan induced 
improvement were also not statistically significant (p>0.44). 
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Very early in the investigation, it became apparent that, in addition to dietary restriction, the optimal 
demonstration of pellet retrieval by the operated (left hand) forelimbs required the additional 
reduction of the number of pellets available to the right forelimb. The earlier studies repeatedly 
Graph 17: Performance of pellets retrieval.  
The mean maximum of each individuals training performance was compared to each 
individual maximum pellet retrieval after surgery and plotted as maximal percentage of 
performance. Non-seeded matrices (n=8) showed highest performance compared to 
OEC seeded implants (n=12), Spongostan implants (n=5) or lesioned only animals 
(n=6). A significant difference was only detectable for non-seeded matrices compared to 
lesioned only animals (p< 0.0002), while other significance values were greater than 
p>0.05. 
Significance measured by one-way ANOVA, p< 0.05 (*), values are given as mean ± 
SEM. 
  *   p<0.057 
  p<0.072 
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suggested that animals became sufficiently satiated by the number of food pellets retrieved by the 
right (non-operated) forelimb, while they rapidly lost their interest in receiving pellets from the left 
(operated) forelimb. This loss of interest was readily reduced by the reduction of available food 
pellets on the right stairs by 50%. The training phase still employed the use of 4 pellets per stair on 
both sides while after surgery the left stairs received 4 pellets and the right stairs 2 pellets only. It 
was not possible, therefore, to obtain any meaningful information about the post lesional 
performance of the right forelimb.  
The grasping movement of the left forelimb before and after surgery appeared to be different in 
regard to speed and animation. Before the surgery the movements were fast and the animals were 
able to close their fingers to hold food pellets, however, after surgery the movement of the affected 
forelimb was much slower, and the food pellets were retrieved in a “sliding” movement. The pellets 
were pressed between hand and side wall of the test chamber rather than being grasped with closed 
fingers. This suggests some form of compensation rather than complete recovery of function. These 
qualitative observations were not pursued any further because they would have required detailed 
kinematic analysis of forelimb movement. 
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5. Discussion 
5.1. Introduction to tissue engineering 
Tissue engineering strategies for bridging spinal cord injury aim to remove damaged tissue, 
replacing it with an axon growth promoting substrate, which is capable of integrating within the 
host and supporting neuronal and glial cell survival, axon regeneration and functional improvement.  
In cases of human and experimental SCI, significant secondary loss of spinal cord tissue takes 
place, resulting in cystic cavitation which dramatically impedes axon regeneration (e.g. McDonald 
& Sadowsky, 2002). Therefore, repair strategies in spinal cord injury will not only focus on tissue 
preservation and neuron survival, but also on tissue replacement by grafting axon growth promoting 
substrates to bridge the lesion sites (Schwab, 2002). In early experimental studies, different bridging 
experiments were performed using autologous or allogenic living tissue, comprising of foetal spinal 
cord tissue, peripheral nerve grafts or neuronal tissue (Clowry et al., 1991; Jaeger et al, 1993; 
Iwashita et al., 1994; Giovanni et al., 1997; Senoo et al., 1998; Sims et al, 1999). An alternative 
approach to promote axonal regeneration in SCI has been the transplantation of cell suspensions to 
bridge the cyst or spinal injury (for reviews see Ramon-Cueto 2000; Bunge, 2001; Jones et al., 
2001). In most of these studies, some degree of CNS axonal regeneration into the grafts did take 
place; however, there are a number of ethical and practical concerns for all of these approaches. The 
grafting of foetal tissue raised great moral and ethical concerns (Seiger, 1989; Harrower & Barker, 
2004), and access to autologous nerves is limited and allogenic tissue is usually associated with 
immunological problems and the need for immunosuppression. With such considerations in mind, 
the last decade has witnessed much effort, world-wide, in the attempt to develop artificial growth 
promoting scaffolds, using natural or synthetic polymers. In keeping with this goal, the main 
emphasis of the present thesis has been the development and characterisation of novel, highly 
orientated scaffold prototypes made from porcine collagen.  
Ideally, an artificial substrate intended for bridging spinal cord lesions should have the following 
properties, which will be discussed in greater detail. The structure should: (1) be readily modifiable 
and sterilisable, (2) be able to serve as a cell carrier, (3) be immunologically neutral and (4) be 
absorbable (for review see Fawcett, 2002).  
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5.2. Cytocompatibility of the collagenous matrix 
The material used in the present investigation was a prototype of natural origin, made of porcine 
collagen, fabricated with highly uniform orientated pore-like structures (procedure modified from 
Schoof et al., 2001, Kuberka et al., 2002). In this thesis it could be shown that the material is readily 
prepared to the desired size by cutting or “punching”. Punching with the biopsy tool proved to be 
the most reliable method for the manipulation of the material, permitting reproducible processing 
during the staining procedures as well as during cell seeding experiments. 
As mentioned earlier, an important part of this thesis was the determination of the cytocompatibility 
of this new material with neural cells. It has already been reported that similar collagen materials 
with different pore sizes were suitable for cell seeding experiments with human preadipocytes, 
fibroblasts and keratinocytes (von Heimburg et al., 2001; Kuberka et al., 2002). Modifications of 
the pore sizes as well as sterilisation techniques are important variables which affect 
cytocompatibility (Noah et al., 2002; von Heimburg et al., 2003). Therefore, the Matricel company 
put great effort into the characterisation of the newly developed collagen matrix in vitro before 
being applied in the injured SC in vivo. For the present thesis, we hypothesised that the tissue 
engineered implant could promote functional recovery by integrating into the lesioned spinal cord 
and supporting orientated axonal regeneration.  
5.2.1. Olfactory ensheathing cells 
5.2.1.1. The adult rat olfactory ensheathing cells 
Since the main hypothesis of this thesis was built around the combination of adult OEC with the 
collagen matrix, the cytocompatibility of the scaffold was tested most extensively with this 
population of glia. For several years, it has been well accepted that OEC can greatly contribute to 
axonal regeneration and functional improvement following traumatic SCI or demyelination of the 
spinal cord (e.g. Li et al., 1997; Ramon-Cueto et al., 1998; Franklin, 2003). However, there has 
been much recent debate about the contribution of these cells to remyelination (for excellent review, 
see Boyd et al., 2005). Since the early publications indicated that the best regenerative capacity of 
OEC was observed following the transplantation of large numbers of donor cells (Barnett et al., 
1993; Nash et al., 2001; Plant et al., 2002), a similar strategy was also adopted for the present thesis. 
To generate high numbers of purified OEC, a reduced serum, growth factor containing medium was 
used in combination with magnetic cell sorting (MACS). The combination of both methods 
dramatically reduced numbers of p75-negative, fibronectin-positive fibroblasts in culture, due to the 
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high proliferation of OEC in a low serum containing medium. The low serum content was probably 
important to reduce the growth of contaminating fibroblasts (Breenberg et al., 1977, Hoshi et al., 
1984). The nature of these p75-negative cells still remains a matter of debate. Initially, the p75-
negative cells were believed to have astrocyte- like morphology and characteristics, and were hence 
called “A-cells” (Chuah and Au, 1993; Li et al., 1998). More recently, these cells have been 
renamed “olfactory nerve fibroblasts” (ONF) due to their lack of GFAP immunoreactivity and 
strong fibronectin staining. A number of groups reported that these cells play an important role in 
supporting OEC function by forming channels in which OEC and nerve fibres associate and 
remyelination can take place (Franklin, 2003; Li et al, 2005).  
The highly enriched OEC showed signs of dedifferentiation, including the adoption of spindle 
shaped morphology and the expression of nestin (Walder et al., 2003), and were viable for at least 
10 passages. Thus, only relatively few donor animals were needed to obtain the high numbers of 
cells required for the in vitro investigations (up to 2 million cells/cylinder). An interesting 
observation was that a few OEC cultures that were obtained and treated identically and in parallel 
(i.e. from explanting olfactory bulb tissue to the first passage of the cell culture) showed noteworthy 
differences in cell proliferation. This might indicate donor specific characteristics for each cell 
population, i.e. not all donors may be capable of generating large numbers of cells for 
transplantation. This may be an important consideration for such intervention strategies, but was not 
explored further in the present study. In support of this notion, a similar finding has been observed 
by other groups focusing on the expansion of human primary cultures in vitro (Dr. M. Woeltje, 
BioMAT, UK-Aachen, personal communication).  
5.2.1.2. Other olfactory ensheathing cells 
 In addition to adult rat OEC, other neural cell types were used to characterise the properties of the 
collagen scaffold in vitro. It could be shown that the harvesting protocol used for adult rat OEC was 
also successful for post mortem human OEC (hOEC). Despite the fact that the size of human OB 
tissue was approximately five times greater than that of the rat, the number of viable cells obtained 
was similar. This may indicate that the time lapse between removal of the tissue and processing in 
the cell culture facility is crucial to the final outcome, as these bulbs were not processed 
immediately, unlike rat olfactory bulbs. Given that the number of human bulbs available for the 
investigation was very limited, it is important that future use incorporates higher numbers of bulbs 
to introduce more reliable protocols with limitations of timing the tissue processing.  
No obvious difference could be observed between the properties of purified adult rat OEC and early 
post-natal (pn) rat OEC. Even though early pnOEC had been purified using the cell surface marker 
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O4 instead of p75 (Barnett et al., 1993), no significant difference in antigen expression pattern, cell 
morphology or viability could be identified. On the other hand, hOEC did show a different 
antigenic profile compared to adult rat OEC. Human p75-positive cells seemed to co-express p75 
and fibronectin, a pattern that was not seen in adult rat OEC. Moreover, not all p75-positive hOEC 
expressed nestin (~50% of the cells), which also differed from rat OEC. Consequently, some 
antigenic differences may be possible between p75 purified rat OEC and post-mortem human OEC; 
but since only one human bulb could be successfully processed, a definitive conclusion cannot be 
made. Others have reported that human OEC share numerous features of rat OEC, including the 
expression of NGFr and the need of similar growth factors in cell culture (Barnett et al., 2000). 
5.2.2. Orientated collagen matrix in vitro cytocompatibility 
At the beginning of the investigation, Matricel matrices were not available. However, collagen 
membranes (ACI-Maix), derived from the same type of collagen used for the development of SPGX 
01-03 matrices, as well as 3D bovine collagen matrices from the Helmholtz institute were available 
and were used to establish cell culture and seeding protocols as well as for gathering useful matrix 
handling experience that could be employed as soon as the prototypes from Matricel were available. 
In these preliminary investigations, the growth of OEC on the materials was qualitatively 
comparable to that on tissue culture plastic. In particular, the use of the ACI-Maix membranes 
allowed the determination of the compatibility of OEC with the form of porcine collagen used for 
later 3D matrix development at Matricel. This was an important first observation which had, until 
then, remained unknown. Furthermore, OEC were able to extend processes which adopted the 
orientation of the loose fibres on the rough side of the ACImaix membranes as well as following the 
pores of the highly orientated bovine 3D collagen matrix from the Helmholtz Institute. 
Additionally, astrocytes were also able to extend orientated processes within the pores of the matrix, 
a morphology which was not adopted in normal cell culture in cell culture flasks. This finding 
supports the hypothesis that highly orientated collagen scaffolds are capable of supporting 
orientated cell growth which was further investigated in Matricel 3D matrices. It also became clear 
that if the collagenous matrix underwent obvious degeneration, its ability to support the survival of 
OEC was also compromised.  
When the three different prototypes of Matricel 3D collagen matrices were eventually delivered by 
Matricel, it was important to rapidly identify which of these would be the most suitable for later in 
vivo investigations. These new matrices differed from the Helmholtz Institute matrices in some 
important details, one of which was the degree of hydrophilicy and the absence of colour change 
when HBSS was applied. This indicated that the acetic acid residues had been successfully removed 
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during Matricel processing and the surface characteristics of these three new prototype matrices 
allowed rapid liquid absorption. The ability of matrices from Matricel to rapidly absorb fluid 
provided the mechanism for rapid seeding, not just at the surface but also deeper within the pores. 
This characteristic was not present in the Helmholtz Institute matrix.  
The instability of the SPGX 01 matrix internal structure during the basic cell culture methods led to 
its elimination as a potential candidate for the final in vivo investigations. In support of the 
preliminary investigations, the loss of structural integrity resulted in seeded cells adopting a 
rounded morphology with condensed or fragmented nuclear DNA, classical indicators of apoptosis 
when cell-surface contact was lost (Kressel & Groscurth, 1994; Re et al., 1994).  
The remaining two matrices (SPGX 02 and SPGX 03) were both compatible with OEC binding, 
migration and proliferation. Here, it was interesting to find that OEC, when growing from the side 
of the cylinders, could migrate into the matrix, perpendicular to the main orientation of the internal 
pores. This demonstrates the high porosity of the matrix, not only for cells but also for nutrients, an 
important finding for later in vivo experiments.  
The CyQUANT test was a reliable method to study cell proliferation on 3D collagen matrices. It 
was clear that OEC proliferate on the matrix at a rate comparable to that on poly-L-lysine coated 
dishes. In some cases, the rate of proliferation was higher on the SPGX 02 matrices, which may be 
due to the third dimension and much higher surface area within the scaffold, where proliferating 
cells will have more space to grow compared to the 2D culture dishes. Nevertheless, it must be 
noted that the absorbance of 5000 cells applied onto PLL-coated dishes compared to 5000 cells 
applied onto the matrices differed greatly. This finding might indicate that not all of the DNA could 
be extracted from the matrices during the experimental processing. Still, the much higher 
absorbance detected after 5 days on matrices seeded with 5000 OEC was proof for rapid cell 
proliferation on the material. 
Cell survival within the matrices was highly influenced by the initial cell seeding concentration. A 
number of previous investigations had indicated that the use of high numbers of cells would be 
advantageous for the ultimate goal of promoting tissue repair. Cell concentrations ranging from 
50,000 cells/µl up to semi-solid cell pellets have been used in implantation studies (e.g. Li et al., 
2003; Lakatos et al., 2003; Cao et al., 2004). In the present tissue engineering approach, a seeding 
concentration of 40,000 cells/µl revealed numerous apoptotic looking cells with fragmented nuclei 
after 7 days of culture, while almost no such cells were found at lower cell concentrations. A cell 
concentration of 20,000 cells/µl was therefore used with most cell seeding experiments, 
representing a compromise between optimal cell survival and cell loading. The occurrence of a 
density gradient on cell seeding and cell migration suggested a filtration or limited diffusion effect 
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of the collagen matrices. A possible deficit in the supply of nutrients to the deeper parts of matrices 
with greater dimensions than used in this thesis during tissue culture could therefore not be 
excluded. The high concentration of cells at the outer surface of the biomaterials after seeding and 
several days of culture might support this notion since cells usually favour regions that present the 
most favourable growth conditions (Wang et al, 2005). It could prove advantageous for future 
culturing approaches to include a bioreactor-based system to actively provide fresh medium and 
enhance cell growth.  
It was interesting to note that all glial cell types used, apart from adult Schwann cells, demonstrated 
a similar orientated morphology and growth on the Matricel 3D collagen matrices. Schwann cells, 
which are widely acknowledged to have very similar properties to OEC (Wewetzer et al., 2002; 
Boyed et al, 2005), revealed apoptotic behaviour (rounded morphology and fragmented nuclei) after 
seeding onto the matrices and obvious reduction of cell density after 4 weeks of culture. 
Interestingly, this behaviour was not seen when Schwann cells migrated out of DRG explants. In 
such cases, association with regenerating axons appears to maintain Schwann cell survival deep 
within the matrix. Several reasons could be responsible for this (i) Schwann cells may be more 
sensitive to the reduced supply of nutrients deep within the matrix (however, this would not explain 
the presence of fewer surviving cells at the surface of the material observed at 28 days, (ii) the 
medium could probably not be favourable for the 3D culture of the cells, but this medium shows 
strong proliferative activity when used on 2D culture and a differentiation medium with slow 
proliferative activity may be favoured, (iii) Schwann cells do not favour growth onto collagen 
matrices compared to their laminin growth substrate in 2D culture, or the presence of axons derived 
signals makes the Schwann cells less sensitive to degenerative changes. Nevertheless, Schwann 
cells grow on collagen coated cell surfaces as well as Matricel ACI-Maix matrices (preliminary data 
from Dr. med. Bozkurt, UK Aachen). So far, no definitive conclusions can be drawn and the 
behaviour of Schwann cells on collagen matrices is the subject of ongoing investigations by the 
group.  
Most importantly, numerous axons were capable of migrating out of DRG explants into the 
orientated pores of the matrices. While this finding is under further investigation by Drs. Brook and 
Bozkurt at the UK Aachen, the preliminary results indicated that orientated axonal regeneration into 
the matrices is possible, an important in vitro finding supporting the use of this matrix as a bridging 
material in acute spinal cord lesions in the animal model. Only very few recent studies showed a 
similar neurite outgrowth into orientated channels of matrices in vitro (Luo & Shoichet, 2004; 
Ahmet et al., 2006) 
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It can be concluded that Matricel 3D collagen matrices are generally cytocompatible due to a 
number of reasons, including the fact that they supported cell attachment, migration and 
proliferation of a variety of glial cell types, as well as promoting axonal regeneration. Furthermore, 
the structure of the matrix supports highly orientated cell morphology which was one of the goals at 
the beginning of the project. Nevertheless, colonisation of the matrix might be further optimised 
through an improved cell seeding method, active medium support using bio-reactors or through 
chemical modification of the matrix. Such approaches have improved cell growth on a number of 
other biomaterials in other experimental set-ups (Godbey et al., 2004; Hsu et al., 2005; Mao et al., 
2005) and are under further investigation in several tissue engineering approaches by other groups, 
continuously adding data to this relatively new field of medical science.  
5.3. Biocompatibility of orientated collagen matrices 
5.3.1. Introduction to the biocompatibility 
The in vivo studies were divided into two phases: (i) the ParaMaix prototype was investigated for its 
ability to integrate with the host tissue, and (ii) in long term investigations, the functional outcome 
of implanting the material was investigated.  
The biocompatibility of a material may be defined in a number of ways, generally describing the 
properties of a material for the biological system in regard of producing toxic or injurious effects or 
inducing an excessive immunological response. Ideally, in experimental animals, the material 
would be neutral, or even better, promote cell infiltration and integration. To prevent problems 
occurring at the implant-host interface, it would also be ideal that the matrix possess similar 
viscous-elastic properties to the host tissues. This would ensure similar physical properties between 
the implants and the host tissues. For example, while a bone replacement would need hard and 
tensile properties to support structural integrity, a tissue replacement for the spinal cord would need 
soft and flexible structural properties in order to allow “normal” movement of the repaired spinal 
cord in the vertebral canal. Likewise, a hard and stiff artificial replacement implanted into soft 
tissue will provoke shear forces at the interface that may not allow implant integration into the host 
tissue. The viscous-elastic properties of the Matricel SPGX 02 scaffolds were shown to be slightly 
softer than spinal cord tissue (Tunturi 1978, Tunturi 1980), therefore neglecting possible shear 
forces from the matrix to the injured spinal cord 
With regard to the spinal cord, a cell based regenerative strategy should support axonal elongation 
across the lesion site, allowing axon stabilisation and remyelination without evoking an excessive 
inflammatory response. Based on these criteria, Matricel SPGX 02 and SPGX 03 matrices were 
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tested in acute injuries of the high cervical spinal cord of adult inbred LEWIS rats. This was done 
either with or without pre-seeding of the matrices with 40,000 cells/µl few days before the 
implantation to assure optimal cell loading. Even though 20,000 cells/µl were found to be optimal 
for in vitro analysis, the use of 40,000 cells was guessed to deliver more OEC into the lesioned 
spinal cord, since the implantation of 50,000 cells/µl or higher concentrations were used earlier in 
other studies (e.g. Li et al., 2003; Lakatos et al., 2003; Cao et al., 2004). Here, the freshly lesioned 
spinal cord may provide an unfavourable environment for the relatively high number of implanted 
OEC due to the early inflammatory response; therefore a higher number of cells were implanted to 
overcome probable OEC death due to acute inflammation or bleeding in the lesion site.  
A number of indicators of integration between the graft and host were used to identify the 
biocompatibility of Matricel 3D collagen matrices following implantation into the spinal cord 
lesion, including cell infiltration, inflammatory response, glial scarring, axonal regeneration, 
vascularisation and ECM deposition. These parameters should sufficiently describe the usefulness 
of the tissue engineering and cell-based transplantation strategy with regard to functional outcome 
and results from other groups (Anderson 1988, Hunt & Williams, 1995). 
5.3.2. Biocompatibility properties of orientated collagen matrices 
5.3.2.1. Macrophage and astrocytic host response 
Two collagen matrix prototypes (SPGX 02 and SPGX 03) remained as potential bridging substrates 
after the in vitro investigations. It was therefore decided to focus on the inflammatory response, to 
identify possible differences between these samples. Macrophages play an important role in the host 
tissue response to a biomaterial (Rosengren et al., 1997; Farber et al., 2001) as well as in the 
primary and secondary injury processes following SCI (Popovich et al., 1997; Sroga et al, 2003). In 
this study, the inflammatory response was assessed using the anti-ED1 antibody. This is a useful 
approach because it identifies a cytoplasmic protein that is associated with newly recruited blood 
derived macrophages (Dijkstra et al., 1985; Rhodes et al, 1997). However, it must be pointed out 
that ED1 does not identify all cells associated with the host inflammatory response, e.g. T cells or B 
cells. 
It could be shown that SPGX 03 matrix induced a qualitatively and quantitavely more intense 
inflammatory cell infiltration and significantly higher ED1-positive macrophage response compared 
to the SPGX 02 matrix four weeks after implantation. The main differences between these 2 
prototypes of collagen matrix are located in the early manufacturing steps as well as cross-linking 
after manufacture. By request of the Matricel GmbH, these differences may not be disclosed.  
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On the basis of the strong host inflammatory response to SPGX 03 matrices, the remaining 
experiments focussed on SPGX 02 matrices. It was shown earlier that a strong inflammatory 
response directed against graft implants may considerably reduce the axonal regeneration by the 
host tissue (e.g. Mosahebi et al., 2002; Udina et al., 2004). The intense cell infiltration of the SPGX 
03 matrix made it also difficult to make any statement about the stability of SPGX 03 matrices by 4 
week post implantation. Others have reported that rapidly disintegrating biomaterials result in a 
massive cell infiltration and strong ED1 response (Gogolewski et al., 1993; Mainil-Varlet et al., 
1996). These observations highlight the difficulty in predicting the in vivo degradation of a 
biomaterial.  
The SPGX02 matrix never provoked such an intense ED1-positive host inflammatory response, 
even in comparison to the host spinal cord. The macrophage response was strongest at 2-4 weeks 
survival times. An interesting finding of this study was the slightly but not significant higher 
macrophage response to OEC seeded collagen matrices compared to non-seeded matrices at any 
given time point of the investigation. This gives rise to the question if OEC either (i) attract more 
macrophages to the lesion site due to secretion of macrophage mobilising factors, resulting into 
better clean-up of the area of regeneration, or (ii) if the slightly higher inflammation is a response 
directed against the implanted OEC in some ways. While the use of inbred experimental rats (Lewis 
strain) should prevent a rejection of the implanted cells, the experimental expansion of the cells in 
the cell culture laboratory may have changed properties of the OEC in a way which provoked a 
slight rejection of some of these cells. It is well known that certain cell culture conditions may 
dedifferentiate primary glial cell types (e.g. Grinspan et al., 1996; Mirsky et al., 1996; Yokojama et 
al., 2004) which may further affect the host response to these cells. If in this investigation the likely 
dedifferentiation of the OEC in vitro (as indicated by nestin expression and rapid proliferation) may 
have influenced the inflammation in vivo needs further investigation. It also is possible that the 
implanted OEC differentiate rapidly and stop dividing as was shown recently for human OEC 
(Deng et al., 2006) and that apoptotic OEC induce the slightly higher macrophage response for the 
full length of the investigation. So far, no real conclusion can be made and needs further 
investigation. 
Furthermore, the number of ED1-positive cells at the site of the injury significantly decreased at the 
longer survival times, showing significantly less ED1-positive cells in the implant compared to 
ED1-positive cells found in the spinal cord next to the implant. An enhanced ED1 immunoreactivity 
could also be observed in spinal cord fibre tracts far away of the lesion. This most likely indicates 
the degeneration of axons and oligodendrocytes during Wallerian degeneration in this territory (e.g. 
Torvik, 1975). In comparison, other tissue engineering approaches in SCI have revealed an 
    
 
 
120
inflammatory response induced by the implant that was similar in intensity to that of animals 
receiving a simple lesion (Gautier et al., 1998; Kataoka et al., 2004), indicating possible advantages 
in the use of Matricel 3D collagen matrices.  
Most of the tissue engineering approaches employed to date have attempted to develop and use 
artificial polymeric biomaterials with biodegradable features, polymerised from lactic acids (PLA), 
glycolic acids (PGA) or a combination of both (PLGA) (Kiyotani et al., 1996; Oudega et al., 2001; 
Moore, 2005). All these materials incorporated hydrolysis properties. It is commonly known that 
non-degradable materials provoke a foreign body response, mainly due to the stiffness of the 
materials used, inducing local damage and irritation by generated shearing forces (Xu et al., 1995; 
Xu et al., 1997; Cadee et al., 2000). However, as mentioned above, rapidly degrading biomaterials 
may provoke a massive inflammatory response and apoptosis due to the flooding of the injury sites 
with potentionally harmful degradation residues such as lactic acid (Fabre et al., 1999). A 
biomaterial for use in SCI would therefore ideally support regeneration for as long as the repair 
process is required and should be resorbed by the host once the new tissue is formed. The main 
questions relating to this balance of properties are (i) how long does it take for the newly 
regenerated tissue to form and (ii) at what point should the supporting biomaterial start to degrade. 
These issues are far from being resolved in experimental tissues and are even less well defined for 
patients.  
Using a highly cross-linked collagen scaffold with very slow auto-hydrolysis properties in the 
present study, a different approach to tissue regeneration was followed: here, the properties of the 
host cells themselves are thought to determine the rate at which the degradation of the material 
takes place since astrocytes, activated macrophages and blood vessels are known to possess 
metalloproteinases (MMP) capable of digesting collagen (Gottschall et al., 1995; Deb and 
Gottschall, 1996; Seandel et al., 2001). Instead of implanting a material which dissolves at a certain 
time point, a very stable material was used. This may explain why relatively few ED1-positive 
macrophages could be seen in the scaffold and why much of the matrix was still visible at long 
survival times. It is possible that such a matrix provided much needed structural support for the 
lesion area, but additional investigations, including expression studies of MMP are needed to clarify 
this idea.  
Another indication for the degree of integration of an implanted biomaterial in the spinal cord is the 
astroglial response. Similar to the formation of a fibroblastic scar in the periphery, where a foreign 
material may be encapsulated and isolated from the rest of the body, reactive astrocytosis (involving 
mitosis and hypertrophy of local astrocytes) is an important response which can effectively seal an 
injury site (or isolate a foreign body), thereby protecting the adjacent surviving tissue . Such an 
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astrocytic response evolves around foreign material through juxtaposition of astrocytic end feet end 
deposition of collagen (Menei et al., 1994). During this process, cystic cavitation takes place which 
contributes to secondary tissue degeneration (Butovsky et al., 2001). The implantation of the 3D 
collagen matrices resulted in a relatively mild astrocytic response around the implanted scaffolds 
with only moderately raised GFAP immunoreactivity and scattered and small cyst-like formations 
at the host – matrix interface. Furthermore, numerous GFAP positive processes could be identified 
in the rostral and caudal site of the implants between 2 weeks and 6 month post surgery, especially 
in OEC seeded matrices, which may contribute to the finding that OEC implantation into spinal 
lesions reduced cavitations and astrogliosis (Verdu et al., 2001). This may also indicate that after 
the initial surgical insult, astrocytes slowly integrated it into the matrix. These signs of good graft-
host integration are further supported by the formation of new blood vessels as early as 7 days after 
implantation. Not only does this prove that the collagen matrix is not “sealed off” or isolated from 
the host tissue but is actually incorporated into the tissue with the ability to provide nutrients deep 
within the implant. Such a response is crucial for maintaining cell viability and functions deep 
within the scaffold, and has been demonstrated in other collagen scaffolds (e.g. Seandel et al., 2001; 
Sweenie et al., 2003). Therefore, OECs seeded onto the matrix would only require a few days of 
passive nutrition by diffusion until blood vessels would be able to provide further support. The 
vascularisation of the implanted matrix was stable for the duration of the investigation, indicating 
long term integration of the material, even in the absence of its resorption by the host tissue. The 
newly formed blood vessels were intensely immunoreactive for collagen type IV and laminin, 
confirming earlier reports (e.g. Hermanns et al., 2001). Such successful vascularisation has also 
been reported following the implantation of other biomaterials (e.g. PLA-based materials; Partist et 
al., 2004; Hurtado et al., 2005). Grippingly, some of the blood vessels growing throughout the 
Matricel collagen matrix grew perpendicular to the main orientation of the internal pores, which 
was particularly evident at later time points. This indicates that the formation a real 3D blood vessel 
network is possible within such collagen matrices. The highly orientated pore formation therefore 
may give initial support to the regenerating tissue, but does not restrict the regrowing tissue to the 
longitudinal orientation.  
The in vivo results discussed so far were not strikingly dependent on or affected by the presence of 
OECs within the Matricel collagen matrix. There were no significant differences between the non-
seeded and seeded matrices regarding the matrix stability, macrophage response, astrocytic scarring 
or vascularisation. In contrast, the lower macrophage response within the implants compared to that 
seen in the host tissue, the good degree of vascularisation and the penetration of astrocytic processes 
with the implants are indicators of good integration of the matrices into the host spinal cord. 
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5.3.2.2. Axonal regeneration within the implants 
As presented in the results section, the most impressive differences that could be detected were seen 
when antibodies for NGFr (p75) and axonal antigens (NF200, 5HT, CGRP) were used. Following 
implantation of non-seeded scaffolds, some of the infiltrating cells were NGFr-positive, most likely 
reflecting the presence of Schwann cells migrating from damaged spinal nerve roots. This notion is 
supported by the fact that these cells also expressed weak GFAP-, nestin and collagen type IV 
immunoreactivity, characteristics typical of Schwann cells (e.g. Wewetzer et al., 2002). 
Interestingly, the meninges and other areas of the spinal cord were also found to be NGFr-positive 
(Urschel & Hursebosch, 1992). Although many previous reports have concluded that the NGFr-
positive elements within spinal cord lesions were Schwann cells (e.g. Wang et al., 1996; Gai et al., 
1996), it is unlikely that all these structures within the SPGX matrices were Schwann cells but may 
also be NGFr positive meningal cells, axons or be derived from other cell populations.  
Nevertheless, orientated NGFr-positive Schwann cell networks were found in lesions of the spinal 
cord (Brook et al., 1998, 2000), and similar observations have been found in this thesis. The 
postulated early Schwann cell-mediated support for axonal regeneration may have been augmented 
by the structural support provided by the implanted SPGX 02 collagen matrix. Some infiltrating 
NGFr-positive cells (presumably Schwann cells) were associated with regenerating axons, and 
numerous NGFr-positive cells could be identified at the matrix – host interface. Here, Schwann 
cells as well as lesioned axons and leptomeningal cells may be expressing NGFr as a reaction to the 
lesion (Koliatsos et al., 1991). Interestingly, the expression of NGFr remained high for up to 6 
months in the non-seeded grafts.  
The number of regenerating axons within the non-seeded matrices, either with or without associated 
Schwann cells was nevertheless relatively low. In comparison to other studies (e.g. Brook et al., 
1998; 2000) and the lesion only control animals performed in this study, a relatively low level of 
Schwann cell associated axonal regeneration was evident. This finding dramatically changed when 
adult OEC were introduced to the scaffold prior to implantation. Not only was a strong and highly 
orientated growth of large and small calibre axons obviously and significantly supported by OEC, 
but it could also be shown that unorientated fibres at the host–matrix interface adopted the 
longitudinal orientation when entering the matrix. Since a continuous band of cellular NGFr 
expression extended from bundles within the matrix and reached into the host-matrix interface, it 
may be postulated that OEC entered this area. On the other hand, a strong, long distance migration 
of donor OEC into the adjacent host spinal cord was not seen. This is in contrast to the migratory 
behaviour (<500µm) of transplanted OECs reported by other groups (for review see Nieto-
Sampedro, 2003; most recent study by Deng et al., 2006). Nonetheless, it must be kept in mind that 
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the implanted OEC were not prelabelled. A definitive answer to the question of OEC survival and 
migration cannot be stated. 
The OEC-seeded matrix was heavily infiltrated by regenerating NF200-positive axons, probably 
from both rostral and caudal sides, but it was not possible to clearly determine if axons were 
traversing the complete implant. Nevertheless, the numbers of axons entering the seeded matrices 
were significantly higher compared to non-seeded matrices, which favours the original notion that 
(i) the collagen matrix supports orientated axonal regeneration, and (ii) the addition of adult 
olfactory ensheathing cells further enhances the regeneration of axons in the lesion site.  
Some of the regenerating axons were found to be serotoninergic (5HT) or CGRP-positive. In 
particular, the finding that some 5HT-positive axons were found ispilateral and caudal to the matrix 
might indicate that these descending fibres had regenerated through the matrix. However, the 
possibility of axonal growth around the implant or even sprouting of axons from contralateral non-
lesioned fibres cannot be excluded. Anterograde labelling of the descending rubrospinal tract 
revealed that the functional improvement of the animals (see later) was not due to axon regeneration 
of these fibres through the implant, however, there were some indications that such axons grew 
around the lesion site. Nevertheless, these axons could also be ‘compressed’ into the non-damaged 
spinal cord by slightly oversized implants, a finding which could not be further explained. 
5.3.2.3. Extracellular matrix expression in lesion sites 
The ability of axons to penetrate a lesion or implant depends heavily on the extent to which certain 
ECM molecules are expressed in and around the area. ECM molecules are known to have both axon 
growth-promoting and repulsive effects. Within the lesion site and SPGX scaffolds, a strong 
expression of NG2 (a member of the chondroitin sulphate proteoglycans) and laminin was detected, 
whereas only a moderate expression of collagen type IV around the implant was observed. While 
laminin is widely regarded as being a strong axon growth promoting substrate, NG2 and also, 
indirectly, collagen type IV, have been reported to have axon growth repulsive properties (for 
review see Plant et al., 2001; Morgenstern et al., 2002; Grimpe & Silver, 2002). However, it must 
be stated that there has been much controversy within this field over the last years.  
It has been shown, that Schwann cells express laminin as well as NG2 and that areas of NG2 
expression may also be growth permissive in rubrospinal tract lesions (for review see Jones et al., 
2003). The cellular expression of laminin found within the implant may therefore be attributed to 
the infiltrating Schwann cells or OEC. Additionally, the overall growth permissive or inhibitory 
activity of a particular region of CNS (lesion site or implant site) will ultimately depend on the 
balance between growth supporting and inhibitory molecules. In particular certain laminin peptides 
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may actually modify or overcome the growth inhibiting activity of other ECM molecules (Wiksten 
et al., 2004). Furthermore, other groups reported that another growth promoting cell adhesion 
molecule (L1) has also been shown to reverse, if not neutralise, the inhibitory properties of NG2 
(e.g. Dou and Levine, 1994). The present data also supports such a notion. The axon growth 
promoting effects of laminin identified in the present investigation may have shifted the positive-
negative balance of the ECM to be able to support regeneration, at least by some populations of 
axons. This, plus the fact that either OEC or host Schwann cells are known to secrete axon growth 
promoting factors (e.g. NGF, BDNF, Wewetzer et al., 2002; Lipson et al., 2003) may contribute to 
axonal regeneration within the matrices. This may be responsible for the significant improvement of 
axonal regeneration seen in OEC seeded collagen matrices compared to non-seeded matrices. Since 
NGFr expressing cells and processes extend beyond the collagen IV rich host – matrix interface, it 
may also be argued that the donor OEC may have facilitated axonal growth across the collagen type 
IV rich inhibitory region. Here, collagen type IV is thought to impede axonal regeneration within a 
CNS scar by binding growth inhibitory ECM molecules and acting as a molecular barrier (Stichel et 
al., 1999). However, the influence of collagen IV on the behaviour of regenerating axons is not 
homogeneous. Some populations of spontaneously regenerating axons appear to be able to penetrate 
the fibro-adhesive, collagen IV-rich scar, even in the absence of donor glial cells or implanted 
matrices (Joosten et al., 2000; Iseda et al., 2003, 2004). 
5.3.3. Behavioural improvement after implanting Matricel collagen 
matrices 
Contrary to the strong axonal regeneration response identified following transplantation of OEC 
seeded scaffolds; the present investigation was not able to identify a similarly strong functional 
improvement in the staircase analysis. Surprisingly, the implantation of non-seeded scaffolds 
supported greater functional improvement than that observed following implantation of OEC 
seeded scaffolds, even though this difference did not reach statistical significance. This leads to a 
number of possible interpretations, the most obvious being that the significantly stronger axonal 
regeneration observed within the OEC-seeded scaffold has no direct bearing on the functional 
improvement of the animals, since non-seeded scaffolds with only minor axonal regeneration 
induced a statistically non- significant, but strong trend (p>0.057) of better return of function 
compared to the strong axonal regeneration within OEC seeded implants.  
The original hypothesis for the research was that scaffold induced axon regeneration of the lesioned 
rubrospinal tract would lead to the return of fine motor control of the affected forelimb. The 
anterograde tracing experiments revealed no penetration of the implant (either seeded with OEC or 
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non-seeded) by BDA-labelled axons. Close inspection of the performing animals suggested that 
transplanted animals did not recover fine grasping control of the affected paw. It is possible that 
lesion-only animals had less sensation in the affected forelimb resulting in reduced coordination. It 
also would be possible that these animals sense more pain compared to scaffold implanted animals 
due to the lesion and cyst formation which may result into less motivated feeding behaviour 
compared to either scaffold implanted animals. Some neurosurgeons suggest that cyst formation in 
SCI leads to intractable pain sensation (Nashold et al., 1990) and that alteration of the cyst 
dimensions may lead to reduction of this discomfort (Lee et al., 2000). Such a mechanism has also 
been postulated elsewhere (Mills et al., 2001). This would be intrinsic and maybe steady pain 
sensation since animals that were tested did not to feel squeezing of the forelimb with forceps 
during the whole testing phase. The staircase test used in this investigation to assess return of 
function is suitable for demonstrating objectively the return of function but cannot determine the 
mechanisms of return of function. To test the mechanism underlining the recovery of animals, other 
tests would have to be applied, e.g. electrophysiological tests of the animals. 
Partial sparring of lesioned spinal cord matter in all three experimental groups may be one reason 
for the better functional recovery of scaffold implanted animals due to a number of reasons. Recent 
studies in which grey matter was pharmacologically rescued after a thoracic contusion injury 
showed an increase in the control of trunk musculature, although hind limb locomotion did not 
improve (Mills et all, 2002). Professor Reier has raised an interesting point about cervical short-
projecting propriospinal neurons (PSNs) (Reier, 2004). It is reported, that C3–C4 PSNs in the cat 
project monosynaptically onto motoneurons, la inhibitory interneurons, spinoreticular and 
spinocerebellar neurons at the forelimb segments of C6–Th1. These neurons receive converging 
cortical and brainstem projections and mediate the command for visually guided target-reaching 
movements and conjoint control of axial muscles to stabilize the trunk during target reaching. If the 
scaffold in the present investigation allows some degree of regeneration along its surface as well as 
promoting neuronal sparing (particularly of short distance projections within the close grey matter) 
as indicated in the results section, it is possible that this may have prompted the functional 
improvement. Very similar findings and conclusions were also presented from a most recent tissue 
engineering approach combining cell graft and pharmacological intervention simultaneously (e.g. 
Fouad et al., 2005). Fouad and colleagues reported strong axonal growth through a tissue 
engineered bridge, but concluded that PSN axons may be responsible for the functional 
improvement by acting as relays for ascending and descending fibre tracts. 
Therefore, the results produced in this thesis represent another promising intervention strategy to 
promote axonal regeneration and functional recovery after certain types of SCI. A more skilled 
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implantation procedure might be needed in order to reduce compromising effects of badly 
orientated implants or unsuccessful closure of the dura after implantation. The inability to close the 
dura provoked muscle and fibrous tissue infiltration into the implant as well as outward 
displacement of the spinal cord tissue at the host-matrix interaction site (also see Brook et al., 
2000), which proved to be unfavourable for this implantation strategy. As a matter of fact, the 
implantation procedure itself seemed to be the greatest variable within the in vivo investigation part 
and may need highly trained neurosurgeons for later human implementation of the Matricel 
collagen matrix in clinical trials. It seemed that when the matrices did not perfectly fit into the 
lesion gap, but left some areas of the lesioned spinal cord without contact to the implant, large cysts 
formed which led to the retraction of some host spinal cord matter away from the implants. Large 
cyst formation at the lesion site was also evident in most lesioned only animals which proved to 
show the worst recovery of function. Therefore, precisely fitting implants may favour functional 
recovery, partly by the prevention of cystic cavity formation and add to the general regeneration 
process by supplying a stable, highly orientated growth permissive substrate to the spinal cord 
tissue, including connective tissue, blood vessels and axons. 
Two immediate targets of this strategy would be replacement of lost spinal cord tissue in acute 
injury or replacement of cystic cavitation in chronic spinal cord injury, which has not yet been 
studied using this material. Collagen as a bridging material in SCI has been widely used by other 
groups (de la Torre, 1982; de la Torre & Goldsmith, 1992, 1994; Bunge 1994; Kataoka et al., 2004; 
Yoshii et al., 2004) providing a non-hostile substrate for regenerating axons. In particular, the 
Yoshii group showed that orientation of implanted collagen fibres in transected spinal cord is 
important to support strong axonal regeneration which was also associated with functional 
improvement. Therefore, replacement of lost tissue after penetration injury or stab wounds may be 
warranted where substantial damage has already been caused. There are relatively few clinical 
investigations concerning intervention strategies to promote repair following human SCI, e.g. 
implanting autologous nerve grafts in combination with fibrin glue, containing acidic fibroblast 
growth factor, into a chronic stab wound of the spinal cord (Cheng et al., 2004). Here, substantial 
improvement of the patient’s motor score could be achieved, which is one of very few examples of 
an intervention treatment similar to the experimental set up of this investigation. In the future it is 
possible that combining of growth promoting factors to the Matricel collagen matrix may be more 
favourable for tissue repair. It seems unlikely to include combination with autologous olfactory 
ensheathing cells due to low availability of such donor cells. Improvements in harvesting of OEC 
from nasal mucosa, expanding and differentiating precursors from the human nasal epithelium may, 
however, change this opinion and was performed most recently, where three paraplegics received 
    
 
 
127
autologous OEC implants (Feron et al., 2005). Also the use of other human progenitor cells (e.g. 
mesenchymal stem cells from the bone marrow, Callera & de Nasciemento, 2006) may be an 
alternative in the middle or near future. 
The implantation of any device or scaffold in chronically injured patients may seem appealing at 
first glance, but this runs the very serious risk of inducing further surgical damage to any preserved 
tissue. This could jeopardise the continuity of any residual nerve fibres (and therefore function) - a 
situation that most neurosurgeons would consider most unfavourably.  
In all situations, the addition of other complimentary treatment strategies to further promote 
functional improvement seems to be required and is also proposed and discussed by other authors 
(Jones et al., 2003; Kleitman, 2004). For example, some success was reported when 
pharmacological treatment was applied to spinal cord injury by using either chemicals to reduce the 
early inflammatory response to injuries or even antibodies to overcome inhibitory effects of ECM 
molecules (Kobayashi et al., 2003; Hall & Springer, 2004). A combination strategy using 
pharmacological as well as cell based scaffold intervention, as recently shown in an experimental 
model of SCI (Fouad et al., 2005) is very likely to be the basis of any successful future bridging 
strategy using Matricel collagen matrices or any other suitable biomaterials. A possible scenario 
would be the use of a biomaterial to (i) bridge a defect by additionally giving (ii) structural support 
and replacement of lost tissue. The addition of cells to the biomaterial would support the integration 
of the biomaterial to the host tissue, while additional injections of cells into the host spinal cord 
might supply more growth promoting molecules. Parallel application of inflammation reducing 
factors, antibodies directed against growth inhibitory substances and medication to enhance 
neuronal sprouting would further enhance possible axonal regeneration. Additionally, physical 
therapy to the injured patient would round up this set up by e.g. reducing muscle atrophy.  
At present, the structural design of the Matricel collagen matrix as a highly orientated and 
extremely porous scaffold seems to represent a highly attractive substrate for repairing acutely 
damaged spinal cord tissue. Its highly orientated inner pore structure presents great advantages as a 
guidance structure to replace spinal cord white matter as compared to the tubular scaffolds (e.g. 
Bunge, 1994) or porous scaffolds (e.g. Kataoka 2004) that have been used so far. Furthermore, the 
very low immune response of the host tissue strongly supports further use of this material in applied 
models of spinal cord injury. 
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6. Summary 
In conclusion, the following statements can be made from the main results of this thesis: 
 
• The Matricel collagen matrix is a highly stable and cytocompatible scaffold, supporting 
highly orientated growth of a variety of neural cell types. 
• The matrix is well integrated into the acutely injured spinal cord, promoting cell infiltration 
and early vascularisation and no excessive inflammatory response.  
• It supports highly orientated axonal regeneration in vivo, which is significantly improved by 
the addition of adult olfactory ensheathing cells. 
• The matrix supports functional improvement after acute spinal cord funiculotomy in the 
animal model. 
• Despite other bridging materials studied before, Matricel SPGX 02 matrix is of a natural 
protein already in use as medical products by this company and approval for medical use 
may be easily accomplished if further investigations acknowledge these promising findings. 
• Future improvement of this tissue replacement strategy may be the use of other cell types, 
cell culture techniques as part of the tissue engineering process as well as the combination of 
the implantation of the tissue engineered product with other pharmacological and surgical 
procedures.  
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bv   Blood Vessels 
CCD   Charge Coupled Device, a digital camera chip 
cLSM   confocal Laser Scanning Microscope 
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MACS   Magnetic Cell Sorting, Miltenyi Biotech 
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NGF-r   Nerve Growth Factor Receptor 
OEC   Olfactory Ensheathing Cell 
ONEC   Olfactory Nerve Ensheathing Cell (Medium) 
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ONF   Olfactory Nerve Fibroblast 
P75   NGF-Receptor antibody 
ParaMAIX  Matricel orientated collagen type I matrix 
PBS   Phosphate Buffered Saline 
PFA   ParaFormAldehyde 
PLL   Poly-L-Lysine 
PNS   Peripheral Nervous System 
pnOEC  Post natal Olfactory Ensheathing Cell 
S   Sponge (or matrix) 
S100   Intracellular protein 
SC   Sponge + cells 
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SCI   Spinal Cord Injury 
SCOTTS GF  SCOTTS-Medium with Growth Factors 
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SD   Sprague Derwley 
SEM   Scanning Electron Microscope 
SEM   Statistical Error of the Mean 
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Persönliche Zusammenfassung: 
 
Die Verletzung des Rückenmarks stellt für den betroffenen Patienten sofort und unausweichlich das 
Eintreten von schwersten Veränderungen innerhalb seines bisherigen Lebens dar. Diese Art der 
Verletzung ist so dramatisch, und vor allem so vielfältig, dass bis zu dem heutigen Tage keine 
Aussicht auf Heilung vorhanden ist. Insbesondere in der Vielfalt der Verletzungsmöglichkeiten liegt 
die Schwierigkeit, eine Behandlungsstrategie zu entwerfen und zu entwickeln. Schon kleinste 
Drücke auf diesen Bereich des zentralen Nervensystems führen unausweichlich zum Absterben von 
den sehr sensiblen Zellen und einer daraus resultierenden Vernarbung. Auch ist die Durchtrennung 
des Rückenmarks, wie weitläufig angenommen wird, zum Beispiel durch das „gebrochene Genick“, 
bei weitem nicht die häufigste Verletzungsart. Vielmehr treten Verletzungen durch Verlagerung der 
Bandscheiben, durch das Brechen von Wirbeln, das Perforieren von Gefäßen, durch Tumore oder 
sogar durch einfache biologische Erreger auf, welche zurzeit zwar hinsichtlich der Symptome 
eventuell behandelbar sind, aber praktisch nicht gänzlich heilbar sind.  
Hierin liegt auch die Schwierigkeit für die verschiedenen Forschungsgebiete, DIE eine 
Behandlungsstrategie zu entwerfen für den gelähmten Patienten, denn es gibt sie nicht. Jeder 
betroffene Patient ist individuell zu erachten, und so müssen auch die Behandlungsstrategien, 
welche zurzeit erforscht werden, als speziell und einzigartig erkannt werden. 
Meine Doktorarbeit hatte dabei den für den normalen Menschen am bildlichsten vorstellbaren 
Behandlungsweg als Schwerpunkt, nämlich die Überbrückung eines Defektes, so dass Nervenfasern 
wieder über eine Verletzung hinweg ihr ehemaliges Zielgebiet erreichen können.  
Hierzu wurde zunächst vom Helmholtz Institut in Aachen, später von der Firma Matricel ein 
Kollagenkonstrukt entwickelt, welches augenscheinlich eine ideale Brücke für die zumeist längs 
orientierten Nervenfasern im zentralen Rückenmark darstellen sollte. Hochaufgereinigtes Kollagen 
sollte biokompatible Eigenschaften haben, um vollständig vom Zielgewebe aufgenommen zu 
werden, ohne eine Abwehrreaktion hervorzurufen. Weiterhin war zu Beginn der Doktorarbeit im 
Jahr 2001 in der Wissenschaft ein regelrechter „Hype“ um spezielle Gliazellen des olfaktorischen 
Systems aufgekommen: OECs, den olfaktorischen Hüllzellen der Nase. Es wird angenommen, dass 
diese Zellen in der Lage sind, die Grenze des peripheren und des zentralen Nervensystems zu 
durchbrechen und regenerierende Axone in beiden Bereichen des Nervensystems zu begleiten und 
zu umhüllen. Dies machte sie zu dem idealen Kandidaten, um in Verbindung mit dem 
Kollagenkonstrukt eine tissue-engineerte Überbrückung im verletzten Rückenmark aufzubauen. 
Aus diesem Grund wurde im ersten Abschnitt der Doktorarbeit die Zellkultur der OECs entwickelt. 
Diese werden aus dem olfaktorischen Bulbus von Versuchstieren gewonnen, kultiviert und 
aufgereinigt. Insbesondere der Schritt der Aufreinigung der Zellen stellte eine erste große Hürde der 
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Doktorarbeit dar. Die Primärkultur der Zellen enthält eine Reihe verschiedener Zelltypen, u.a. 
Endothelzellen, Astrozyten, OECs und fibroblastenähnliche Zellen. Insbesondere die Expression 
des Rezeptors für den Wachstumsfaktor NGF (p75) unterscheidet die OECs von den anderen 
Zelltypen. Verschiedene Ansätze aus der Fachliteratur zur Anreicherung dieser Zellen konnten nicht 
erfolgreich umgesetzt werden oder waren schlicht unpraktikabel. Speziell zu späteren Zeitpunkten 
der Doktorarbeit kamen von der Firma Matricel vermehrt Impulse, ein medizinisch umsetzbares 
Konstrukt zu entwickeln, so dass zum Beispiel der Einsatz von Rinderhypophysenextrakt zum 
Kulturmedium als nicht umsetzbar erschien. Erst durch den Einsatz der magnetischen 
Zellseparation nach p75 und dem Einsatz eines sehr speziellen Wachstumsmediums konnte nach 
einem Jahr die Zellkultur reproduktiv etabliert werden. Parallel zur Etablierung der OEC-Kultur 
wurden die Kollagenschwämme entwickelt, so dass zeitweise bis zu 8 verschiedene Materialien mit 
den OEC und anderen Zelltypen im zweiten Schritt der Doktorarbeit ausgetestet wurden. Besonders 
die Astrozyten stellten als Modellzellen des zentralen Nervensystems ein mögliches Kriterium für 
ein in vitro-Verträglichkeitsmodell dar; wuchsen diese Zellen nicht auf den Kollagenträgern, so 
hätte angenommen werden können, dass dieser Kollagenträger auch nicht von den Astrozyten im 
Rückenmark des lebendigen Tieres angenommen würde. 
Schließlich wurden aus den zahlreichen Erfahrungen der Vorversuche nur noch 3 Qualitäten von 
Kollagenträger geliefert (SPGX 01-03). Ziel war es, hieraus möglichst frühzeitig den idealen 
Kollagenschwamm zu isolieren, welcher für die späteren Lebendversuche verwendet werden 
konnte. Aus zeitlichen und rein logistischen Gründen konnten hier nur wenige Tests durchgeführt 
werden, jedoch schied eine Qualität relativ früh durch Instabilität vor und nach der Kultivierung mit 
Zellen aus. Auch konnten Erfahrungen zur Besiedlung dieses bis dato einzigartigen 
Kollagenkonstruktes gesammelt werden. So wurde eine maximale Zellzahl erkannt, über die hinaus 
die Zellen nach Besiedlung eine „ungesunde“ Morphologie aufwiesen. Leider gab es in der 
Literatur zu diesem Zeitpunkt keinerlei Ansatzpunkte und Entscheidungskriterien für die 
zytokompatible Beurteilung eines porösen Konstruktes, so dass eigene Kriterien entworfen werden 
mussten. Auch war die Umsetzung von etablierten Zellkulturtechniken zur Charakterisierung des 
Zellwachstums, zum Beispiel durch so genannte BrdU-tests, Life-Death-tests und 
Migrationsversuche in der 3D-Kultur im Kollagenschwamm aus verschiedenen Gründen nicht 
möglich, so dass auch hier neuartige Methoden entwickelt wurden.  
Schließlich gab es genügend Erfahrungswerte, um im dritten Schritt der Doktorarbeit die zwei 
verblieben Qualitäten des Kollagenkonstruktes im Tiermodell mit und ohne Besiedlung mit OEC zu 
untersuchen. Hierbei stellte sich nach 4 Wochen wiederholt heraus, dass der Einsatz der OEC 
tatsächlich, wie in der Literatur beschrieben, einen deutlich positiven Einfluss auf die axonale 
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Regeneration von Nerven im Rückenmark hat. Weiterhin konnte erkannt werden, dass eine weitere 
Qualität des Kollagenkonstruktes (SPGX 03) durch sehr starke Makrophagenreaktion innerhalb des 
Implantates als extrem negatives Ereignis aussortiert werden konnte. Nachdem weitere 
Tierversuche nur mit der verbliebenen Qualität des Konstruktes unternommen wurden, um die 
Eigenschaften des Implantates, hinsichtlich Verträglichkeit, Einsatz von OECs und 
Implantationstechnik, näher zu erkunden, wurden abschließend Langzeitversuche mit insgesamt 
vier Gruppen unternommen, um auch eine funktionale Regenerationskapazität der 
Behandlungsstrategie zu untersuchen. Hierbei sollte der Schwerpunkt der Doktorarbeit liegen, um 
zeigen zu können, dass der Einsatz des Kollagenträgers mit oder ohne OECs im Vergleich zur 
einfachen Läsion einen deutlich positiveren Einfluss auf die axonale und funktionale Regeneration 
hat. Dieses würde den momentanen klinischen Bedingungen nahe kommen, da Penetrationswunden 
des Rückenmarks beim Patienten zwar gereinigt und versorgt werden, die entstandenen Lücken 
jedoch (noch) nicht von Ersatzmaterial aufgefüllt werden.  
Hierbei zeigte sich, dass nach drei Monaten tatsächlich eine deutliche funktionale Verbesserung 
nach Implantation des Kollagenkonstruktes, im Vergleich zur einfachen Läsion, auftrat. 
Überraschenderweise war dieser Erfolg jedoch bei den nicht besiedelten Implantaten leicht besser 
als bei den mit OECs besiedelten Kollagenträgern. Dies steht entgegen der Tatsache, dass der 
Einsatz dieser Zellen mehr Axone im Implantat regenerieren lässt als im zellfreien Implantat, 
welches reichlich Raum für Diskussionen lässt, zumal nach 3 Monaten dort weniger Axone 
vorhanden sind als 4 Wochen nach Implantation. 
Meine Meinung dazu ist, dass der Einsatz des verwendeten Kollagenträgers auf jeden Fall eine sehr 
aussichtsreiche Methode zur Behandlung von Penetrationsverletzungen im Rückenmark darstellen 
kann im Vergleich zum alleinigen Reinigen und Verschließen der Wunde. Dass die OECs eine 
verstärkte axonale Regeneration hervorrufen, die vermutlich aber keinen direkten Einfluss auf die 
funktionale Regeneration hat, kann weitreichende Aussagen ermöglichen, u.a. dass diese 
regenerierenden Axone keinen direkten Einfluss auf die Wiedergewinnung der Funktion haben. 
Dies lässt Raum für Überlegungen, die Zelldosis zu untersuchen oder gar den verwendeten Zelltyp 
zu variieren. Vieles spricht für letzteres, da Zellen des olfaktorischen Bulbus nur sehr schwierig zu 
gewinnen sind und zudem eine aufwändige Aufbereitung benötigen. Auch ist eine weitere 
Optimierung des Kollagenträgers, wie es zurzeit bei der Firma Matricel unternommen wird, eine 
weitere Alternative. 
Als Fazit meiner Doktorarbeit muss ich sagen, dass die anfängliche Euphorie über die Ergebnisse 
einem optimistischen Realismus gewichen ist. Dies ist noch keine umsetzbare 
Behandlungsstrategie, aber ein guter Schritt in die richtige Richtung, welcher unbedingt weiter 
verfolgt werden sollte. 
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